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Mas oncogene was originally idenitified from a human epidermoid carcinoma by a 
tumorigenicity assay. The mas oncogene encodes a protein that consists of seven 
putative transmembrane segments, a characteristic structure of the G protein-coupled 
receptor family. In rodents, mas mRNA was detected in testis, kidney, heart, and in 
various brain regions. In may-deficient mice, an increase of anxiety and duration of 
long-term potentiation were detected. In contrast, in transgenic mice over-expressing 
mas in the retina cone cells, massive loss of cone cells was observed. 
Rearrangement of the 5'-upstream of mas has been detected in various tumors, 
including epidermoid carcinoma, ovarian carcinoma, and acute leukaemia. In order to 
evaluate whether over-expression of mas oncogene itself is sufficient to induce tumor 
formation, the mas oncogene was cloned into an expression vector containing the 
dihydrofolate reductase (DHFR) gene as a selection marker. After transfection of the 
recombinant vector into the DHFR deficienct CHO cells and stepwisely increasing the 
concentrations of the methotrexate (MTX) in culture medium to 80 |u.M, the mas 
transgene copy number and expression level were increased in the stably transfected 
CHO cells. The expression level of mas is directly proportional to the mas transgene 
copy number. It was demonstrated that the mas-stdihXy transfected CHO cells caused 
tumor formation in nude mice, but not in the wild type and vector-transfected CHO 
cells. Furthermore, the extent of tumor formation directly dose-dependently with level 
of mas gene expression. The over-expression of mas in the transfected CHO cells 
(4-80 |jM MTX treatment) induced tumor formation more potently than that of 
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transfected CHO cells with lower mas expression (without MIX treatment). 
Fluorescent differential display (FluoroDD) was used to investigate the alternation of 
gene expression profiles in the mas over-expressing CHO cells. The growth related 
gene (Gro) is up-regulated while the suppressor of K+ transport defect gene (Skd3) is 
down-regulated in mas over-expressing CHO cells. In addition, several novel clones 
have been identified in FluoroDD, clone SY 1，SY 3, and SY 13 were up-regulated 







































List of Abbreviation 
BCIP 5-Bromo-4-chloro-3-indolyl-phosphate, 4-toluidine salt 
(X-phosphate, 4-toluidine salt) 
CIP Calf intestinal alkaline phosphatase 
CHO Chinese Hamster Ovary Cell 
DEPC Diethyl Pyrocarbonate 
DHFR Dihydrofolate Reductase 
DIG Digoxigenin 
DIG-11-dUTP Digoxigenin-11 -2' -deoxy-uridine-5 'triphosphate 
FBS Fetal Bovine Serum 
FluoroDD Fluoresecent Differential Display 
HT Sodium Hypoxanthine and Thymidine 
IMDM Iscove's Modified Dulbecco's Medium 
MTX Methotrexate 
NBT Nitroblue Tetrazolium Chloride 
PBS Dulbecco's Phosphate-Buffered Saline 
PGR Polymerase Chain Reaction 
P/S Penicillin and Streptomycin 
RT-PCR Reverse Transcription Polymerase Chain Reaction 
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1.1 Isolation and activation oimas oncogene 
Mas oncogene was detected by a tumorigenicity assay in which NIH 3T3 cells were 
transfected with DNA from three different human neoplasms; an epidermoid 
carcinoma (Young et al.，1986), an ovarian carcinoma (van't Veer et al., 1988) and an 
acute leukaemia (Janssen et al.，1988). Mas oncogene was firstly discovered by Young 
and co-workers in 1986 by using a tumorigenicity assay in nude mice. Genomic DNA 
from a human epidermoid carcinoma was cotransfected NIH 3T3 cell with plasmid 
pKOneo which contained the selection marker for G418, and transfected cells were 
selected with neomycin analogue G418. After screening, transfected cells were 
injected into nude mice, one of six nude mice developed a "primary" tumor within 4 
weeks. Nude mice that injected with cells which were cotransfected with DNA 
isolated from this primary tumor and plasmid pKOneo developed "secondary" tumor 
within 2 weeks. After a third round of cotransfection and injection into nude mice, 
DNA was purified from the "tertiary" tumor, and a genomic library was constructed in 
a cosmid vector pHC97 (Figure 1.1). Four overlapping cosmid clones that contained 
human DNA were isolated by filter hybridization to total human DNA (Gusella et al., 
1980; Shih and Weihberg, 1982; Young et al., 1986). Characterization of these 
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Figure 1.1 The figure showed the process of isolation of mas oncogene by Young 
and co-workers (Young et al., 1986) 
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comsid clones by restriction mapping and Southern hybridization to total human DNA 
revealed that one of the cosmids，named as pMASl, contained a 22 kb stretch of 
human DNA flanked by mouse DNA on both sides. The pMAS 1 cosmid was tested by 
cotransfection and tumorigenicity assay to determine whether it has tumorigenic 
potential. Nude mice developed tumors within 2 weeks after injecting of cells that had 
been cotransfected with pMASl and pKOneo after selection for resistance to G418. 
The NIH 3T3 cells that were transformed with pMASl had displayed a weak 
focus-inducing activity. These foci formed by pMASl transfected NIH 3T3 cells were 
not characterized by an abnormal morphology of the constituent cells, but by an 
exceedingly high cell density (Young et al., 1986). 
Southern analysis of normal human DNA with DNA derived from the tertiary nude 
mice tumor indicated a difference in size and intensity ofEcoR I restriction fragments 
homologous to mas. Young and co-workers (1986) suggested that the mas gene was 
rearranged and activated in the transformants. They also suggested that the region of 
rearrangement was in the 5,-non coding region of mas oncogene, leaving the coding 
region of mas intact. Finally, they concluded that the rearrangement of the 5，-non 
coding region of mas during gene transfer was responsible for activation of mas 
transforming potential (Young et al., 1986). 
Similarly, an activated mas oncogene was found in four independent transfection 
experiments performed with one human ovarian carcinoma DNA (van't Veer et al., 
1988). They reported that in all cases mas sequences have recombined to the human 
alphoid DNA repeat. They also found that the alphoid DNA originated from 
centromere of chromosome three. In reconstruction experiments, alphoid DNA cloned 
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directly upstream of the mas coding sequences is capable of inducing transformation 
and tumourigenicity of NIH 3T3 cells. In the nude mice tumuorgenicity assay, only 
the mas sequences in conjunction with the alphoid DNA were found to be amplified in 
the tumor tissues. Van't Veer's and co-workers concluded that in the NIH 3T3 cells, 
presence of the alphoid repeat DNA in the mas construct promotes amplification, 
thereby increasing the tumourigenicity of cells (van't Veer et al., 1988). 
1,2 Amino acid sequence of may oncogene 
Cloning and sequence analysis showed that the amino acid sequence of mas is highly 
conserved among different species including mouse, rat and human. The mouse mas 
protein shares 97% and 91% amino acid homology with the rat and the human mas 
proteins respectively (Metzger et al., 1995). The rat and human mas gene are almost 
identical except in their amino- and carboxyl-terminal domain. The mouse and rat 
sequences code for a protein with 324 amino acid residues, whereas the human mas 
protein contains 325 amino acid residues. There is an addition of amino acid valine in 
the position 11 in the human mas protein (Figure 1.2) (Young et al., 1988). 
Rabin and co-workers (1987) shown that human mas gene was localized within a 
region on the long arm of chromosome 6 (Rabin et al., 1987; Trent et al, 1989). Other 
groups reported that mouse mas gene was mapped to chromosome 17 (Cebra-Thomas 
et al., 1992). It was found that the mouse mas gene contained a single continuous 
reading frame of 972 nucleotides that is not interrupted by an intron. This is a 
property shared by G-protein coupled receptors (Metzger et al., 1995). 
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Figure 1.2 Alignment of the amino acid sequences of the mouse (M-mas), rat 
(R-mas), and human (H-mas) protein. Dots indicated amino acids identical with 
the mouse mas sequence. The dashes at position 11 indicate the insertion of the 
amino acid valine in the human mas. The mouse mas protein shares 97% and 91% 
amino acid homology with rat and the human mas respectivity. The mouse and rat 
sequences code for a protein with 324 amino acid residues, whereas the human 
mas protein contains 325 amino acid residues (Metzger et al., 1995). 
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Hydrophobicity plot of the mas sequence by a method of Kyte and Doolittle (1982) 
reveals that mas protein has seven distinct hydrophobic regions, supporting that mas 
protein consists of seven putative transmembrane domains corresponding to the seven 
hydrophobic regions (Kyte and Doolittle, 1982). Each of the hydrophobic regions is 
separated by hydrophilic regions that contain a predicted “ -turn secondary structure 
(Chou and Fasman, 1978). Both the amino- and carboxyl-terminal ends of the mas 
protein are hydrophilic. This analysis strongly suggests that mas protein is an integral 
membrane protein with seven transmembrane domains (Figure 1.3). The mas protein 
does not contained an amino-terminal hydrophobic signal sequence characteristic of 
many membrane proteins (Wickner and Lodish, 1985). However, it was reported that 
some member proteins with multiple transmembrane domains lack amino-terminal 
signal sequence, such as bovine rhodopsin, the erythrocyte anion exchange protein, 
and the sodium channel protein. In the first two cases, the insertion of the proteins 
into the membrane is cotranslational and requires internal signal sequences (Braell 
and Lodish, 1982; Friedlander and Biobel, 1985). Since the mas protein does not 
contained an amino-terminal hydrophobic signal sequence, its integration in the 
membrane may also depend on the internal signal sequences, or alternatively, it may 
spontaneously become inserted into the membrane because of its hydrophobic nature 
(Biobel, 1980; Engelman and Steitz, 1981). 
The tripeptide consensus sequence Asn-X-Thr/Ser is a site for N-glycosylation in 
secreted and transmembrane proteins (Kornfeld et al., 1985), although not all of these 
sequences are glycosylated (Struck and Lennarz, 1980). There are four potential sites 
for the N-glycosylation in the predicted mas protein sequence at positions 5, 16, 21, 
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Figure 1.3 The hydrophobic domains of mas protein assuming an a -helical 
structure with 3.6 residue per turn. The predicted human mas protein contained 
325 amino acids and exhibited a seven putative transmembrane domain. The 
hydrophobic amino acids Leu, lie, Val, Phe, Ala and Met are showed in red color. 
There are four potential sites for N-glycosylation in the predicted protein sequence 
of mas at position 5, 16, 22 and 272 (black line labeled) (Young et al., 1986). 
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amino-terminal region, while the fourth site is in the seventh hydrophobic domain 
(Figure 1.3) (Young et al., 1986, Metzger et al.，1995). 
The mas protein shares a close structural similarity with a group of receptors for 
neurotransmitters and hormones that include the visual opsins, adrenergic receptor 
and substance K receptor. These receptors all share limited amino acid sequence 
homology, which suggested that they might have been derived from a common 
ancestral gene (Nathans et al., 1986). In addition to their structural similarity, these 
receptors have been shown to be linked to second-messenger pathways through the 
activation of a guanine nucleotide binding regulatory protein (G protein). Based on 
these similarities, the mas protein was suggested to be a receptor that activates a G 
protein (Young et al., 1988). 
1.3 Expression of mas oncogene 
By using the in situ hybridization and RNase protection assay, expression of mas 
mRNA is found in the testis, heart, kidney and brain. Moreover, expression of mas in 
brain is predominantly in the forebrain of mice and rat. (Bunnemann et al., 1990; 
Martin et al 1992; Martin et al., 1993; Metzger et al., 1995; Alenina et al., 2002). 
Martin and co-workers (1992) suggested that mas transcript was most abundant in 
hippocampal pyramidal neurons and dentate granule cells, but present at low level in 
the cortex and thalamus in adult rat. They also found that the mas mRNA was first 
expressed in the hippocampus and dentate at postnatal day 1 of rat, and the level of 
the mas mRNA remained abundant throughout the development. In contrast, the 
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expression oimas mRNAin cortex and thalamus decreased during ontogeny. The mas 
expression in cortex and thalamus is high in the postnatal stage but the expression 
decreases throughout development (Martin et al.，1992). In the postnatal brain, strong 
signal was found in forebrain and cerebellum. The level of mas mRNA remained high 
throughout development, while mas mRNA expression decreased during ontogeny in 
the cerebellum (Metzger et al., 1995). 
Mas gene expression was low in heart and kidney in the young rats, but it was hardly 
detectable in adult rats. Mas gene expression seemed to be primarily expressed in 
brain, and localized exclusively to neuronal cells. In addition, its expression appeared 
to be absent from most of the peripheral organs (Bunnemann et al., 1990; Metzger et 
al, 1995). However, in 1994, Kitaoka and co-workers found that mas expressed in the 
rhesus macaque retina by in situ hybridization. They also suggested that high signal 
was found in the retinal pigment epithelial cells (Kitaoka et al., 1994). Then, other 
reports suggested the expression of mas gene in rat cerebral microvessel endothelial 
cells (Kumar et al., 1996). In 1997, there was a report suggesting mas expression in 
human breast tissue (Miller et al., 1997). 
A developmental regulation of mas gene expression was also found in testis. As 
evidence by the RNase protection assay, mas transcript was low in rat testis after birth, 
but increased at 5 weeks and reaching the highest expression level at 15 weeks of age. 
The mas gene expression in the testis then remained stable (Metzger et al., 1995). 
Recently, by using RNase protection assay, it has been shown in 12-day-old mice that 
mas gene expression was not detectable in testis as well as cultured Sertoli and Leydig 
cells. However, mas gene expression is detected in 18-day-old mice and the 
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expression level increase continuously until 6 months of age. By using in situ 
hybridization, the mas gene expression is localized to Leydig cells and Sertoli cells, 
and the mas mRNA signal is found to be much more in the Leydig cells. A weak 
signal is detected in primary spermatocytes (Alenina et al 2002). 
1.4 Possible physiological role of mas oncogene 
The mas oncogene shares a high homology to the neurokinin A (NKA) receptor which 
has been shown to be linked to second-messenger pathways through the activation of 
guanine nucleotide-binding regulatory proteins (Jackson et al., 1988). Since it was 
predicted that mas would encode a peptide receptor with mitogenic activity, the 
functional ligands that bind to the receptor were investigated. In 1988, Jackson and 
co-workers suggested that the mas protein represents a G-protein-coupled receptor for 
angiotensins. Xenopus oocytes that were injected with the RNA transcripts derived 
from the cloned mas genes gave a novel sensitivity to angiotensin under 
voltage-clamp conditions. The mas-expressing oocytes exhibited a dose-dependent 
induction of an inward current in response to bath-applied angiotensin II and III. In 
agreement with the fact that mas is tumorigenic in nude mice, and displays 
transforming activity on NIH3T3 cells, angiotensin II and in were shown to initiate 
[^H] thymidine incorporation in Twa^-transfected neural cell line 403L-C3. In addition, 
the neural cells that were stably transfected with mas gene could be stimulated by 
angiotensin II and III in increasing the cellular level of inositol phosphates and 
mobilizing intracellular calcium ions (Poyner et al., 1990; Jackson et al., 1988). 
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However, the suggestion that mas protein is an angiotensin receptor has been 
challenged by other studies. The activation of an inward current by angiotensin in the 
mas-injected oocytes was not inhibited by the angiotensin antagonists [Sar^ , Val^ 
Ala^]-ANG II and [Sar ,^ Val^]-ANG H (Metzger et al., 1995). In 1991, Ambroz and 
co-workers showed that angiotensin could not induce any calcium ion mobilization in 
ma^-injected Xenopus oocytes (Ambroz et al.，1991). In addition, the major 
angiotensin II receptors, ATi and AT】，only exhibited 8% and 19% amino acid identity, 
respectively, to the mas protein. The tissue distributions of mas transcripts was 
significantly different to that of angiotensin receptors (Metzer et al., 1995). All of 
these evidences suggested that angiotensin II and III were not the functional ligands 
for mas. It was suggested that mas may enhance the expression or signaling sensitivity 
of endogenous angiotensin II receptors and their activation pathways (Ambroz et al., 
1991). 
Lines of evidence suggested that mas oncogene expression was developmentally 
regulated in the testis of rat and mouse. Mas mRNA level was low in testis in the 
postnatal animals, but mas mRNA level was increased in the adult animals. According 
to this finding, it was suggested that mas oncogene might play a role in the testis 
maturation and function (Metzger et al., 1995; Alenina et al., 2002). In addition, mas 
mRNA is restricted in the brain and found abundantly in the hippocampus and 
cerebellum (Martin et al., 1992; Metzger et al., 1995). In other peripheral organs, the 
mas mRNA was hard to detect no matter by using the RNase protection assay or the in 
situ hybridization (Bunnemann et al., 1990; Martin et al, 1993). This extremely 
restricted pattern of expression suggests that mas oncogene might function in 
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determining the morphology and connections of specific cell types in the 
hippocampus (Martin et al., 1992). 
In contrast to previous discussion, studies of the mas knockout mice raised another 
point of view. Targeted disruption of the mas oncogene resulted in increasing 
durability of long-term potentiation and anxiety in the hippocampus. The mas 
knockout mice exhibited normal hippocampal morphology, basal synaptic 
transmission, and presynaptic function. Though there is high expression of mas in 
testis, mas deficient mice are fertile. In male, the number and motility of 
spermatocytes as well as testis morphology was unchanged. Mas oncogene seemed to 
modulate the function of receptors in brain thereby influencing synaptic plasticity and 
behavior (Walther et al, 1998). This study also revealed mas influences the anxiety 
behavior in a sex-specific manner. Walther and co-workers (2000) suggested that 
knockout of mas did not exert an effect on spatial learning and anxiety in the female 
mice, but showing an increased anxiety and sustained long-term potentiation in the 
male mice (Walther et al., 2000). In addition, there is a decrease in heart rate 
variability in female knockout mice, while an increase in blood pressure variability is 
detected in males (Walther et al., 2000). Hence, it is suggested that expression of mas 
in testis and its influence on gonadal hormone production in males may be responsible 
for the differential effect of /way-deficiency on anxiety behavior of male and female 
mice (Walther et al., 2000). 
Targeted transfer of mas oncogene the cone photoreceptor cells by using the human 
red-green cone opsin promoter, Xu and co-workers (2000) suggested that mas 
oncogene expression in cones induced cell death without tumor formation. They 
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found that over-expression of mas oncogene leading to cone degeneration that was 
proportional to the level of transgene expression. Their finding suggested that aberrant 
oncogene expression might underline some forms of hereditary retinal degeneration 
(Al-Ubaidi et al., 1989; Peachey et al., 1995; Xu et al., 2000). 
Recently, a family consisting of approximately 50 G protein-coupled receptors 
(GPCRs) was found to be related to mas, called (mas-related genes) mrgs, a subset of 
which was found to be expressed in specific subpopulations of sensory neurons that 
detect painful stimuli. The expression patterns of mrgs revealed an unexpected degree 
of molecular diversity among nocieptive neurons. Since some of these receptors can > 
If 
t 
be specifically activated in heterologous cells by RFamide neuropeptides such as 
NPFF and NPAF, which are analgesic in vivo. It was suggested that mrgs may regulate 
nociceptor function and/or development, including the sensation or modulation of 
pain (Dong et al., 2001). 
1.5 Gene related to mas family 
Genes structurally related to mas have been identified. One of them was the 
Twos-related gene {mrg) and another one was the rat thoracic aorta (RTA) gene (Figure 
1.4). In 1991, Monnot and co-workers identified the wos-related gene in the human 
genome by screening with the mas probe. Cloning and sequence analysis suggested 
that mrg sequence contained an open reading frame of 1134 nucleotides and shared 46 
% nucleotide homology to the mas sequence. It was suggested that the open reading 
frame of mrg encods a protein of 378 amino acids (42,400 Daltons) that shares 35 % 
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Figure 1.4 Comparsion of the amino acid sequences of RTA, mrg, and mas. The 
best alignment was obtained by introducing gaps within the sequences (-). 
Amino acid identities between the mrg product and the two other proteins are 
indicated by the symbols (:). Putative membrane-spanning domains are indicated 
by broken lines (Monnot et al., 1991). 
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amino acid identity with mas protein over a 290-amino acid overlap (Monnot et al 
1991). Analysis by the method of Kyte and Doolittle of the hydropathy plot suggested 
that mrg protein is a seven-transmembrane domain protein similar to mas protein. 
Both of them had no signal peptide sequences (Kyte et al., 1982). In order to 
investigate whether the physiological activity of mrg related to mas, responsiveness of 
mrg product to angiotensin peptides were tested. However, Monnot and co-workers 
(1991) found that mrg mRNAwas not detected in several rat and human adult tissues 
that normally express the angiotensin II receptor, and transfections of COS and CHO 
cells with mrg gene did not modify the number of angiotensin II binding sites. These 
results indicated that mrg and angiotensin II receptor genes were not identical. 
However, injection of mrg mRNA into Xenopus oocytes apparently increased the 
electrophysiological response to angiotensin peptides, which indicated some 
functional similarities with the mas product (Monnot et al 1991). The murine mrg 
family of G protein-coupled receptors contains three major subfamilies {mrgA, B and 
C), each consisting of > 10 highly duplicated genes. A subset of these genes, including 
mrgAs and mrgD, is specifically expressed in Griffonia simplicifolia lectin IB4+ 
sensory neurons, a subpopulation that includes cutaneous nociceptors and which has 
been implicated in "neuropathic" (nerve injury-induced) pain (Malmberg et al., 1997). 
Their expression in these neurons suggested that they could be involved in pain 
sensation or its modulation. In heterologous cells, mrgAl and mrgA4 could be 
activated by the RFamide neuropeptides NPFF and NPAF, respectively, which 
produced long-lasting analgesic effects that were injected intraspinally. This finding, 
suggested that ligands of these receptors might include neuropeptides that modulate 
pain sensitivity (Dong et al., 2001). 
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In 1990，by using a 53-residue oligonucletoide encoding 18 amino acids of 
transmembrane segment of the Mi muscarinic receptor to screen a rat thoracic aorta 
cDNA library and a rat genomic library under low stringency conditions, Rose and 
co-workers (1991) identified a gene containing a single extended translation reading 
frame encoding a protein of 343 amino acids (38,325 Daltons) and named it as rat 
thoracic aorta (RTA) gene. Sequence analysis showed that the RTA protein is most 
closely related to the predicted mas encoded protein with 34 % identity in a 
295-amino acid overlap. The hydropathy analysis revealed that RTA protein contained 
seven highly hydrophobic regions and was predicted to be a seven transmembrane 
domain protein. The RTA protein also lacked an apparent hydrophobic amino-terminal ) 
signal peptide (Ross et al., 1990). The RTA mRNA was detected predominantly in 
smooth muscle, including the vas deferens, uterus, large and small intestines, stomach, 
and aorta. Low level of RTA mRNA was also detected in the liver and kidney. The 
only brain region that showed high levels of RTA mRNA is the cerebellum. The RTA 
was tested to determine whether it is an alternative form of the angiotensin receptor. 
Both the Xenopus oocytes injection and the COS cell transfection experiments with 
RTA did not give any response to angiotensin (Ross et al., 1990). 
1.6 Aims of study 
A rearrangement of the 5' non-coding region of mas has been linked to the activation 
of mas oncogene (Young et al., 1986; Janssen al., 1988). As there is no change in 
ma^-coding sequence, questions have been arisen whether the rearrangement of 5' 
non-coding region was essential for Twa -^induced tumorgenesis due to activation or 
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activation of some key genes involved in regulation of cell growth (Young et al., 1986; 
Jahannes et al., 1988), or the over-expression of mas gene was enough to cause the 
tumorgenesis. 
The aims of our project were to investigate whether over-expression of mas gene itself 
is enough to induce tumor formation, efforts were also made to characterize the 
molecular mechanism involved in /way-inducing tumor formation. In the first part of 
our study, we constructed a stable mas over-expressing cell line by cloning the 
full-length coding sequence of mas gene into a mammalian expression vector pFRSV 
that contained a dihydrofolate reductase (DHFR) gene as the selection marker. The 
constructed recombinant DNA was transfected into a dihydrofolate reductase deficient 
CHO cells. By treating the transfected CHO cells with stepwisely increasing 
concentrations of methotroxate (MTX)，a potent DHFR inhibitor, supplemented in 
culture medium, the transfected mas and DHFR genes were co-amplified. The 
increased gene copy number of mas and over-expression of mas oncogene were 
confirmed by Southern blot and Northern blot analysis. 
In the second part of the project, the mas over-expressed CHO cells were injected into 
nude mice to test for their tumorgenicity. The resulting tumor tissues were studied for 
mas gene expression by using Northern blot analysis. 
In the third part，fluorescent differential display was used to study whether there were 
any alternations in gene expression profiles in mas over-expressing CHO cells, which 
might mediate the mas-induced tumorgenic transformation. 
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Chapter 2 
Over-expression of mas oncogene 
2.1 Introduction 
Previous reports suggested that activation of mas oncogene by rearrangement of the 5' 
upstream non-coding region of mas had been detected in the transformed NIH 3T3 
cells transfected with genomic DNA from human epidermoid carcinoma. It was also 
proposed that mas oncogene was found to be activated in the tumor tissues DNA after 
the transformed NIH 3T3 cells were injected into nude mice (Young et al.，1986). In 
order to evaluate the possibility that over expression of mas oncogene itself caused 
tumor formation in nude mice, we have established a stable mas over-expressing cell 
line by transfecting of NIH 3T3 cell with a rat mas cDNA cloned into mammalian 
expression vector pOPRSV (pOPRSV/zwos^ ), and tested for its tumorigenicity in nude 
mice. The nude mice got tumor and died after injected with pOPRSV or 
pOPRSV/ma^-tranfected NIH 3T3 cells. It was suggested that the mammalian 
expression vector, pOPRSV, contained Rous sarcoma virus (RSV) promoter which 
was a strong promoter leading to the over-expression of the gene in the site of 
integration and causing to tumor formation. Hence, we applied another strategy by 
using an mammalian expression vector, pFRSV, which contained SV 40 promoter as 
well as dihydrofloate reductase gene as selection marker. 
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To establish mas over-expressing cell lines, the recombinant DNA was then 
introduced into a dihydrofolate reductase deficient Chinese hamster ovary cell 
(DHFR-deficient CHO). After the mas stably transfected cell line was established, the 
transfectant was treated with increasing concentration of methotrexate (MTX). 
Methotrexate is a folic acid analog, which binds to and inhibits DHFR, leading to cell 
death. Transfected cells were growth in sequentially increasing concentrations of 
MTX for selection, the surviving population contained increased copy number of 
DHFR gene, and expressed several thousand fold elevated levels of DHFR mRNA. 
Since the mas gene was co-transfected with DHFR gene into the CHO cells, by 
increasing concentration of methotrexate in the culture medium, the dihydrofolate 




After the mas over-expressed cell lines were established, it was important to confirm | 
i 
that the mas gene copy number was amplified in the transfectants by Southern blot 
analysis. When the blots were hybridized with DIG-labeled mas cDNA probes, the i: 
relatively gene copy number of mas gene in different concentrations of MTX treated 
Twa^-transfected CHO cells were calculated by comparing the band intensity of 
transgene with endogenous mas gene. Afterward, the mas transcriptional levels in the 
mas transfectants were studied by using Northern blot analysis. 




Phenol: chloroform: Isoamyl Alcohol (25:24:1), TRIZOL® Reagent, DNAZOL® Reagent, 
all DNA primers, dNTP, 1 kb DNA marker, 100 bp marker, supercoiled DNA marker 
and agarose (electrophoresis grade), Iscove's Modified Dulbecco's Medium (IMDM), 
fetal bovine serum (FBS), Dulbecco's Phosphate-Buffered Saline (PBS), fetal bovine 
serum Dialyzed (FBS Dialyzed), penicillin and streptomycin, trypsin-EDTA, 
HT-supplement were obtained from Invitrogen Corporation. DIG Easy Hybridization 
solution, Blocking Reagent, Nitroblue Tetrazolium Chloride (NET), 
5-Bromo-4-chloro-3-indolyl-phosphate, 4-toluidine salt (X-phosphate, 4-toluidine salt) 
(BCIP), Digoxigenin-11 -2，-deoxy-uridine-5 'triphosphate (DIG-11 -dUTP), 
Anti-digoxigenin-AP (Fab fragments), and DNA molecular weight marker III 
(digoxigenin-labeled, 0.12-21.2 kb) were purchased from Roche. Methotrexate (MIX) 
was obtained from Sigma. All other standard chemicals and reagents were from 
Sigma Chemicals. 
2.2.1.2 Enzyme 
AmpliTaq DNA Polymerase was obtained Perkin Elmer. Cloned Pfu DNA 
Polymerase was obtained from Stratagene, and calf intestinal alkaline phosphatase 
(CIP) were obtained from New England Biolabs (NEB). T4 DNA ligase was obtained 
from Invitrogen Corporation. Restriction enzymes including the EcoR I, Sea I, Pst I 
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and BamH I were obtained from New England Biolabs (NEB). 
2.2.1.3 DNA Purification Kit 
QIAprep® Spin Miniprep Kit and QIAquick® gel extraction kit were obtained from 
QIAGEN 
i 




The gel digitizing software Un-Scant-It gel was purchased from Silk Scientific Inc. i 
2.2.2 Methods 
2.2.2.1 Strategy of construct preparation 
In order to obtain establish mas over-expressing cell lines, full-length coding 
sequence of mas gene was cloned into an expression vector pFRSV. The expression 
vector pFRSV contains a mutated dihydrofolate reductase (DHFR) gene as the 
selection marker as well as the driving force for the amplification of the cloned mas 
gene. The pFRSV contained only a unique EcoR I cloning site, in order to ligate the 
full-length mas cDNA into the pFRSV vector, the full-length mas cDNA was 
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genetically joined with an EcoR I cutting site on both 5' and 3，end by polymerase 
chain reaction (PGR) method. 
A cDNA of rat mas consists of entire coding sequence in a mammalian expression 
vector, pOPRSVI/MCS (Strategene) was used as template for PGR reaction. The 
EcoR I fragment of full-length mas cDNA (990 bp) was generated by using PGR with 
forward primer (5，CCG GAA TTC ATG GAC CAA TCA AAT ATG AC 3，) and 
backward primer (5，CCG GAA TTC TCC TCA GAC CAC AGT CTC A3，) that 
contained an EcoR I restriction site at their 5' end. After mas cDNA was cloned into 
mammalian expression vector, pFRSV, orientation of the mas DNA was analyzed by 
restriction mapping. The construction of the pFRSV/zwa^ plasmid was shown in 
Figure 2.1. 
2.2.2.2 Preparation of linearized vector, pFRSV 
2.2.2.2.1 Cloning of vectors 
pFRSV plamsid DNA (1 ng) was transformed into 100 of DH5-a competent cells 
by incubating on ice for 30 minutes and then heat-shock at 42 °C for exactly 1.5 
minutes. The heat-shocked competent cells were chilled into ice immediately for 2 
minutes. After incubation on ice, Luria-Bartani (LB) medium (400 jil) was added to 
the heat-shocked competent cells. The mixture was then shaken at 200 rpm at 37°C 
for 60 minutes. The transformed cells were spread onto 90 mm LB agar plates 
containing 100 |ig/ml of ampicillin. The plates were then incubated at 37°C overnight. 
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3' EcoR I restriction sites 
Rmas 990 bp ，r 
5’ EcoR I restriction sites **_'�,,,•„_ 
_ j ‘ 1 EcoR I cloning site 
SV 40 early prolxjmter ^ ^ 
ampf 驚 
• pFRSV I 
• 6800 bp 層 
V ‘ 
^ ^ mutant 
^ ^ ^ DHFR 
Figure 2.1 The construction of pFRSV/wa5 expression vector. The EcoR I 
fragment of full length Rmas (990 bp) was ligated into the mammalian 
expression vector pFRSV (6800 bp) in the EcoR I cloning site. The Rmas 
fragment was cloned into the cloning site just behind the SV 40 early promoter. 
The expression vector pFRSV contained the ampicillin resistance gene and 
dihydrofolate reductase (DHFR) gene as selection marker as well as the 
driving force for the amplification of mas gene. 
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Colonies were picked and each grown in 2 ml of LB containing 100 [ig/m\ ampicillin 
in a 15-ml snap cap tube. After overnight incubation at 37 °C with shaking at 250 rpm, 
the bacterial cells were collected and purified by QIAprep® spin miniprep kit 
(QIAGEN). 
2.2.2.2.2 Restriction enzyme digestion and DNA dephosphorylation 
In order to prepare the vector for cloning, the vectors were firstly linearized by EcoR I 
digestion. The reaction mixture contained 5 |ag of DNA vector, IX EcoR I NEBuffer 
(50 mM NaCl, 100 mM Tris-HCl, 10 mM MgCl】，0.025% Triton X-100, pH 7.5), 20 
[ 
U EcoR I (20 U/[xl), and sterile water in a final volume of 50 [il The mixture was 
incubated at 37 °C overnight. The reaction mixture was then incubated at 65 °C for 20 
1 
minutes to heat-inactivate the restriction enzyme. Then the linearized vectors were i 
. I 
treated with calf intestine alkaline phosphatase (CIP) to avoid self-ligation. CIP (1 [ 
unit/pmol DNA ends) was added into the reaction mixture containing IX EcoR I 
•I, 
NEBuffer. The mixtures were incubated at 37°C for 60 minutes. After 
dephosphorylation, the CIP was heat inactivated at 75°C for 10 minutes. 
2.2.2.2.3 DNA purification by agarose gel electro-elution 
The CIP treated linearized vectors were separated by using 1% agarose gel 
electrophoresis in the presence of 0.5 jig/ml ethidium bromide. The desired DNA 
fragment was visualized under UV light and cut out from the agarose gel. The gel 
fragments were put into a dialysis tube (M.W. cutoff 3500) and subjected to 
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electroelution for 10 minutes at 150 volt in order to elute the DNA out of the gel. At 
the end of electroelution, the direction of voltage was reversed for 30 seconds at 150 
voltages in order to make sure that DNA was not fixed onto the dialysis membrane. 
The sterile water containing the DNA elutes was transferred into a new 15-ml tube 
and mixed with equal volume of phenol. After vortex, the mixture was centrifuged at 
1000 g for 10 minutes at 25 °C. The upper aqueous layer was collected and mixed 
with equal volume of 2-butanol in order to reduce the volume. The mixture was 
vortex and centriftiged at 1600 g for 2 minutes. The upper 2-butanol layer was 
removed and appropriate volume of fresh 2-butanol was further added to reduce the 
water until 200 i^l of aqueous layer was left. Equal volume of choloform was added to 
remove the trace amount of protein. After vortex and centrifugation at 20000 g for 2 
minutes, the upper aqueous layer was then mixed with equal volume of phenol: 
choloform: isoamyl alcohol (25:24:1). After vortex and centrifugation at 20000 g for 2 | 
I 
minutes, the upper aqueous layer was mixed with 0.1 volume of 3 M sodium acetate ； 
(pH 5.3), 2.5 volumes of absolute ethanol and precipitating the DNA by putting the 
mixture at -20 °C overnight. The DNA precipitation was washed with 75% ethanol ； 
and resuspended into sterile water. The DNA was stored at -20 °C until use. 
2.2.2.3 Preparation of pFRSV/mas construct 
2.2.2.3.1 PCR amplification 
A rat mas full-length cDNA was cloned into a mammalian expression vector 
pOPRSVI (Strategene) as follows: EcoR l-mas fragment was generated by PCR with 
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pOPRSVI/woy as template. Briefly, a pair of forward and backward primers 
containing an EcoR I restriction site at the 5，ends was used to amplify the mas 
fragment (about Ikb). The PGR mixture contained 10 ng of the vector, pOPRSVl/ma^, 
as the template; 2.5 i^l of lOX cloned Pfu reaction buffer [200 mM Tris-HCl (pH8.8), 
100 mM KCl, 100 mM (NH4)2S04, 20 mM MgSO, 1% Triton® X-100, 1 mg/ml 
nuclease-free bovine serum albumin (BSA)]; 1 [l\ of 25 mM MgCl2； 5 of 1 mM 
dNTP mix; 1 i^l each of 10 ^M forward primer (5，CCG GAATTC ATG GAC CAA 
TCA AAT ATG AC 3，）and 10 [M backward primer (5，CCG GAATTC TCC TCA 
GAC CAC AGT CTC A3') in a final volume of 25 [il The mixtures were denatured 
i 
at 94 °C for 2 minutes and 1 [d of cloned Pfu DNA Polymerase (2.5 U/|il) was added 
to each tube. The PCR reactions were carried out at a denaturation temperature at 94 
� C for 30 seconds, an annealing temperature at 60 °C for 30 seconds, and an extension 
temperature at 72 °C for 90 seconds for 30 cycles. After a prolonged icubation at 72 j 
I 
for 5 minutes, the PCR products were separated by 1% agarose gel in presence of ! 
i 
0.5 |ig/ml ethidium bromide. The PCR products was extracted and purified by using 
the QIAquick® gel extraction kit (QIAGEN). 丨 
2.2.2.3.2 Restriction enzyme digestion 
A reaction mixture contained 10 [ig of PCR cDNA fragments, IX EcoR I NEBuffer 
(50 mM NaCl, 100 mM Tris-HCl, 10 mM MgCls, 0.025% Triton X-100, pH 7.5), 1 
of EcoR I (20 U/|j1), and sterile water in a final volume of 100 [il. The mixture was 
incubated at 37°C overnight. The mixture was mixed with an equal volume of phenol: 
choloform: isoamyl alcohol (25:24:1). After vortex and centrifugation at 20000 g for 2 
minutes, the upper aqueous layer was mixed with 0.1-volume of 3 M sodium acetate 
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(pH 5.3), 2.5 volumes of absolute ethanol and precipitating the DNA by putting the 
mixture at -20 °C overnight. The DNA precipitation was washed with 75% ethanol 
and resuspended into sterile water. The EcoR I-cut mas cDNA fragments were stored 
at -20 °C until use. 
2.2.2.4 Ligation and analysis 
The reaction mixtures contained 16 fmol (80 ng) of EcoR I-linearized, CIP-treated 
pFRSV; 48 fmol (40 ng) of EcoR I-digested mas fragment; 2 jil of 5X T4 DNA ligase 
buffer [250 mM Tris-HCl (pH 7.6), 50 mM MgCk, 5 mM ATP, 5 mM DTT, 25% (w/v) 
j 
polyethylene glycol-8000]; and 1 of T4 DNA ligase (1 U/|il) in a final volume of 20 
|il. The reaction mixtures were incubated at 16°C for 16 hours and stored at -20 °C. | 
I 
Ligation product (2 |xl) was transformed into 200 [d of DH5-a competent cells by ！ 
incubation in ice for 30 minutes and then heat-shock at 42 °C for exactly 1.5 minutes. 
The heat-shocked competent cells were chilled into ice immediately for 2 minutes. 1^： 
After incubation in ice, 600 jil of Luria-Bartani (LB) medium was added into the 
heat-shocked competent cells. The mixture was then shaken at 200 rpm at 37 °C for 
60 minutes. The transformed cells were spread onto 90 mm LB agar plates containing 
100 |ig/ml of ampicillin. The plates were then incubated at 37 °C overnight. 
Colonies were picked and each grown in 2 ml of LB containing 100 |ig/ml ampicillin 
in a 15-ml snap cap tube. After overnight incubation at 37 °C with shaking at 250 rpm, 
the bacterial cells were collected and plasmid was purified by QIAprep® spin 
miniprep kit (QIAGEN). The orientation of mas cDNA in the pFRSV vectors were 
analyzed by restriction enzyme mapping. The reaction mixtures contained the purified 
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ligation vectors, IX Sea I NEBufFer (100 mM NaCl, 10 mM Tris-HCl, 10 mM MgCk， 
1 mM DTT, pH 7.4), 1 of Sea I (10 U/ i^l), and sterile water in a final volume of 50 
[lI The reaction mixtures were incubated at 37 °C for 16 hours. The digested DNA 
was analyzed in the 1% agarose gel with 0.5 |ig/ml ethidium bromide. 
2.2.2.5 Purification of DNA by cesium chloride 
2.2.2.5.1 Large-scale bacterial culturing 
i 
A bacterial stock containing the transformed pFRSV/zwos or pFRSV only were 
streaked onto a 90 mm agar plate containing 100 jig/ml ampicillin and incubated at 37 




of LB medium containing 100 jig/ml ampicillin in a 15-ml snap capped tubes. After ！ 
. I 
incubation at 37 °C for 4 � 8 hours with shaking at 250 rpm, the bacterial cultures were 
transferred to conical E-flasks with 20 ml of LB medium containing 100 [ig/ml 
ampicillin. After incubation at 37 °C for 16 hours with shaking at 250 rpm, the 
bacterial cultures of each sample were transferred to conical E-flasks with 200 ml of 
LB medium containing 100 |ig/ml ampicillin and incubated at 37 °C for 3 hours with 
shaking at 250 rpm. 
After incubation for 3 hours, the bacterial cultures were centrifuged at 2000 g at 4 °C 
for 20 minutes. The cell pellets were resuspended in 16 ml of solution I (50 mM 
sucrose, 25 mM Tris-HCl, pH 8.0 and 10 mM EDTA, pH 8.0) (8 % of the initial 
volume of cell culture) containing lyzozyme (4 mg/ml solution I), and incubated at 
room temperature for 5 minutes. After incubation, 32 ml of solution II (0.2 N NaOH 
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and 0.1 % SDS) (16 % of the initial volume of cell culture) was added and the 
mixtures were mixed by gently inversion. The mixtures were incubated at room 
temperature for 5 minutes. After 5 minutes incubation, 12 ml of solution III [3 M 
potassium acetate and 11.5 % (v/v) acetic acid] (12 % of the initial volume of cell 
culture), the mixtures were mixed several times by gentle inversion. The mixtures 
were incubated in ice for 5 minutes. The mixtures were then centrifuged at 15000 g 
for 10 minutes. The DNA in the supernatant was collected and purified by ethanol 
precipitation. 
2.2.2.5.2 Ethanol precipitation 
For DNA purification by ethanol precipitation, the DNA solution was mixed with 0.1 
volume of 3 M sodium acetate; pH 5.2, and 2.5 volumes of absolute ethanol. Then the 
mixtures were kept at -20 °C for 1 hour or longer. The mixture was centrifuged at 
15000 g for 10 minutes and the DNA pellets were washed with 70 % ethanol. After 
washing, the DNA was resuspended into sterile distilled water. 
2.2.2.5.3 Cesium chloride purification 
For the cesium chloride purification, 37 g of cesium chloride was firstly dissolved in 
approximately 30 ml of sterile nanopure water. The resuspended DNA was transferred 
to 15-ml falcon tubes, and 50 [il of SYBR@ green was added to the tubes. The 
mixtures were then transferred into 50-ml falcon tubes containing the dissolved 
cesium chloride solution. Sterile distilled water was added to make a final volume of 
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40 ml. The cesium chloride and DNA mixtures were then transferred to the Beckman 
TNI 
OptiSeal tubes filling up to near the base of the neck. The mixtures were 
centrifuged at 40,200 g at 20 °C for 20�24 hours in a near-vertical tube rotor (NVT65, 
Beckman). 
2.2.2.5.4 Removal of DNA dye by dialysis and ethanol precipitation 
After centrifugation, the lower closed circular plasmid DNA band was removed from 
the centrifuge tube by a syringe and transferred to new 15-ml tubes. In order to 
efficiently remove SYBR@ green, the DNA plasmid was purified by ethanol 
precipitation and the pellets were resuspended in 5 ml of sterile distilled water. 
In order to eliminate the cesium chloride in the mixtures, the resuspended DNA was 
dialyzed against 4 L of dialysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl and 
10 mM EDTA, pH 8.0) at room temperature for 24 hours with dialysis membrane that 
gave a molecular-weight-cut-off (MWCO) of 3500. The dialysis buffer was changed 
twice during dialysis. 
After dialysis, the plasmid DNA mixtures were purified by ethanol precipitation and 
the pellets were washed twice with 75% ethanol. After centrifliging at 15,000 g at 4°C 
for 10 minutes, the DNA pellets were resuspended in 200�3 00 i^l of 10 mM Tris-HCl, 
pH 8.0. 
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2.2.2.6 Transfection by electroporation 
Chinese hamster ovary cells (CHO) with dihydrofolate reductase (DHFR) deficiency 
were grown on 100-mm tissues culture dishes with IMDM medium supplemented 
with 10% (v/v) fetal bovine serum (FBS); 1% (v/v) penicillin/streptomycin; 1% (v/v) 
HT supplement (0.1 mM sodium hypoxanthine and 0.016 mM thymidine). Cells were 
kept in a 5 % CO2 incubator at 37 °C. One day before electroporation, the cells were 
seeded at a density of 1 x 10^  cells per 10 ml of the growing medium in 100-mm 
tissues culture dishes. Prior to electroporation, cells were washed with pre-warm PBS, 
pH 7.4 and then harvested by brief trypsinization. The cells were then washed twice 
with pre-warm IX cytomix (120 mM KCl; 0.15 mM CaCk； 10 mM K2HPO4/KH2PO4, 
pH 7.6; 25 mM HEPES, pH 7.6; 2 mM EGTA, pH 7.6; 5 mM MgCl�)，and pelleted at 
800 g. The cell pellets were resuspended at a density of 4-5 x 10^  cells/ml in IX 
cytomix. Cells (700 yd) were mixed with 100 (30 - 50 |ig) of the DNA into an 
electroporation cuvette (4 mm gap) and the mixture was kept in ice for 10 minutes. 
The electroporation cuvette containing the cells and DNA was then transferred into 
the electroporation chamber and the cells were pulsed at 250 - 360 voltage at 960 jiF 
capacitance for about 50 ms. Following electroporation, the transfected cells inside 
the cuvette were incubated on ice for 10 minutes. The electroporated cells of each 
sample were resuspended in 10 ml of IMDM medium supplemented with 10% (v/v) 
fetal bovine serum (FBS); 1% (v/v) penicllin/streptomycin; 1% (v/v) HT supplement 
(0.1 mM sodium hypoxanthine and 0.016 mM thymidine). The cells were then kept in 
100 mm tissue culture plate and placed in a 5 % CO2 incubator at 37 °C. 
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12.1.1 Screening for the stably transfected cells 
After 24 hours following electroporation, the culture medium was replaced with fresh 
IMDM medium supplemented with 10% (v/v) fetal bovine serum (FBS); 1% (v/v) 
penicillin/streptomycin; 1% (v/v) HT supplement (0.1 mM sodium hypoxanthine and 
0.016 mM thymidine) in order to discard the floating dead cells and cell debris. After 
growing for another 24 hours, the transfected cells were selected by switching the 
ordinary growing medium into selection medium [IMDM medium supplemented with 
10% (v/v) dialyzed fetal bovine serum (FBS); 1% (v/v) penicillin/streptomycin]. The 
selection medium was replenished 1 - 2 times a week to remove debris of dead cells 
and to permit resistant cells to grow. After 2 weeks screening with selection medium, 
resistant colonies were checked by holding the dish above one's head at an angle and 
looking for opaque patches. The colonies to be picked were circled by using a 
laboratory marker. For cell cloning, one end of a cloning cylinder was coated with 
sterile vacuum grease and placed around the colony to be picked. The colony inside 
the cloning cylinder was rinsed with pre-warm phosphate-buffered saline (PBS). 
Trypsin/EDTA solution (0.25% Trypsin, 1 mM EDTA-4Na) (200 jil) was added into 
the cloning cylinder and incubated for 3 minutes. Selection medium (200 jil) was 
added into the cloning cylinder, and the cell suspension was repeatedly pipetted up 
and down through a 100 |il pipette tip in order to disperse the trypsinized cells. 
Each single colony was grown in an individual well of a 24-well culture plate and 
kept in a 5 % CO2 incubator at 37 °C. The selection medium was replenished twice a 
week and cells were sub-cultured with 0.25% trypsin in phosphate-buffered saline 
every 4 days. At confluence, the cells were transferred to a 6-well culture plate. At 
confluence, the cells of each well were transferred to lOO-mm tissue culture dishes. 
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2.2.2.8 RT-PCR analysis of the mas transfectant 
To confirm the mas and DHFR genes have indeed been integrated into the cell 
genome in a functional form, total RNA of the Twa^-transfected DHFR" CHO cell was 
reversely transcribed into cDNA and then polymerase chain reaction (PCR) was used 
to amplify the target genes with specific primers. 
2.2.2.8.1 Isolation of the total R N A from the mas transfectants by TRIZOL ® 
Reagent 
The transfected DHFR" CHO cells were grown to confluence in the selection medium 
i 
[IMDM medium supplemented with 10% (v/v) dialyzed fetal bovine serum (FBS); 
i 
1% (v/v) penicillin/streptomycin] in 100-mm tissue culture dishes. The cells on the 
.j 
plate were lysed by adding 3 ml of TRIZOL® Reagent and passing the cell lysate 
several times through a 1000 [i\ pipette tip. The lysate was incubated at room 
temperature for 5 minutes and transferred into 1.5 ml centrifuge tube. Chloroform (0.2 
ml/ml of TRIZOL® Reagent) was added to the lysates. Tubes were shaken vigorously 
by hand for 15 seconds and then incubated at room temperature for 2 to 3 minutes. 
The samples were centrifuged at 12,000 g for 15 minutes at 4 °C. The aqueous phases 
containing the RNA were transferred to a fresh tube. Isopropyl alcohol (0.5 ml/ml of 
TRIZOL® Reagent) was added to precipitate the RNA. Samples were incubated at room 
temperature for 10 minutes and centrifuged at 12,000 g for 10 minutes at 4 °C. 
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The supernatant was discarded. The RNA pellet was washed once with 1 ml of 75% 
ethanol. The RNA was centrifuged at 7,500 g for 5 minutes at 4 At the end of the 
procedure, the RNA pellet was dried at room temperature for 5-10 minutes. It is 
important not to let the RNA pellet dry completely as this will greatly decrease its 
solubility. The RNA pellet was re-dissolved in DEPC-treated water. 
2.2.2.8.2 Reverse transcription of the total RNA into cDNA 
The reaction mixture contained 1 ng - 5 [ig of total RNA, 1 fxl of Oligo (dT) u-is 
primer (0.5 |ig/(j,l), 1 |il of 10 mM dNTP Mix, and sterile distilled water to make a 
final volume of 13 i^l. The mixture was heated at 65 for 5 minutes and quick 
chilled on ice. Four microliter of 5X First-Strand Buffer [250 mM Tris-HCl (pH 8.3 at i 
j 
room temperature), 375 mM KCl, 15 mM MgCy, and 2 of 0.1 M DTT were added j 
into the mixture to a final volume of 19 |il. The mixture was incubated at 42 °C for 2 
minutes. Then 1 [d (200 units) of SuperScript™ II RNase H' Reverse Transcriptase 
was added and mixed by pipetting gently up and down. The mixture was incubated at 
42 °C for 50 minutes and then heated at 70 °C for 15 minutes to inactivate the 
enzyme. 
2.2.2.8.3 Analysis of the transfected mas expression by PCR 
The mas expression in the transfectant was analyzed by polymerase chain reaction 
(PCR) method. The PCR reaction contained IX PCR buffer; 2 mM MgCk; 0.2 mM 
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dNTP and 0.2 pM forward and reverse primers each; 10% of RT product (2 fxl) and 5 
U of Taq NDA polymerase in a final volume of 50 (il. The PGR primers were 
designed based on the reported sequence of full-length mas sequence (Young et al., 
1988). The sequence of forward primer is 5'-CAT GGA CCA ATC AAA TAT GAC 
ATC CT-3' (from 29 to 55 of the mas cDNA) (GenBank accession no. 103823) and 
reverse primer is 5，-TCC TCA GAC CAC AGT CTC AAT GGA T-3, (from 984 to 
1008 complementary to mas cDNA). 
The reaction mixture was denaturated at 94 °C for 2 minutes and 1 [il of Taq DNA 
polymerase (5 U/(xl) was added�The PCR reaction was carried out at a denaturation 
temperature at 94 for 30 seconds, an annealing temperature at 62 for 30 
seconds and extension temperature at 72 °C for 90 seconds for 30 cycles. After a I 
i 
i 
prolonged incubation at 72 °C for 5 minutes, the PCR was analyzed in a 1% agarose 
j 
gel in the presence of 0.5 |ag/ml ethidium bromide. i 
i 
i 
2.2.2.8.4 Analysis of the transfected DHFR expression by PCR 
The DHFR expression in the transfectant was analyzed by PCR method. The PCR 
reaction contained IX PCR buffer; 2 mM MgCk； 0.2 mM dNTP; 0.2 |iM forward and 
reverse primers each; 10% of RT product (2 |il) and 5 U of Taq DNA polymerase in a 
final volume of 50 [il. The primers were designed based on the mouse mRNA 
sequence of the dihydrofolate reductase variant (GenBank accession no. X56066). 
The sequence of forward primer is 5'- CGG GAT CCC GTC GGA GGC AGT TCT 
GTT -3' (from 369 to 385 of the DHFR mRNA sequence) and the reverse primer is 
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5，- CGG ATT TCC OCT TCC TGT TAG TCT TTC TTC TC -3 ' (from 572 to 593 
with complementary to the DHFR mRNA sequence). 
The reaction mixture was denaturated at 94 °C for 2 minutes and 1 jil of Taq DNA 
polymerase (5 U/|il) was added. The PGR reaction was carried out for 30 cycles at a 
denaturation temperature at 94 for 30 seconds, an annealing temperature at 59 
for 30 seconds, and extension temperature at 7 2 � C for 1 minute. After an extended 
incubation at 72 for 5 minutes, the PCR was analyzed in a 1% agarose gel in the 
presence of 0.5 \ig/m\ ethidium bromide. 
2.2.2.8.5 Analysis of endogenous GAPDH expression by PCR 
The endogenous GAPDH expression was analyzed by PCR method. The PCR 
i 
reaction contained IX PCR buffer; 2 mM MgCl2； 0.2 mM dNTP; 0.2 joM forward and | 
reverse primers each; 10% of RT product (2 fxl) and 5 U of Taq polymerase in a final 
volume of 50 jil. The primers were designed based on the sequence of the hamster 
GAPDH mRNA (GenBank accession no. X52123). The sequence of forward primer is 
5，-CGG GAT CCC OCT CCC TCA AGA TTC TCA G-3' (from 493 to 510 of the 
GAPDH mRNA sequence) and the reverse primer is 5'-CGG AAT TCC GCA GGG 
TGG OCT TCT TAG T-3' (from 1071 to 1088 with complementary to the GAPDH 
mRNA sequence). 
The reaction mixture was denaturated at 94 °C for 2 minutes and 1 [il of Taq DNA 
polymerase (5 U/^1) was added. The PCR reaction was carried out for 30 cycles at a 
denaturation temperature at 94 °C for 30 seconds, an annealing temperature at 59 °C 
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for 30 seconds and extension temperature at 72 °C for 1 minute. After an extended 
incubation at 72 °C for 5 minutes, the PCR was analyzed in a 1% agarose gel in the 
presence of 0.5 |xg/ml ethidium bromide. 
2.2.2.9 Amplification of mas transgene by using methotrexate 
After confirming the integration of mas and dihydrofolate reductase (DHFR) gene 
into the DHFR-deficient CHO cell genome in a functional form, the mas expression 
was amplified by selecting the transfectants with stepwise increases in the 
concentration of methotrexate (MTX)，a potent inhibitor of DHFR. The concentration 
of the initial dose of the MTX was determined experimentally, which is dependent on 
the efficiency of DHFR expression from the transfected gene. Two different stable 
. . I 
cell lines were established: a low dosage treatment with an initial concentration of , 
f i 
0.02 [iM and a high dosage treatment with an initial concentration of 1 fiM MTX were ‘ 
used for amplification studies. 
2.2.2.9.1 Amplification by low dosage MTX treatment 
The transfected DHFR" CHO cells were grown to confluence in the selection medium 
[EVDDM medium supplemented with 10% (v/v) dialyzed fetal bovine serum (FBS); 
1% (v/v) penicillin/streptomycin]. Cells (2 x 10 )^ were seeded with selection medium 
containing 0.02 |aM methotrexate in a 100-mm tissue culture dish. The cells were 
subcultured at a ratio of 1:6 in selection medium containing 0.02 joM methotrexate 
during the first week. Then the cells were subcultured at a ratio of 1:10 in selection 
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medium with 0.02 [oM methotrexate in the second week of drug treatment. After the 
cells were grown in selection medium containing with 0.02 (oM methotrexate for two 
weeks, the cells were counted and 2 x 10^  cells were subcultured in a 100-mm tissues 
culture dishes in selection medium supplemented with 0.1 [M methotrexate. The cells 
were subcultured at a ratio of 1:6 in selection medium containing 0.1 joM 
methotrexate in the first week of drug treatment. Then the cells were subcultured at a 
ratio of 1:10 in selection medium containing 0.1 [M methotrexate in the second week 
of drug treatment. The cells reached confluency fairly readily after two weeks growth 
in selection medium containing 0.1 [\M methotrexate. The cells were counted and 2 x 
10^  cells were subcultured in a 100-mm tissues culture dishes in selection medium 
i 
I 
supplemented with 0.5 yM methotrexate. The cells were subcultured at a ratio of 1:6 I 
i 
in selective medium containing 0.5 [oM methotrexate in the first week of increasing i 
I 
concentration of MIX. The cells were then subcultured at a ratio of 1:10 in selection 
I 
medium containing with 0.5 \xM methotrexate in the second week and then at a ratio 丨 
i 
of 1:15 in the third week of 0.5 foM methotrexate treatment. The cells were counted 
5 'i and 2 X 10 cells were subcultured in a 100-mm tissues culture dishes in selection 丨 
medium supplemented with 2 |JM methotrexate. The cells were subcultured at a ratio 
of 1:6 in selection medium containing with 2 joM methotrexate in the first week of 
increasing concentration ofMTX. The cells were then subcultured at a ratio of 1:10 in 
selection medium containing with 2 (JM methotrexate in the second week and then at 
a ratio of 1:15 in the third week of 2 \jM methotrexate treatment. After the cells grew 
stably in the presence of 2 |JM methotrexate, the cells were subcultured at a ratio of 
1:6 into selection medium containing with 10 |iM methotrexate in the first week of 
increasing MIX treatment. The cells were then kept splitting at a ratio of 1:8, then 
1:10, then 1:15 in selection medium containing 10 |iM methotrexate. After the cells 
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grew stably in 10 |JM methotrexate, they were kept splitting at a ratio of 1:15 in 
selection medium supplemented with 10 joM methotrexate 2-3 times per week. 
2.2.2.9.2 Amplification by high dosage MTX treatment 
The mos-transfected DHFR" CHO cells were grown to confluence in the selection 
medium [IMDM medium supplemented with 10% (v/v) dialyzed fetal bovine serum 
(FBS); 1% (v/v) penicillin/streptomycin]. The cell number was determined and 2 x 
10^  cells were subcultured in a 100-mm tissues culture dishes in selection medium 
containing 1 [\M methotrexate. The cells were subcultured at a ratio of 1:6 in selection 
medium containing 1 |jM methotrexate in the first week of drug treatment. Then the i 
j 
cells were subcultured at a ratio of 1:10 in selection medium containing 1 |xM 
methotrexate in the second week of drug treatment. After the cells grew in selection I 
^ I 
medium containing 1 fjM methotrexate for two weeks, the cells were counted and 2 x 丨 
10)5 cells were subcultured in a 100-mm tissues culture dishes in selection medium i 
supplemented with 4 [M. methotrexate. The cells were subcultured at a ratio of 1:6 in 
selection medium containig 4 joM methotrexate in the first week of drug treatment. 
Then the cells were subcultured at a ratio of 1:10 and 1:15 in selection medium 
containing 4 joM methotrexate in the second and third week of drug treatment 
respectively. The cells were counted and 2 x 10^  cells were subcultured in a 100-mm 
tissues culture dishes in selection medium supplemented with 20 jiM methotrexate. 
The cells were subcultured at a ratio of 1:6 in selection medium containing 20 joM 
methotrexate in the first week of increasing MTX concentration. Then cells were 
subcultured at ratio of 1:8 in selection medium containing 20 jjM methotrexate in the 
second week and then subcultured at a ratio of 1:10 in the third week of 20 |iM 
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methotrexate treatment. Then cells were kept in splitting at a ratio of 1:15 in selection 
medium supplemented containing 20 \xM methotrexate 2-3 times per week. After the 
cells grew stably in 20 joM methotrexate treatment, the cells were subcultured at a 
ratio of 1:6 in selection medium containing 80 ^M methotrexate in the first week of 
increasing MTX treatment. The cells were then kept splitting at a ratio of 1:8, then 
1:10, then 1:15 in selection medium containing 80 [M methotrexate. After the cells 
grew stably in 80 |jM methotrexate, they were kept splitting 1:15 in selection medium 
supplemented with 80 |jM methotrexate 2-3 time per week. 




After the mas transfectants were treated with different concentrations of methotrexate 
j 
(MTX) for 4 months, it was important to confirm that the mas and DHFR gene copy j 
. 丨j 
number were increased. Southern blot analyses were used to investigate the mas gene I 
ii 
copy number in the transfectants, assuming that there is only two endogenous mas ; 
gene per diploid. The genomic DNA was firstly isolated from the MTX treated 
transfectants and digested with EcoR I. The resulting fragments were separated 
according to size by electrophoresis through a standard agarose gel. The DNA was 
then denatured in situ and transferred from the gel to a positively charged nylon 
membrane. The DNA attached to the membrane was hybridized to DIG-labeled DNA 
probes and genomic fragments that were complementary to the probe are located by 
NBT detection system. 
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2.2.2.10.1 Preparation of DIG-labelled mas probe 
The DIG-labelled mas probe was prepared by PGR method. The PGR reaction 
contained IX PGR buffer; 2 mM MgCk； 0.2 mM dNTP; 0.2 pM forward and reverse 
primers each; 20 ng of full-length mas cDNA template (1155 bp), and 5 U of Taq 
DNA polymerase in a final volume of 50 (il. Digoxigenin-11 -dUTP was added to 
thymidylate at a ratio of 4:1 (dTTP: DIG-dUTP). The sequence of forward primer is 
5,-CAT GGA CCA ATC AAA TAT GAC ATC CT-3, (from 29 to 55 of the rat mas 
cDNA) and reverse primer is 5'-TCC TCA GAC CAC AGT CTC AAT GGA T-3' 
(from 984to 1008 with complementary to mas cDNA). 
I 
The reaction mixture was denaturated at 94 °C for 2 minutes and 1 |il of Taq DNA I 
polymerase (5 U/JJI) was added. The PCR reaction was carried out for 30 cycles at a J 
I I 
denaturation temperature at 94 °C for 30 seconds, an annealing temperature at 6 2 � C \ 
. i 
for 30 seconds, and an extension temperature at 72 °C for 90 seconds. After an 丨 
extended incubation at 7 2 � C for 5 minutes, the PCR was analyzed in a 1% agarose ；: 
I 
gel in the presence of 0.5 (ig/ml ethidium bromide. The DIG-labelled mas probe was 
stored at -20 °C until use. 
2.2.2.10.2 Preparation of DIG-labelled DHFR probe 
The DIG-Labelled DHFR probe was prepared by PCR method. The PCR reaction 
contained IX PCR buffer; 2 mM MgCk; 0.2 mM dNTP; 0.2 jjM forward and reverse 
primers; 20 ng of DHFR cDNA template, and 5 U of Taq DNA polymerase in a final 
volume of 50 (il. Digoxigenin-11 -dUTP was added to thymidylate at a ratio of 4:1 
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(dTTP: DIG-dUTP). The DHFR cDNA was obtained by the reverse transcription of 
the total RNA prepared from the pFRSV/Rmas-transfected CHO cells. The sequence 
of forward primer is 5,-CGG GAT CCC GTG CCA TCA TGG TTC GAC-3' (from 
107 to 124 of the mouse DHFR mRNA sequence, GenBank accession no: X56066) 
and the reverse primer is 5,-CGG AAT TCC GCT TCC TGT TAG TCT TTC TTC 
TC-3, (from 572 to 593 with complementary to the mouse DHFR mRNA sequence). 
The reaction mixture was denaturated at 94 for 2 minutes and 1 |il of Taq DNA 
polymerase (5 U/|xl) was added. The PCR reaction was carried out for 30 cycles at a 
denaturation temperature of 94 °C for 30 seconds, an annealing temperature at 5 9 � C 
for 30 seconds, and an extension temperature at 7 2 � C for 1 minute. After an extended 
incubation at 72 °C for 5 minutes, the PCR was analyzed in a 1% agarose gel in the 
presence of 0.5 (ig/ml ethidium bromide. The DIG-labelled DHFR probe was stored at 
-20 °C until use. 
2.2.2.10.3 Preparation of DIG-labelled GAPDH probe 
The DIG-Labelled GAPDH probe was prepared by PCR method. The PCR reaction 
contained IX PCR buffer; 2 mM MgCk; 0.2 mM dNTP, 0.2 joM forward and reverse 
primers; 20 ng of GAPDH cDNA template, and 5 U of Taq DNA polymerase in a final 
volume of 50 |il. Digoxigenin-11 -dUTP was added to thymidylate at a ratio of 4:1 
(dTTP: DIG-dUTP). The GAPDH cDNA was obtained by the reverse transcription of 
the total RNA prepared from the pFRSV/zwa '^-transfected CHO cells. The sequence of 
forward primer is 5'-CGG GAT CCC GCT CCC TCA AGATTC TCAG-3，(from 493 
to 510 of hamster GAPDH mRNA sequence, GenBank accession no: X52123) and the 
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reverse primer is 5'-CGG AAT TCC GCA GGG TGG GCT TCT TAG T-3，(from 
1071 to 1088 with complementary to hamster GAPDH mRNA sequence). 
The reaction mixture was denaturated at 94 for 2 minutes and 1 [d of Taq DNA 
polymerase (5 U/(il) was added. The PCR reaction was carried out for 30 cycles at a 
denaturation temperature at 94 °C for 30 seconds, an annealing temperature at 5 9 � C 
for 30 seconds, and an extension temperature at 7 2 � C for 1 minute. After an extended 
temperature at 7 2 � C for 5 minutes, the PCR was analyzed in a 1% agarose gel in the 
presence of 0.5 [ig/m\ ethidium bromide. The DIG-labelled GAPDH probe was stored 
at -20 °C until use. 
2.2.2.10.4 Isolation of Genomic DNA from the mas transfectants by 
DNA,oi® Reagent 
The transfected DHFR. CHO cells were grown to confluence in the selection medium 
[IMDM medium supplemented with 10% (v/v) dialyzed fetal bovine serum (FBS); 
1% (v/v) penicillin/streptomycin] in 100-mm tissue culture dishes. The cells on the 
plate were lysed by adding 1 ml of DNAZOL® Reagent and the cell lysate was pipetted 
up and down several times in a 1-ml pipette tip. The lysate was incubated at room 
temperature for 5 minutes and transferred into 1.5 ml centrifuge tube. The lysate was 
centri&ged at 10,000 g for 10 minutes at ambient temperature. After centrifugation, 
the resulting viscous supernatant was transferred to a 1.5-ml centrifuge tube. Absolute 
ethanol (0.5 ml/ml of DNAZOL® Reagent) was added to the lysate to precipitate the 
DNA. The mixtures were mixed by inversion and stored at room temperature for 1-3 
53 
minutes. The DNA precipitate was collected by spooling with a pipette tip and 
transferred into a fresh 1.5-ml centrifuge tube. The tubes were placed upright for 1 
minutes and the remaining lysate were aspirated from the bottom of the tubes. 
The DNA precipitate was washed twice with 1 ml of 75% ethanol. The tubes were 
placed vertically for 1 minute to allow the DNA to settle to the bottom of the tubes 
and ethanol was removed by pipetting. The DNA pellets were allowed to dry in room 
temperature for 15 seconds. The DNA pellets were then dissolved in sterile distilled 
water. 
2.2.2.10.5 Enzymatic restriction of genomic DNA and Gel electrophoresis 
Genomic DNA (20 |ig) extracted from the cells was digested with 40 units of EcoR I 
at 3 7 � C for 16 hours. After confirming that the genomic DNA was completely 
digested by EcoR I by checking a small portion of the digestion mixture in a 0.8 % 
agarose gel, the digestion mixtures were purified with phenol: chloroform: isoamyl 
alcohol to eliminate the enzyme that remained. 
2.2.2.10.6 DNA transferring to positive charged Nylon membrane 
EcoR I-restricted genomic DNA (20 jig) and digoxigenin-labeled DNA molecular 
weight marker (50 ng) were loaded into a 0.7 % agarose gel in the presence of 0.5 
|ig/ml ethidium bromide. The DNA was electrophoresized with IX TBE buffer at 30 
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voltages for 16 hours. The gel was then rinsed with sterile distilled pure water and 
placed in a baked glass tray containing 0.25 M HCl. It was shaken slowly on a 
platform shaker for 30 minutes at room temperature. The gel was then rinsed with 
sterile distilled water and placed into the denaturation solution (0.5 M NaOH, 1.5 M 
NaCl) with shaking for 20 minutes for twice. The gel was rinsed with sterile distilled 
water and placed into the neutralization solution (0.5 M Tris/HCl pH 7.5, 1.5 M NaCl) 
with shaking for 20 minutes for twice and then rinsed with sterile distilled water. A 
positive charged Nylon membrane was cut to the same size as the gel and 3 MM 
Whatman paper were cut to the same size as the gel. Both the membrane and the 
Whatman paper were wet in the sterile distilled water for 10 minutes. An upward 
capillary transfer was assembled by placing a stack of gel blotting paper in the baked 
glass tray containing 20X SSC. The gel was inverted so that its underside was 
uppermost and the inverted gel was placed on the top of the wet gel blotting paper 
slowly. The gel was wetted with 20X SSC and the wet membrane was placed slowly 
on the top of the gel. A glass rod was used to smooth out all air bubbles by rolling on 
the top of the membrane slowly. Two wet Whatman paper were placed on the top of 
the membrane and a glass rod was rolled across the surface to smooth away air 
bubbles. Two dry Whatman paper were placed above and a stack of paper towels with 
the same size of the gel were placed on the top of the dry Whatman paper. A glass 
plate was placed above the paper stack and it was weighted down with an 1 kg-weight. 
The transfer was allowed to proceed for 16 hours. After the completion of transfer, the 
paper towels and the Whatman paper above the gel was removed. The gel and the 
membrane attached was turned over and laid in gel side up on a dry Whatman paper. 
The positions of the gel slots on the membrane were marked with a very soft lead 
pencil. The membrane was placed into 6X SSC for shaking 5 minutes at room 
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temperature. The membrane was removed for the solution and placed on the dry 
Whatman paper to dry for 1 hour at room temperature. The dry membrane was 
irradiated at 254 nm to cross-link the DNA to the membrane by exposing the dry 
membrane to a total energy of 0.12 J/cm^. 
2.2.2.10.7 Pre-hybridization and hybridization 
The membrane was gently rolled into shape of a cylinder and was put inside a 
hybridization roller bottle. It was wet with 2X SSC gently and replaced with 20 ml of 
prehybridization solution. The hybridization tube was put inside a prewarmed 
hybridization oven at 42 °C and it was rotated inside for 4 hours. After 
prehybridization, 0.2 jig of DIG-labeled probe was boiled at 100 °C for 10 minutes 
and then chilled in ice immediately for 5 minutes. The boiled DIG-labeled probe was 
then added into 20 ml of fresh prehybridization solution. The prehybridization 
solution was poured out from the hybridization tube and was replaced with the fresh 
hybridization solution containing the probe. It was incubated in the hybridization oven 
at 42 °C for 16 hours with gently rolling. 
2.2.2.10.8 Post-hybridization washing and blocking 
After the hybridization process was finished, the hybridization solution was poured 
out from the tube. The membrane was washed twice with 2X SSC/ 0.1% SDS for 10 
minutes at 37 °C inside the hybridization tube. Then the membrane was washed with 
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0.5X SSC/ 0.1 % SDS for 15 minutes at 65 twice inside the hybridization tube. 
After washing, the membrane was placed in a baked glass tray and washed with 
washing buffer (0.1 M maleic acid, 0.15 M NaCl; pH 7.5, 0.3 % tween 20) for 5 
minutes. The membrane was incubated with IX Blocking reagent (1 %, w/v in maleic 
acid buffer) with shaking for 45 minutes. After 45 minutes blocking, an 
Anti-Digoxigenin-AP, Fab fragments was added to the Blocking reagent at dilution of 
1:5000. It was incubated at room temperature with shaking for 1 hour. The Blocking 
solution was discarded and the membrane was washed with washing buffer (0.1 M 
maleic acid, 0.15 M NaCl; pH 7.5, 0.3 % tween 20) for 15 minutes at room 
temperature with shaking for twice. The membrane was equilibrated with detection 
buffer (0.1 M NaCl, 0.1 M Tris/HCl pH 9.5) for 5 minutes at room temperature. 
2.2.2.10.9 Detection 
The membrane was then transferred into a clean baked glass tray that was wrapped 
with tin foil. NET solution (0.1 M NaCl, 0.1 M Tris/HCl pH 9.5, 0.05 M MgCk, 0.5 
mg/ml NET, 0.19 mg/ml BCIP) was added slowly onto the membrane and the glass 
tray was covered with tin foil until the color was fully developed. 
2.2.2.11 Northern blot analysis 
Northern hybridization was used to measure the amount and size of RNA transcribed 
from the transfectants and to estimate their abundance. In order to study the 
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over-expression of the mas gene in the MTX-treated mas transfectants, RNA was 
isolated from the transfectants and put into electrophoresis through denaturing agarose 
gels. The separated RNA was then transferred into the positively charged nylon 
membrane and hybridized with the probes. The levels of the RNA abundance in 
different samples were then compared. 
2.2.2.11.1 Preparation of the agarose gel containing formaldehyde 
For preparation of 150 ml of 1% agarose gel containing 0,67% formaldehyde, 1.5 g of 
agarose was added into 100 ml of sterile distilled water. It was dissolved by boiling in 
a microwave oven. After the solution was cooled down to 60 15 ml of 1 OX MOPS 
electrophoresis buffer (200 mM 4-morpholinopropane-sulfonic acid, 50 mM sodium 
acetate, 10 mM EDTA, pH 7) and 2.7 ml of 37% (w/v) formaldehyde were added to 
the solution. Sterile distilled water was added to a final volume of 150 ml. The 
agarose gel was casted with slots inside the chemical hood. 
2.2.2.11.2 Preparation of the RNA sample 
RNA samples were adjusted to a concentration of 2 |ig/|il. RNA (10 jil) was mixed 
with IX MOPS, 5.6% formaldehyde, and DEPC-treated water to a final volume of 20 
|il. The mixed RNA samples were denatured by heating at 65 °C for 15 minutes. After 
denaturation, the RNA samples were quickly chilled in ice. Gel-loading dyes and 
0.5 |ig/ml ethidium bromide were added into the RNA samples to a final volume of 24 
58 
2.2.2.11.3 Gel electrophoresis and transferring 
The RNA samples were loaded into the wells of the gels and subjected to 
electrophoresis at 30 V for 16 hours with IX MOPS as the running buffer. After 
electrophoresis, gels were rinsed with the DEPC-treated water. Gels were then 
immersed into alkaline transfer buffer (3M NaCl, O.OIM NaOH) and shaken at room 
temperature for 20 minutes. 
A piece of positively charged nylon membrane was cut into same size as the gels and 
wet in sterile distilled water. The membrane was then immersed in lOX SSC for at 
least 5 minutes. 
An upward capillary transfer was set up by placing a stack of gel blotting paper in a 
baked glass tray containing alkaline transfer buffer (3M NaCl, O.OIM NaOH). The gel 
was inverted so that its underside was uppermost and the inverted gel was placed on 
the top of 3 MM Whatman paper slowly. The gel was wet with alkaline transfer buffer 
and a wet membrane was placed slowly on the top of the gel. A glass rod was used to 
smooth out all air bubbles by rolling on the top of the membrane slowly. Two wet 
Whatman paper were placed on the top of the membrane and a glass rod was rolled 
across the surface to smooth out air bubbles. Two dry Whatman paper were placed 
above and a stack of paper towels with the same size of the gel were placed on the top 
of the Whatman paper. A glass plate was placed above of the paper stack and it was 
weighted down with an 1 kg-weight. The transfer was allowed to proceed for 8-24 
hours. After the transfer was finished, the paper towels and the Whatman paper above 
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the gel were removed. The gel and the membrane attached was turned over and laid 
on a dry Whatman paper with nylon membrane facing up. The positions of the gel 
slots on the membrane were marked with a very soft lead pencil. The membrane was 
washed with 6X SSC for 5 minutes at room temperature with gentle shaking, then 
placed on the dry Whatman paper to dry for 1 hour at room temperature. The dry 
membrane was irradiated at 254 nm to cross-link the RNA to the membrane by 
exposing the dry membrane to a total energy of 0.12 J/cm^. 
2.2.2.11.5 Pre-hybridization and hybridization 
The dry membrane was put inside a hybridization roller bottle and rinsed with 2X 
SSC gently and replaced with 20 ml of prehybridization solution. The hybridization 
tube was put inside a prewarmed hybridization oven at 4 2 � C and it was rotated inside 
for 4 hours. After 4 hours prehybridization, 0.2 [ig of DIG-labeled probe was boiled at 
100 °C for 10 minutes and then chilled on ice for 5 minutes. The boiled DIG-labeled 
probe was added into 20 ml of fresh prehybridization solution. The prehybridization 
solution was poured out from the hybridization tube and was replaced with fresh 
hybridization solution containing the probe. The blot was then incubated in the 
hybridization over at 42 °C for 16 hours with gentle rotation. 
2.2.2.11.4 Post-hybridization washing and blocking 
After hybridization, the membrane was washed with 2X SSC/ 0.1% SDS for 10 
minutes at 37 °C twice inside the hybridization tube. Then the membrane was washed 
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with 0.5X SSC/ O.l % SDS for 15 minutes at 65 °C twice inside the hybridization 
tube. After washing, the membrane was placed in a baked glass tray and washed with 
washing buffer (0.1 M maleic acid, 0.15 M NaCl; pH 7.5, 0.3 % tween 20) for 5 
minutes. The membrane was incubated with IX Blocking reagent (1 %, w/v in maleic 
acid buffer) with shaking for 45 minutes. After blocking, an anti-digoxigenin-AP, (Fab 
fragments) was added to the Blocking reagent in a dilution of 1:5000. It was 
incubated at room temperature with shaking for 1 hour. The Blocking solution was 
discarded and the membrane was washed with washing buffer (0.1 M maleic acid, 
0.15 M NaCl; pH 7.5, 0.3 % tween 20) for 15 minutes at room temperature with 
shaking twice. The membrane was equilibrated with detection buffer (0.1 M NaCl, 0.1 
M Tris/HCl pH 9.5) for 5 minutes at room temperature. 
2.2.2.11.6 Detection 
The washed membrane was then transferred into a clean baked glass tray that was 
wrapped with tin foil. NET solution (0.1 M NaCl, 0.1 M Tris/HCl pH 9.5, 0.05 M 
MgCli, 0.5 mg/ml NET, 0.19 mg/ml BCIP) was added slowly onto the membrane and 
the glass tray was covered with tin foil until the color was fully developed. 
2.2.2.11.7 Stripping and rehybridization 
The membrane was put into the hybridization bag and N'-N'-dimethylformamide was 
added to wash off the color (NBT/BCIP). The hybridization bag was incubated at 65 
°C for 1 hour until the color was completely removed. After rinsing with sterile 
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distilled water, the membrane was then washed with 0.2 M NaOH, 0.1% (w/v) SDS at 
37 for 20 minutes twice under constant agitation. After washing, the membrane 
was equilibrated briefly in 2X SSC. The membrane can be prehybridized and 
incubated with second probe. 
2.3 Results 
2.3.1 RT-PCR analysis of gene expression in the stably transfectant 
According to the DNA sequences from GenBank and the positions of the specific 
primers, the expected molecular size of PCR products of mas gene, DHFR gene and 




Total RNA isolated from wild type DHFR-deficient CHO cells were used for RT-PCR ‘ 
reactions using the mas and DHFR primers, respectively. As illustrated in Figure 2.2, ( 
there was none of mas mRNA (Ikb length) and DHFR mRNA (225 bp) in the wild 
type CHO cells. On the other hand, it was found that mas and DHFR genes were 
expressed abundantly in the pFRSV//wa^-transfected DHFR-deficient CHO cells. 
Total RNA isolated from pFRSV-transfected DHFR-deficient CHO cells was used for 
RT-PCR with mas and DHFR primers only DHFR DNA (225 bp) was amplified in the 
PCR reaction. However, if GAPDH primers was used for RT-PCR, GAPDH amplicon 
(590 bp) was detected in all three samples indicating that the RT-PCR conditions were 
normalized among three samples. 
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Figure 2.2 RT-PCR analysis of gene expression. Total RNA were prepared from 
wild-type DHFR-deficient CHO cell (lane 3); pFRSV/wa^-transfected CHO cell 
(lane 4); pFRSV-transfected CHO cell (lane 5). RT-PCR reactions were 
performed separately with the respective primers. Mas DNA was found in the 
pFRSV/zwos-transfected CHO cell (lane 4); DHFR DNA were found in the 
pFRSV//wa^-transfected CHO cell (lane 4) and pFRSV-transfected CHO cell 
(lane 5). Lane 1 is 1-kb DNA size marker standard, lane 7 is 100-bp DNA size 
marker standard. The experiment is a representative of 3 separate experiments 
with similar results. 
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Based on the results obtained from the RT-PCR analysis, endogenous mas and 
dihydrofolate reducatase (DHFR) genes expression was not detectable in the wild 
type DHFR-deficient CHO cells. In contrast, the CHO cells transfected with the 
recombinant plasmid, pFRSV/zwoy, expressed the mas and DHFR transgenes, 
suggesting that the mas and DHFR transgenes have integrated into the cell genome. 
2.3.2 Morphology of the mas transfectant 
Wild-type DHFR-deficient CHO cell growing in HT supplemented IMDM medium 
gave a polygonal shape and grew as separate colonies (Figure 2.3 A). When the 
wild-type DHFR-deficient CHO cells grew in the selection medium without HT 
supplement, they exhibited a spread-out morphology and the cell density dropped 
dramatically (Figure 2.3 B). The cells became dead after one cell passage. In contrast, 
the pFRSV-transfected DHFR-deficient CHO cell (vector transfected) and 
pFRSV/zwoy-transfected DHFR-deficient CHO cell (mas transfected) grew in the 
selection medium properly (Figure 2.3 C and D). They displayed a flat, spread-out 
morphology indicating that the cells were under selection to screen out the 
untransfected cells. After subculture of several passages, the transfected cells became 
stable. The mas stably transfected CHO cells exhibited a spindle morphology, and 
cells grew in scatter pattern (Figure 2.3 D) while the vector stably transfected CHO 
cells exhibited a polygonal shape, and cells grew in cluster colonies similar to that of 
wild-type DHFR-deficient CHO cells (Figure 2.3 C). 
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Figure 2.3 Micrograph of cells. Morphology of wild-type DHFR-deficient CHO cells 
(A) in HT supplement medium which gave a polygonal shape and displayed as 
separated colonies; wild-type DHFR-deficient CHO cells (B) in selection medium 
which exhibited a spread-out morphology and the cell density dropped dramatically; 
pFRSV-transfected DHFR-deficient CHO cells (C, E) in selection medium containing 
80 jiM MTX which gave a polygonal shape and cluster colonies similar to that of 
wild-type DHFR-deficient CHO cells; pFRSV/wos-transfected DHFR-deficient CHO 
(D, F) cell in the selection medium containing 80 |iM MTX which exhibited a spindle 
morphology and grew in scatter pattern. Cells were viewed and photographed with a 
Zeiss phase contrast microscope at 20x and 32x magnification. 
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2.3.3 Determination of mas gene copy number by Southern blot 
analysis in the mas transfectants 
In order to analyses the mas gene copy number of mas transfectants that grew in 
different concentrations of methotrexate (MTX), genomic DNA of transfectants were 
prepared and hybridized with DIG-labeled 1 kb mas cDNA probe and the DIG-labeled 
578 bp DHFR cDNA probe. The size of DIG-labeled mas cDNA fragment (Figure 2.4; 
lane 2; 1.1 kb) was apparently higher than that of unlabeled mas cDNA fragment 
(Figure 2.4; lane 3; 1 kb). Similarly, the size of DIG-labeled DHFR cDNA fragment 
(Figure 2.5; lane 2; 700 bp) was apparently higher than that of unlabeled DHFR 
cDNA fragment (Figure 2.5; lane 3; 600 bp). The increased in size of the DIG-labeled 
cDNA was due to the incorporation of heavy DIG-dUTP into the cDNA in the PGR 
reactions. 
Before looking on the gene copy number of mas in transfectants, it was important to 
confirm whether DHFR genes have amplified in the MTX treated transfectants. As 
illustrated in Figure 2.6, there was no hybridization signal found in the EcoR 
I-digested genomic DNA from the wild type DHFR-deficient CHO cells (lane 1), 
which indicated that the wild type CHO cells lack of endogenous DHFR gene. For the 
EcoR I-digested genomic DNA samples of pFRSV-transfected CHO cells treated with 
80 |iM MTX, there were two signal bands that were detected at position of about 7.7 
kb (band A) and 5.1 kb (band B). For the EcoR I-digested genomic DNA samples of 
pFRSV/Tway-transfected CHO cells with different concentrations of MTX treatment, 
there were two signal bands that were detected at position of about 7.7 kb (band A) 
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Figure 2.4 Preparation ofDIG-labeled mas probe by PCR method. The mas 
cDNA fragment (lane 3), DIG-dUTP-labeled mas cDNA fragment (lane 2), 
1-kb DNA size marker standard (lane 1)，and 100-bp DNA size marker 
standard (lane 4) were showed. The size of the DIG-labeled mas cDNA 
fragment (lane 2; 1.1 kb) was apparently higher than that of unlabeled mas 
cDNAfragment (lane 3; 1 kb) 
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Figure 2.5 Preparation of DIG-labeled DHFR probe by PCR method. The 
DHFR cDNA ftagment, 578 kb (lane 3), DIG-dUTP-labeled DHFR cDNA 
fragment, 700 kb (lane2), and 100-bp DNA size marker standard (lane 1) was 
showed. The DIG-dUTP-labeled DHFR cDNA fragment was apparently higher 
than that of unlabeled DHFR cDNA fragment and changed from 578 kb to 700 
kb. 
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Figure 2.6 Southern blot analysis of DHFR gene in the stably-transfected CHO 
cell. EcoR I digested genomic DNA from wild-type DHFR-deficient CHO cell 
(lane 1)，pFRSV-stably transfected DHFR-deficient CHO cell treated with 80 
^M MTX (lane 2)，pFRSV/zwos-stably transfected cell without MTX treatment 
(lane 3)，with 0.5 \iM MTX treatment (lane 4)，with 4 }iM MTX treatment (lane 
5), with 10 ^M MTX treatment (lane 6)，with 80 i^M MTX treatment (lane 7). 
Un-digest genomic DNA from wild-type DHFR-deficient CHO cell (lane 8)， 
pFRSV/ffia^-stably transfected cell with 80 ^M MTX treatment (lane 9). DIG-
labeled DNA marker standard was shown on lane M. 
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and 4.2 kb (band C). Since the bands were obtained by hybridization with the 
DIG-labeled DHFR cDNA probe and appeared only in the genomic DNA of pFRSV 
and pFRSV/Vwoy-transfected CHO cells but not in the wild type DHFR-deficient CHO 
cells, it was suggested that the 7.7 kb (band A), 5.1 kb (band B) and 4.2 kb (band C) 
DNA fragments on the blot were corresponding to the DHFR transgene. It was found 
that the signal intensity of the 7.7 kb DNA fragment (band A) was stronger than that 
of 4.2 kb DNA fragment (band C) in the DNA samples of all mas transfectants. On the 
other hands, the signal intensity of the 7.7 kb DNA fragment (band A) and 5.1 kb 
DNA fragment (band B) was almost equal in the pFRSV transfectants. 
When comparing the signal intensity of the bands in mas transfectants treated with 
different concentrations of MTX treatment (Figure 2.6; lane 3-7), the signal intensity 
of the 7.7 kb DNA fragment (band A) and 4.2 kb DNA fragment (band C) shown an 
increasing trend with an order of: mas transfectants without MTX treatment (lane 3) < 
mas transfectants with 0.5 |jM MTX treatment (lane 4) < mas transfectants with 4 jjM 
MTX treatment (lane 5) < mas transfectants with 10 [M MTX treatment (lane 6) < 
mas transfectants with 80 |iM MTX treatment (lane 7). The mas transfectants treated 
with 80 (jM MTX gave the highest signal intensity among others. In addition, the 
band intensity of 7.7 kb DNA fragment in mas transfectants treated with 80 pM MTX 
(lane 7; band A) and vector transfectants treated with 80 jjM MTX (lane 2; band A) 
were almost same. It was suggested that the DHFR transgene was amplified in the 
MTX-treated transfectants in dose-dependant manner. 
Southern blot analysis with DIG-labeled mas cDNA probe was shown in Figure 2.7. 
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Figure 2.7 Southern blot analysis of mas gene in the stably transfected CHO cell. 
EcoR I digested genomic DNA from wild-type DHFR-deficient CHO cell (lane 
1)，pFRSV-stably transfected DHFR-deficient CHO cell with 80 i^M MTX 
treatment (lane 2), pFRSV/腦5-stably transfected cell without MTX treatment 
(lane 3), with 0.5 pM MTX treatment (lane 4)，with 4 ^M MTX treatment (lane 
5), with 10 |iM MTX treatment (lane 6)，with 80 |iM MTX treatment (lane 7). 
Un-digest genomic DNA from wild-type DHFR-deficient CHO cell (lane 8), 
pFRSV/woy-stably transfected cell with 80 i^M MTX treatment (lane 9). 
DIG-labeled DNA marker standard was shown on lane M. 
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One weak signal band was detected in the genomic DNA of the wild type 
DHFR-deficient CHO cells (lane 1) and pFRSV-transfected CHO cells treated with 80 
mM MTX (lane 2) at the size of about 9.1 kb (band A). Three signal bands were 
detected in the genomic DNA of pFRSV//wa^-transfected CHO cells (lane 3 - 7) at the 
position of 9.1 kb (band A), 1.4 kb (band B), and 1 kb (band C). Among these three 
signal bands found in the mas transfectants genomic DNA, the 1 kb probed DNA 
fragment (band C) gave higher intensity than that of 1.4 kb (band B) and 9.1 kb (band 
A) DNA fragment. In addition, it was found that the signal of the 9.1 kb DNA 
fragment (band A) was almost equal in all genomic DNA samples, including the wild 
type CHO cells, vector transfectants, and mas transfectants with different 
concentrations of MTX treatment. Since the 9.1 kb (band A) DNA fragment was 
detected in the wild type CHO cells, vector transfectants, and the mas transfectants, it 
was suggested that these bands corresponded to the endogenous mas DNA. On the 
other hands, the 1.4 kb (band B) and 1 kb (band C) DNA fragments hybridized to the 
DIG-labeled mas cDNA probe and were only detected in the mas transfectants but not 
in the wild type and vector transfectants, it was suggested that the 1.4 kb (band B) and 
1 kb (band C) DNA fragment corresponded to the mas transgene that integrated at 
different genomic loci. 
When comparing the results of the EcoR I-digested genomic DNA of the mas 
transfectants with different concentrations of MTX treatment, it was found that the 
signal intensity of the 1.4 kb (band B) and 1 kb (band C) DNA fragment shown an 
increasing trend with an order of: mas transfectants without MTX treatment (lane 3) < 
mas transfectants treated with 0.5 |iM MTX (lane 4) < mas transfectants treated with 
4 |jM MTX (lane 5) < mas transfectants treated with 10 joM MTX (lane 6) < mas 
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transfectants treated with 80 |aM MTX (lane 7). The mas transfectants with 80 (jM 
MTX treatment gave the highest band intensity among others. The mas transgene was 
amplified in the mas transfectants in a dose-dependant manner. 
Mas gene amplification was observed in all transfectants irrespective of whether cells 
derived from low initial dosage MTX treatment including 0.5 |iM (Figure 2.7; lane 4) 
and 10 nM (Figure 2.7; lane 6); or from high initial dosage MTX treatment including 
4 \jM (Figure 2.7; lane 5) and 80 pM (Figure 2.7; lane 7), these results suggested that 
mas gene amplified properly which haven't been affected by the initial dosage MTX. 
Furthermore, the results of mas hybridized fragments (band B and C) shown in Figure 
2.7 suggested that gene amplification increased corresponding to the order of MTX 
concentrations. The low initial dosage and high initial dosage MTX treated 
transfectants correlated to each other. 
To determinate the relative gene copy number, the DIG-labeled mas-prohtd blots 
were scanned with a flatbed scanner (Epson GT-9500) and digitized by using a 
software UN-SCAN-ITTM- After scanning and analysis, the relative gene copy number 
of mas gene in mas transfectants with different concentrations of MTX treatment were 
calculated (Table 2.1). The endogenous mas gene was taken as a single gene copy per 
haploid, namely assuming that the wild type CHO cells, vector transfectants, mas 
transfectants without MTX treatment, with 0.5 [M MTX treatment, with 4 jiM MTX 
treatment, with 10 |iM MTX treatment, and with 80 |iM MTX treatment contained 
two endogenous mas gene copy. On the other hand, the wild type CHO cells, vector 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































MTX treatment and with 0.5 jxM MTX treatment contained 4.5 copy o^mas transgene. 
The mas transfectants with 4 joM MTX treatment contained 7.5 copy oimas transgene 
while cells with 10 [oM MTX treatment contained 11.1 copy mas transgene. Obviously, 
the mas transfectants with 80 |jM MTX treatment contained 16.5 copy of mas 
transgene. In conclusion, it was found that the mas transfectants treated with higher 
concentrations of MTX contained higher mas transgene copy number. 
2.3.4 Northern blot analysis of the transcriptional level of mas 
transcripts in mas transfectants 
In order to study the RNA transcriptional level of mas and DHFR gene in mas 
transfectants that were treated with different concentrations of methotrexate (MTX), 
the DIG-labeled 1 kb mas cDNA probe and the DIG-labeled 578 bp DHFR cDNA 
probe were used to hybridized with the total RNA of different cell samples. 
DIG-labeled 600 bp GAPDH cDNA probe was also prepared by PCR for use of 
normalizing the RNA in the blots. Similar to mas and DHFR cDNA probe preparation, 
the size of the DIG-labeled GAPDH cDNA (Figure 2.8; lane 3; 700 bp) was higher 
than that of the unlabeled GAPDH cDNA (Figure 2.8; lane 2; 600 bp). 
Based on the result of the Northern blot hybridized with DIG-labeled DHFR cDNA 
probe as showed in Figure 2.9, no signal could be detected in the total RNA sample of 
wild type DHFR-deficient CHO cells (Figure 2.9; lane 1), which indicated that these 
cells did not express DHFR mRNA. In the total RNA samples of pFRSV vector 
transfected CHO cells treated with 80 |liM MTX (lane 2), two signal bands were 
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1018 bp — 1 一 1 ^ 1000 bp 
506 bp 600 bp 
200 bp 
Figure 2.8 Preparation of DIG-labeled GAPDH probe by PCR method. The 
GAPDH cDNA fiagment, 600 kb (lane 2), DIG-dUTP-labeled GAPDH cDNA 
fragment, 600 kb (lane 3), 1-kb DNA size marker standard (lane 1), and 100-bp 
DNA size marker standard (lane 4) were showed. The DIG-dUTP-labeled 
GAPDH cDNA fragment was apparently higher than that of unlabeled GAPDH 
cDNA fragment and changed from 600 kb to 700 kb. 
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Figure 2.9 Northern blot analysis of DHFR gene transcription in stably 
transfected CHO cell. Total RNA from wild-type DHFR-deficient CHO cell 
(lane 1), pFRSV-stably transfected DHFR-deficient CHO cell with 80 i^M 
MTX treatment (lane 2), pFRSV/ma^-stably transfected cell without MTX 
(lane 3)，with 0.5 ^M MTX treatment (lane 4)，with 4 i^M MTX treatment 
(lane 5), with 10 ^M MTX treatment (lane 6), with 80 i^M MTX treatment 
(lane 7). DIG-labeled RNA marker standard was shown on lane M. 
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detected at size of about 3.2 kb (Figure 2.9; band C) and 1.8 kb (band D), in which the 
1.8 kb (band D) bands gave stronger signal intensity than that of 3.2 kb (band C). In 
the total RNA samples of pFRSV/zwaMransfected CHO cells treated with different 
concentrations of MTX (lane 3-7), three signal bands were detected at size of about 11 
kb (band A), 4.7 kb (band B) and 1.8 kb (band D)，respectively. Among of the bands 
detected in the pFRSV/wa^ transfectants, the 1.8 kb bands (band D) gave the 
strongest signal intensity which was also detected in the pFRSV transfectants (lane 2; 
band D). It was suggested that the 1.8 kb signal bands (band D) found in the pFRSV 
transfectants and p¥RSY/mas transfectants corresponded to the DHFR mRNA. The 
transcriptional level of the DHFR transgene was higher in the pFRSV/zwos* 
transfectants with increasing concentrations MTX treatment with an order of: 
ipFKSY/mas transfectants without MTX treatment (lane 3) < pFRSV/mos transfectants 
treated with 0.5 [M MTX (lane 4) < pFRSV/^a^ transfectants treated with 4 [M 
MTX (lane 5) < p¥RSY/mas transfectants treated with 10 joM MTX (lane 6) < 
pFRSY/mas transfectants treated with 80 joM MTX (lane 7). Furthermore, it was 
found that transcriptional level of the DHFR transgene was higher in the vector 
transfectants treated with 80 (oM MTX (Figure 2.9; lane 2; band D) than that of the 
mas transfectants treated with 80 joM MTX (Figure 2.9; lane 7; band D). The blot then 
stripped and rehybridized with DIG-labeled GAPDH cDNA probe (Figure 2.10). It 
was found that there was only one signal band detected on the blot, which was 
corresponded to the GAPDH transcripts (1.8 kb). The signal of the GAPDH 
transcripts gave almost equal in all the samples (Figure 2.10; lane 1-7). 
After knowing the transcriptional level of the DHFR transgene was increasing in the 
transfectants with higher concentrations of MTX, the transcriptional level o^mas was 
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Figure 2.10 Normalization by GAPDH gene transcription. Northern blot that 
was probed with DIG-labeled DHFR cDNA probe as showed in Figure 2.9 was 
stripped. The stripped blot was then rehybridized with DIG-labeled GAPDH 
cDNA probe. Total RNA from wild-type DHFR-deficient CHO cell (lane 1)， 
pFRSV-stably transfected DHFR-deficient CHO cell with 80 从M MTX 
treatment (lane 2), pFRSV/wa^-stably transfected cell without MTX (lane 3), 
with 0.5 ^M MTX treatment (lane 4), with 4 i^M MTX treatment (lane 5), with 
10 iiiM MTX treatment (lane 6)，with 80 pM MTX treatment (lane 7). 
DIG-labeled RNA marker standard was shown on lane M. 
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studied. As shown in Figure 2.11，no signal was detected in the total RNA samples of 
wild type DHFR-deficient CHO cells (lane 1) and vector transfectants treated with 80 
|jM MTX (lane 2), suggesting that there was no mas gene expression, or the 
expression level was too low to be detected in these two cell lines. In the total RNA 
samples of the mas transfectants (lane 3-7), there were two signal bands detected on 
the blots at the molecular size of 11 kb (band A) and 4.7 kb (band B). Since these two 
signal bands were detected only in the total RNA samples of the mas transfectants but 
were absence in the wild type and vector transfectants, it was suggested that these two 
signal bands corresponded to the mas transcripts. Moreover, the transcriptional level 
of the mas transgene was higher in the pFRSV//wa^ transfectants that were treated 
with increasing concentrations of MTX in an ascending order as follows: pFRSV/mo? 
transfectants without MTX treatment (lane 3) < pFRSV/zwa^ transfectants treated with 
0.5 [M MTX (lane 4) < pFRSY/mas transfectants treated with 4 ^M MTX (lane 5) < 
pFRSY/mas transfectants treated with 10 [M MTX (lane 6) < pFRSV/z/aa^ 
transfectants treated with 80 |aM MTX (lane 7). In conclusion, the pFRSV/zwos" 
transfectants treated with 80 jjM MTX gave the strongest signal of the mas expression. 
The blot was then stripped and rehybridized with DIG-labeled GAPDH cDNA probe 
(Figure 2.12). It was found that there was only one signal band detected on the blot, 
which corresponded to the GAPDH transcripts (1.8 kb). The intensity of the GAPDH 
band suggested equal RNA content in all the samples (Figure 2.12; lane 1-7). 
To quantify the mas expression, the Northern blots were scanned with a flatbed 
scanner (Epson GT-9500) and digitized by using the software UN-SCAN-ITTM- Since 
the 4.7 kb band (Figure 2.11; band B) was dominant, it was used for the analysis. 
With respect to the scanning results (Table 2.2), it was found that the mas expression 
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Figure 2.11 Northern blot analysis of mas gene transcription in 
stably-transfected CHO cell. Total RNA from wild-type DHFR-deficient 
CHO cell (lane 1)，pFRSV-stably transfected DHFR-deficient CHO cell with 
80 科M MTX treatment (lane 2)，pFRSV/zwa -^stably transfected cell without 
MTX (lane 3), with 0.5 |iM MTX treatment (lane 4)，with 4 i^M MTX 
treatment (lane 5), with 10 fiM MTX treatment (lane 6), with 80 从M MTX 
treatment (lane 7). DIG-labeled RNA marker standard was shown on lane M. 
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Figure 2.12 Normalization by GAPDH gene transcription. Northern blot 
that was probed with DIG-labeled mas cDNA probe as showed in Figure 
2.11 was stripped. The stripped blot was then rehybridized with 
DIG-labeled GAPDH cDNA probe. Total RNA from wild-type 
DHFR-deficient CHO cell (lane 1)，pFRSV-stably transfected 
DHFR-deficient CHO cell wilh 80 |liM MTX treatment (lane 2)， 
pFRSV/wos-stably transfected cell without MTX (lane 3)，with 0.5 \iM 
MTX treatment (lane 4)，with 4 ^M MTX treatment (lane 5)，with 10 ^M 
MTX treatment (lane 6), with 80 pM MTX treatment (lane 7). 
DIG-labeled RNA marker standard was shown on lane M. 
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Table 2.2 Relative transcriptional level of the mas expression in the mas stably 
transfectants. 
Experiment 1 Experiment 2 
Mean 
Normalized Trans- Normalized Trans-
Sample Raw Pixel Raw Pixel trans-
Pixel criptional pixel criptional 
intensity intensity criptional 
intensity level intensity level 
level (Unit) 
WT 
585590 / / 364336 / / / 
Vector 
573224 / / 362497 / / / 
Mas-no 
MTX 598075 18668 1 446172 82755 1 1 
Mas-0.5 
608798 29391 1.6 460534 97117 1.2 1.4 
IJMMTX 
Mas-4 
641348 67941 3.6 474130 110713 1.3 2.5 
MMMTX 
Mas-10 
709305 153450 8.2 496335 132918 1.6 4.9 
MMMTX 
Mas-80 
830911 251504 13.5 547335 183918 2 .2 7.9 
MMMTX 
Northern blots were scanned (Epson GT-9500) and digitized by using the software 
UN-SCAN-ITTM. TWO separated blots were scanned to quantify the relative 
transcriptional level of mas gene in wild-type DHFR-deficient CHO cell (WT), 
pFRSV transfectants (Vector), pFRSV/mas transfectants treated with different 
concentrations of MTX (Mas-MTX). The "normalized pixel intensity" was the pixels 
substracted with the background pixels (mean pixel of the wild-type and vector 
transfectants). The mean pixel of the mas transfectants without MTX treatment was 
used as a single transcriptional level. The relative transcriptional levels of mas were 
calculated by the ratio of the pixels of mas transfectants treated with different 
concentrations of MTX to the pixels of mas transfectants without MTX treatment. 
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in wild type and vector transfectants, if any, were very low in comparison with that of 
mas transfectants. By using of the mean pixels of the mas transfectants without MTX 
as a basal transcriptional units, the relative transcriptional levels of mas in mas 
transfectants treated with different concentrations of MTX were calculated. The 
relative transcriptional level of mas transfectants treated with 0.5 jiM MTX, with 4 
pM MTX, with 10 [M MTX, and with 80 |aM MTX were 1.2, 1.8, 2.8, 4.3, 
respectively. In summary, the transcriptional level of mas was higher in higher 
concentrations of MTX treated CHO cells. It was found that relative transcriptional 
level of mas showed large difference value between two experiments, it was due to 
the difference in the NET development timing on the blots. Also since the probes 
were reused in difference experiments, the signal intensity may also vary in different 
blots. 
After studying the gene copy number of mas transgene and the relative transcriptional 
level in the mas transfectants treated with different concentrations of MTX, the 
relationship between each other was also investigated (Figure 2.13). As illustrated in 
Figure 2.13, the relative transcriptional level of mas was directly proportional to the 
gene copy number of mas transgene in the mas transfectants. 
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Figure 2.13 Relationship between mas transgene copy number and relative 
expression level. The mean relative expression level of mas transgene in the 
Twoy-transfected CHO cells (Table 2.2) was plotted against the mean mas 
transgene copy number (Table 2.1). Data were fitted by non-linear regression 
with a statistic program SigmaStat. The correlation coefficient R value is 
0.99; the P value of analysis of variance is 0.0002; and the Power of test with 
a at 0.05 is 0.996. 
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2.4 Discussion 
When the DHFR-deficient Chinese Hamster Ovary (CHO) cells grown in the 
complete IMDM medium supplemented with 10% (v/v) fetal bovine serum (FBS); 
1% (v/v) penicillin/streptomycin; 1% (v/v) HT supplement (0.1 mM sodium 
hypoxanthine and 0.016 mM thymidine), the cells exhibited a polygonal morphology 
and grew as discrete colonies. The parental CHO cells were deficienct in the 
dihydrofolate reductase (DHFR), an enzyme that catalyzed the conversion of folate to 
tetrahydrofolate (FH4) in the de novo biosynthesis. FH4 is required for the 
biosynthesis of glycine from serine, for biosynthesis of thymidine monophosphate 
from deoxyuridine monophosphate, and for purine biosynthesis. Cells without DHFR 
cannot synthese the purines and pyrimidines via the de novo biosynthesis, leading to 
cell death. In order to sustain the healthy grow of parental CHO cells, HT supplement 
(sodium hypoxanthine and thymidine) has to be added into the medium so that cells 
can utilize purine and pyrimidine salvage pathways. 
After the DHFR-deficient CHO cells were transfected with the pFRSV or pPBSY/mas, 
the cells grow in medium without HT supplement, because the transfected vector 
pFRSV contained DHFR gene that compensated for the host cell deficiency. When the 
pFRSV- or pFRSVAwos-transfected cells were immediately grown in the selection 
medium without HT supplement, cells grew more slowly and took on a flat, 
spread-out morphology, which indicated that they were starved for DHFR. After 2-3 
passages, cells produced enough DHFR so that they regained polygonal morphology. 
The /wos-transfected cells exhibited different morphology compared with the 
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vector-transfected cells that may be due to the expression of the mas protein in the 
mas transfectants. 
Since the selection steps of the MTX treatment were different in different laboratories, 
the initial concentration dosage of MTX had to be investigated experimentally. When 
larger selection steps are employed, mechanisms other than gene amplification may 
be used by cells. Haber and his colleagues (1987) suggested that single-step 
high-level resistance to MTX might result in cells with an altered MTX-resistant 
DHFR enzyme, or with altered MTX transport properties (Haber et al., 1981). In our 
study, we tested two initial concentrations of MTX in the transfectants. The low initial 
concentration was 0.02 |aM while the high initial concentration dosage was 1 |jM 
MTX. The suggested initial selection concentration for MTX resistance is 0.005 or 
0.02 pM, which is dependent on the efficiency of DHFR expression, obtained from 
the transfected plasmid (Milbrandt et al., 1981). We applied 1 |iM of MTX in the 
initial selection step in our pFRSV/ma^-transfected CHO cells that were suggested to 
be much higher than the lethal dosage of the DHFR transfectant CHO cells. However, 
the pFRSVAwos-transfected CHO cells could survive in the high initial concentration 
of MTX treatment and DHFR gene amplified in the transfected CHO cells. It was 
possible that the pFRSV plasmid contained a mutant DHFR gene that shows higher 
resistance to methotrexate than the wild type enzyme (Thillet et al., 1990). Alternately, 
the high resistance to MTX may due to higher expression level of DHFR. In summary, 
the selected cells survived and amplified the DHFR gene and mas transgene, 
suggesting that the low and high initial selection concentrations of MTX didn't exert 
any significant difference in our study model. 
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In our study, we found that the DHFR gene in vector- and /woy-transfected CHO cells 
was amplified in a MTX dose dependant manner. Higher DHFR gene amplification 
was found in vector- and /WOY-transfected CHO cells treated with 80 |liM MTX. Both 
the genomic DNA of vector-transfected CHO cells and /wa^-transfected CHO cells 
exhibited two EcoR I-digested fragments on the Southern blot analysis that were 
hybridized with the DIG-labeled DHFR cDNA. There were two signal bands 
corresponded to DHFR gene in the genomic DNA of pFRSV-transfected and 
pFRSV/mos-transfected CHO cells. One of the signal showed the same molecular size 
in both vector- and moy-transfected CHO cells while another one showed different in 
molecular size. This phenomenon indicated that a possibility of multiple integration of 
pFRSV or pFRSVAwoy DNA into the CHO cells genome. It may be due to the random 
cleavage and integration of the plasmid into the cells genome because we were using 
the circular plasmid to transfect the CHO cells. This random cleavage of the plasmid 
maybe avoided by using the linearised DNA in which the cleavage site was designed 
before transfected to the cells genome. On the Northern blot that hybridized with the 
DIG-labeled DHFR cDNA, it was found that the transcript size of the DHFR gene 
was different in vector-transfected and ma^-transfected CHO cells. The difference in 
the size of DHFR transcripts were due to the expression of the DHFR gene intergrated 
into different loci of the genome. 
We were able to establish the mas over-expressing CHO cells by using the DHFR and 
MTX amplification system. Firstly, we confirmed the gene amplification of the mas 
transgene in the genomic DNA of the /waMransfected CHO cells by using Southern 
blot analysis. On the Southern blots, we found that two signals detected corresponded 
to the mas transgene. The multiple signals maybe due to random cleavage and 
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integration of the pFRSV/zwoy plasmid into the CHO cells genome. There was a weak 
signal found (9.1 kb) in the DNA of wild type and wos-transfected CHO cells, which 
corresponds to the endogenous mas. It was also found that the signal of the 
endogenous mas decreased as the signal of transgene mas increased in the 
mos-transfected CHO cells with increasing concentration of MTX treatment. It was 
because it contained same amount of the genomic DNA (20 |ag) in each sample, since 
the proportion of the transgene mas was increased in the higher concentration of MTX 
treatment, the proportion of the endogenous mas was lower. 
In the Southern blot analysis, we found that there was an endogenous mas gene in the 
wild type and mos-transfected CHO cells. However, we cannot detect any mas 
transcripts in the total RNA sample of wild type CHO cells by Northern blot analysis. 
We suggested that the endogenous mas expression was too low that we could not 
detect in the Northern blot analysis, or the endogenous mas gene was not expressed at 
all in the CHO cells. One interesting finding in the Northern blot analysis was that, 
there were two signal bands detected on the blots hybridized with DIG-labeled mas 
cDNA at the molecular size of 11 kb (Figure 2.11, band A) and 4.7 kb (Figure 2.11, 
band B). These two signal bands were also detected on the blots hybridized with 
DIG-labeled DHFR cDNA at the molecular size of 11 kb (Figure 2.9, band A) and 4.7 
kb (Figure 2.9, band B), but one extra signal band was detected at molecular size of 
1.8 kb (Figure 2.9, band D). This suggests that the mas gene may be co-transcribing 
with DHFR gene in the transfected CHO cells. Since DHFR gene was cloned 
downstream of the mas gene in the pFRSVAwos construct (Figure 2.1), mas transgene 
transcribes itself alone as well as co-transcribes with the DHFR gene in the 
transfected CHO cells. The extra signal band (Figure 2.9, band D) detected on the 
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blots hybridized with DIG-labeled DHFR cDNA corresponding to the DHFR 
transcripts. Another possible explanation for multiple signals detected on the blots 
maybe due to the impurity of the DIG-labeled cDNA probes. Since the DIG-labeled 
mas and DHFR cDNA probes were prepared by PCR using the pFRSV//wa^ DNA as 
template, cDNA other than the mas and DHFR may also be amplified and labeled. 
This trace amount of labeled-cDNA fragments may result in the nono-specific bands 
detected on the Northern blot analysis. To eliminate the non-specific signal, we 
suggest to use DIG-labeled RNA probes in the Northern blot analysis in future studies. 
Since RNA probe was more specific in hybridizing with RNA on the Northern blot. If 
RNA probe was used, the hybridization temperature and washing stringency can be 
increased to eliminate the non-specific binding. Also, the 11 kb signal (Figure 2.9, 
band A) that were detected on the Northern blot analysis may due the contamination 
by the genomic DNA during the RNA isolation. 
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Chapter 3 
In vivo study of physiological effect 
of over-expression of mas 
3.1 Introduction 
After establishing different mas over-expressing cell lines, the next question that 
needs to be addressed is the biological activity of mas in vivo. In this study, we were 
going to investigate whether the full-length coding sequence of mas was sufficient to 
cause tumor formation, and the relationship between the gene copy number of mas 
and tumorigenicity. A tumorigenicity assay in nude mice was performed. In brief, the 
Twos-stable transfectants were injected subcutaneously into nude mice. Time course 
and growth rate of tumors were compared among different groups of nude mice. After 
six weeks of observation, the nude mice were scarified and the tumor tissues were 
collected. Northern blot analysis was used to study the mas gene expression in the 
tumor tissue. 
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3.2 Materials and Methods 
3.2.1 Materials 
Iscove's Modified Dulbecco's Medium (IMDM), fetal bovine serum (FBS), fetal 
bovine serum, dialyzed (FBS Dialyzed), Dulbecco's Phosphate-Buffered Saline (PBS), 
penicillin and streptomycin, trypsin-EDTA, HT- supplement, and TRIZOL® Reagent 
were purchased from Invitrogen Corporation. DIG Easy Hybridization solution, 
Blocking Reagent, Nitroblue Tetrazolium Chloride (NET), 
5-Bromo-4-chloro-3-indolyl-phosphate, 4-toluidine salt (X-phosphate, 4-toluidine salt) 
(BCIP), Digoxigenin-11 -2'-deoxy-uridine-5 'triphosphate (DIG-11 -dUTP), 
Anti-digoxigenin-AP (Fab fragments), and RNA molecular weight marker I 
(digoxigenin-labeled RNA marker standard, 0.3-6.9 kb) were purchased from Roche. 
All other chemicals and reagents were from Sigma Chemicals. 
3.2.2 Methods 
3.2.2.1 Cell culture 
The wild-type DHFR-deficient CHO cells were grown to confluence in IMDM 
medium supplemented with 10% (v/v) fetal bovine serum (FBS); 1% (v/v) 
penicillin/streptomycin; 1% (v/v) HT supplement (0.1 mM sodium hypoxanthine and 
0.016 mM thymidine). The pFRSV- or pFRSV/TTzoy-transfected DHFR-deficient CHO 
cells were grown to confluence in the selection medium [EVEDM medium 
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supplemented with 10% (v/v) dialyzed fetal bovine serum (FBS); 1% (v/v) 
penicillin/streptomycin] in the presence of different concentrations of methotrexate. 
The cells (2 x 10 )^ were seeded in 100-mm tissue culture dish two days before nude 
mice injection. Cells were kept in a 5 % CO2, humidified incubator at 37 At the 
day of nude mice injection, the cells were washed with warm PBS followed by 
trypsinization with trypsin-EDTA (0.25% trypsin/1 mM EDTA-4Na). The trypsinized 
cells were washed with warm PBS twice and resuspended in PBS at a cell density of 
2.5 X 106 cell/ ml. 
3.2.2.2 Subcutaneous injection of nude mice 
This experiment was approved by Department of Health (SAR), and followed the 
Animals (Control of Experiments) Regulations issued in the Licence to Conduct 
Experiment. Cells (5 x 10^  in 200 |nl of PBS) were injected subcutaneously into the 
back of the shoulder of nude mice. The nude mice were restrained by grasping the 
skin of the scruff，and the injection was made into the areas that skin being raised. A 
24-gauge needle was used for the injection. The needle was positioned almost parallel 
to the back of the mouse and then pierced through the skin for most of its length. After 
injection, the nude mice were kept feeding in the animal house for two months with 
free to access of food and water, at 12 hours light and 12 hours dark cycles. The nude 
mice were monitored for the potency of the tumor growth. 
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3.2.2.3 Isolation of the total RNA from the tumor tissues 
After 41 days of observation of nude mice in animal house, the mice were sacrificed 
by cervical dislocation. Tumor tissues were removed from the mice. Tumor tissues 
collected from individual mouse were divided into four pieces and stored in liquid 
nitrogen until use. Tumor tissues were taken out from the liquid nitrogen and put into 
the TRIZOL® Reagent immediately. Tissue samples (50-100 mg per 1 mL of TRIZOL® 
Reagent) were homogenized in TRIZOL® Reagent using a homogenizer (Polytron). 
The homogenate was centrifuged at 12,000 g for 10 minutes at 4 � C to remove cell 
debris. The resulting pellet contains extracellular membranes, polysaccharides, and 
high molecular weight DNA, while the supernatant contains RNA. The cleared 
homogenate was transferred to a clean 1.5-ml microcentrifuge tube. 
Chloroform (0.2 ml per 1 ml of TRIZOL® Reagent) was added to the clear homogenate 
solutions. Tubes were shaken vigorously by hand for 15 seconds and then incubated at 
room temperature for 2 to 3 minutes. The samples were centrifuged at 12,000 g for 15 
minutes at 4 °C. The aqueous phases containing the RNA were transferred to another 
1.5-ml tube. Isopropyl alcohol (0.5 ml per 1 ml of TRIZOL® Reagent) was added into 
the mixtures to precipitate the RNA. Samples were incubated at room temperature for 
10 minutes and centrifuged at 12,000 g for 10 minutes at 4 °C. 
After centrifugation, the supernatant was discarded. The RNA pellet was washed once 
with 1 ml of 75% ethanoL The RNA was centrifuged at 7,500 g for 5 minutes at 4 °C. 
At the end of the procedure, the RNA pellet was dried at room temperature for 5-10 
minutes. It is important not to let the RNA pellet dry completely as this will greatly 
9 5 
decrease its solubility. RNA was then dissolved in 100% formamide. 
3.2.2.4 Northern blot analysis 
Northern blot hybridization was used to evaluate the expression of genes in the tumor 
samples and to estimate their abundance. RNA was isolated from tumor tissues and 
size-separated by electrophoresis through denaturing formaldehyde agarose gels. The 
size-fractionized RNA was then transferred into a positively charged nylon membrane 
by upward capillary transfer and hybridized with the DIG-labeled probes as described 
in Chapter 2 section 2.2.2.11.1 to 2.2.2.11.7. 
3.3 Results 
3.3.1 Tumorgenicity assay of mas oncogene in nude mice 
Seven different cell lines were injected into the nude mice. Each cell line was injected 
into a group of ten nude mice. The cell lines included the wild-type DHFR-deficient 
CHO cell, pFRSV-stably transfected CHO cell treated with 80 ^M MTX, 
pFRSVAwos-stably transfected CHO cell without MTX treatment, pFRSV/zwoy-stably 
transfected CHO cell treated with 0.5 |liM MTX, pFRSV/ZWOY-stably transfected CHO 
cell treated with 4 |liM MTX, pFRSV//wa^-stably transfected CHO cell treated with 10 
|iM MTX, and pFRSV/zwos-stably transfected CHO cell treated with 80 juM MTX. 
Following injection of cell subcutaneously into the nude mice, the development of 
tumor in different group mice was monitored by visual inspection (Figure 3.1). 
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MM 
Figure 3.1 Development of tumor in nude mice. Tumor formations in nude mice after 
injected with (A, D) wild type DHFR-deficient CHO cells, (B, E) pFRSV-transfected 
CHO cell, (C, F) pFRSV/moy-transfected CHO cell treated with 80 i^M MTX. The 
pictures were taken after 25 days of inoculation. The red arrows indicated the nude mice 
that carried tumors. 
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After 42 days inoculation, all nude mice survived the course of experiment. There was 
no tumor grown in nude mice injected with wild-type DHFR-deficient CHO cells 
after 42 days inoculation. Only one nude mouse got tumor development after 21 days 
of inoculation of pFRSV-stably transfected CHO cell treated with 80 [iM MTX, 
afterward, there was no nude mice carried tumor (Figure 3.2). Nude mice injected 
with mas-stably transfected cells carrying different mas gene copy number developed 
tumors at different potency. After 9 days of inoculation, tumors appeared in the nude 
mice. There were five nude mice carried tumors in the group of /wa^-transfected cells 
without MTX treatment, two nude mice carried tumors in the group of 0.5 |liM MTX 
treatment, five nude mice carried tumors in the group of 4 |liM MTX treatment, eight 
nude mice carried tumors in the group of 10 |liM MTX treatment and four nude mice 
carried tumors in the group of 80 )liM MTX treatment. At the 11 days, ten out often 
nude mice got tumor development in both the group of 4 [iM MTX and 10 ^M MTX 
treated mas transfectants-inj ected nude mice, nine out of ten nude mice got tumors in 
the group of no MTX treatment, three out of ten got tumors in the group of 0.5 ^M 
MTX treatment, six out of ten got tumors in the group of 80 |liM MTX treatment 
(Figure 3.2). 
It is intriguing to note that number of nude mice carrying tumor regressed after about 
three weeks of inoculation (Figure 3.2). For instance, in the group of nude mice that 
injected with mas transfectants without MTX treatment, there were nine out of ten 
nude mice got tumors at the day 11, one of them recovered from tumor growth at the 
day 21, and there was a gradual reduction in the nude mice carrying tumor. In the 
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were six out of ten nude mice got tumors at day 14, but there were only five out of ten 
in day 37. It also happened in the 4 |liM MTX and 10 |liM MTX treated groups; tumors 
in the nude mice regressed and recovered at day 22. However, in the group of nude 
mice injected with mas transfectants treated with 80 |iiM MTX, there were eight out of 
ten nude mice got tumors at day 16, the regression of tumor in nude mice took a lower 
rate since at the day 42，eight out of eight nude mice still carried the tumors even 
though the size of the tumors reduced (Figure 3.2). 
After 42 days inoculation, there were five nude mice bore tumor in the group of nude 
mice injected with cells without MTX treatment, and with cells treated with 0.5 juM 
MTX. There were eight nude mice bore tumor in the group of nude mice injected with 
cells treated with 4 pM and 80 |iM MTX. There were nine nude mice bore tumor in 
the group of nude mice injected with cells treated with 10 |liM MTX (Figure 3.2). 
To compare the relationship between the mas transgene copy number and potency of 
tumor formation in nude mice, numbers of tumor bearing mice were plotted against 
mas transgene copy number. As illustrated in Figure 3.3 A, of the number of nude 
mice carried tumor after 10 days (onset of the tumor growth) of inoculation of mas 
transfectants, there were five nude mice carried tumors in the groups of mice injected 
with mas transfectants carrying 4.5 and 7.5 copies of mas transgene, respectively. 
There were eight nude mice carried tumors in the groups of mice injected with mas 
transfectants carrying 11.1 copies of mas transgene, while four nude mice carried 
tumors in the group of mice injected with mas transfectants carrying 16.5 copies of 
mas transgene. On the other hand, the parental CHO cells that carried single gene 
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Figure 3.3 Relationship between the mas transgene copy number and potency 
of tumor formation in nude mice. The number of nude mice bore tumor that 
were injected with mas transfectants carrying different mas transgene at day 10 
(A) and day 40 (B). 
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inoculation, as illustrated in Figure 3.3 B, there were five nude mice carried tumors in 
the group of mice injected with mas transfectants carrying 4.5 copies of mas transgene. 
There were eight nude mice carried tumors in the group of mice injected with mas 
transfectants carrying 7.5 and 16.5 copies of mas transgene. There were nine nude 
mice carried tumors in the group of mice injected with mas transfectants carrying 11.1 
copies of mas transgene. These results suggest the potency of the tumor formation in 
nude mice was directly proportional to the mas transgene copy number. 
After 42 days of injection, nude mice were sacrified and the tumor tissues were 
isolated from the mice. The wet weight of the tumor tissue was measured and a graph 
that illustrated the weight of tumor tissues against the average mas transgene copy 
numer was plotted (Figure 3.4). Although number of nude mice that beared tumor 
increased with higher transgene number, there was no significance difference in the 
tumor size (P<0.001). 
3.3.2 Northern blot analysis of mas expression in the tumor tissues 
Expression of mas transgene in tumor tissue were analysed by Northern blot 
hybridization. As illustrated in Figure 3.5, it was found that only the nude mice that 
developed tumor gave positive signals of mas transcripts in the Northern blot analysis. 
Tissues of nude mice inoculated with wild-type DHFR-deficient CHO cell (lane 1, 2) 
and pFRSV-stably transfected CHO cell with 80 |liM MTX treatment (lane 3, 4) didn't 
give any signal suggesting that these nude mice didn't express mas gene. On the other 
hand, the total RNA collected from the tumor tissues of nude mice inoculated with 
mas-stdb\y transfected CHO cells without MTX treatment (lane 3，4), with 10 [iM 
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Figure 3.4 Relatioship between total weight of tumor tissues and the relative mas 
transgene copy number (P<0.001). 
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Figure 3.5 Northern blot analysis of mas gene transcription in the tumor tissues 
from nude mice. Total RNA from tissues of nude mice injected with wild-type 
DHFR-deficient CHO cell (lane 1，2)，tissues of nude mice with pFRSV-
transfected DHFR-deficient CHO cell treated with 80 \iM MTX (lane 3, 4), 
tumor tissues of pFRSV/ma5-stably transfected cell without MTX (lane 5, 6)， 
tumor tissue of pFRSV/mos-stably transfected cell treated with 10 i^M MTX 
(lane 7, 8)，tumor tissue of pFRSV/ma5-stably transfected cell treated with 80 
HM MTX (lane 9, 10). DIG-labeled RNA marker standard was shown on lane 
M. 
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signals on the blot at molecular size of about 11 kb (band A) and 4.7 kb (band B), 
respectively. By comparing these two signal bands, it was found that the 4.7 kb RNA 
transcripts (band B) gave stronger intensity than that of the 11 kb RNA transcript 
(band A). Since the molecular sizes of these two bands were corresponding to that 
found in the total RNA of the mas transfectants (Chapter 1, Figure 2.11), and lack of 
expression of these bands in tissue of wild type and vector tranfected cells, and hence, 
these two bands were identified as the transgenic mas transcripts. 
It was worth to note that the signal intensity of the 4.7 kb band (Figure 3.5, band B) 
was higher in the nude mice tissues injected with mas transfectants with 80 |LIM MTX 
treatment (lane 9, 10) than that of nude mice tissues injected with mas transfectants 
without MTX treatment (lane 5, 6) and with 10 |LIM MTX treatment (lane 7, 8). To 
confer this dose-dependent increase of transcripts was not relating to uneven loading 
of RNA samples the blot was stripped and rehybridized with DIG-labeled GAPDH 
cDNA probe in order to normalize the total RNA on the blot. As shown in Figure 3.6, 
there was only one signal detected in each RNA samples that was corresponding to 
the GAPDH transcripts. It was found that the signal of GAPDH was almostly equal 
among each RNA samples. 
To quantify the mas transcript, the blot was digitized by scanning with a flatbed 
scanner (Espon GT-9500) and analyzed by using the software UN-SCAN-ITTM. The 
relative transcriptional level of mas gene in different nude mice tissues was compared 
with reference to the 4.7 kb mas transcript. Since mice injected with wild-type CHO 
cells (WT) and vector-transfected CHO cells (Vector) did not give any signal on the 
Northern blot, their mean pixel of the corresponding region on the blot were used as 
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Figure 3.6 Normalization of GAPDH gene transcription in the tumor tissues 
after the blot (Figure 3.4) was stripped and rehybridized. Total RNA from 
tissues of nude mice injected with wild-type DHFR-deficient CHO cell (lane 
1, 2), tissues of nude mice injected with pFRSV-transfected DHFR-deficient 
CHO cell treated with 80 |iM MTX (lane 3，4), tumor tissues of 
pFRSV/zwos-stably transfected cell without MTX treatment (lane 5, 6), tumor 
tissue of pFRSV/zwos-stably transfected cell treated with 10 \iM MTX (lane 
7, 8), tumor tissue of pFRSV/wos-stably transfected cell treated with 80 jiM 
MTX (lane 9’ 10). DIG-labeled RNA marker standard was shown on lane M 
(Blot was previously hybridized with Mas probe). The GAPDH transcripts 
were found to be amostly equal in all the RNA samples. 
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Table 3.1 The relative transcriptional level of mas in the nude mice tumor tissues. 
^ Relative 
Raw pixel Normalization 
Sample . Mean Pixel transcriptional 
intensity pixel intensity  
level (unit) 
WT 436956 / , 
400041 / 
431471 / 
Vector / / 
447390 / 
_ …、， 536173 107208 
Mas-no MTX 121879 1 
565514 136549 
Mas-lOpM 608415 179450 
、_、， 168757 1.4 
MTX 587028 158063 
Mas-80uM 657520 228555 
253240 2 1 
MTX 706889 277924 ’ 
The Northern blot in Figure 3.5 was scanned with a flatbed scanner and analyzed by 
using the software UN-SCAN-ITTM- The mean pixel of WT and vector were used as 
background. The transcriptional level (mean pixel) of nude mice tumor with mas 
transfectants without MTX treatment (Mas-no MTX) was used as single 
transcriptional units. The relative transcriptional level in different samples was 
determined by the intensity ratio of mean pixel of sample (Mas-10 pM MTX and 
Mas-80 jiM MTX) to the mean pixel of reference (Mas-no MTX). 
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background pixel. In comparison with mas over-expressing cells without MTX 
treatment, the mas expression level was increased apparently 1.4 and 2.1 fold in mas 
transfectants with 10 \iM MTX and 80 |LIM MTX treatment, respectively (Table 3.1). 
3.4 Discussion 
Previous studies suggested activation of mas oncogene by rearrangement of the 5, 
upstream non-coding region of mas in the transformed NIH 3T3 cells that were 
transfected with genomic DNA from human epidermoid carcinoma (Young et al., 
1986). In our study, we have transfected CHO cells with full-length coding region of 
mas and found that the Twoy-transfected CHO cells cause tumor formation. We have 
demonstrated that the coding sequences of mas itself was sufficient to induce tumor 
formation in nude mice. In our tumorgenicity assay, almost all the nude mice 
developed tumor after injected with moy-transfected CHO cells either with or without 
MTX treatment. In contrast, there was no tumor formation in the group of nude mice 
injected with wild type DHFR-deficient CHO cells, suggesting that the cell line itself 
could not induce tumor formation in nude mice. In addition, there was only one out of 
ten nude mice got tumor after injected with the vector (pFRSV)-transfected CHO cells 
treated with 80 |LIM MTX, which indicated that the mammalian expression vector 
(pFRSV) itself was not tumorgenic in nude mice. 
In our study, we found that the amplification of mas by the MTX treatment in mas-
stable transfectants increased the potency of tumor formation in the nude mice. In 
agreed with our finding, Van't Veer and co-workers (1988) have reported that the 
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amplification of mas by the alphoid repeat may contribute to the tumorgenicity in 
nude mice (Van't Veer et al., 1988). 
Without any obvious reason, we found that the tumors in the nude mice regressed 
after a period of time (Figure 3.2). The rate of the regression of tumor tissues was 
slower in nude mice that were injected with mas over-expressing CHO cells treated 
with a higher level of MTX (80 pM MTX treated cells). Recently, Xu and co-worker 
(2000) reported that over-expression of mas oncogene in target transgenic mice lead 
to cone degeneration that was proportional to the level of transgene expression (Xu et 
al., 2000). These results suggest that the tumors developed in nude mice by the 
/wos-transfected CHO cells were result from a balance between growth and apoptosis 
in transfectants. Cells that have a medium expression level of mas might trigger 
growth as well as apoptotic response. However, excessive expression of mas may lead 
to excessive growth response and lead to cancerous. 
In conclusion, we found that over-expression of mas in the transformed CHO cells 
(4-80 (iM MTX treatment) induced tumor formation more potently than that of 
transformed CHO cells with lower mas expression (without MTX treatment) in the 
nude mice tumorgenicity assay. The regression rate of tumor tissues was also slower 
in nude mice injected with transfectants that contained higher copy number of mas 




Fluorescent differential display 
analysis of mas transfectants 
4.1 Introduction 
In chapter 3, we have presented evidence that mas over-expression contributed to 
tumor formation in nude mice. Our laboratory had found that transferring of mas gene 
into NIH 3T3 enhanced endogenous expression of angiotensin lA receptor (Tang, 
1999). Mas seem to modulate its biological activity in part by affecting the gene 
expression profile. To further investigate the changes in gene expression pattern that 
might contribute to mas-induced tumor formation, we compared the gene expression 
profile of control and mas over-expressing CHO cells by fluorescent differential 
display (fluoroDD). 
Differential display reverse transcription-polymerase chain reaction (DDRT-PCR) is 
proved to be highly effective in identifying sequences that are differentially expressed 
in various cell types and, more importantly, in detecting genes that are 
underrepresented in an RNA population (Colonna-Romano et al., 1998). In this 
chapter, the pFRSV/Twos and pFRSV-stably transfected CHO cells that were treated 
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with 80 fjM MTX were chosen to be the study model. 
In order to study gene expression profile between the mas over-expressing CHO cells 
with control, total RNA from the samples was firstly isolated and purified. After 
removal of genome DNA contamination by DNase-I treatment, the RNA was 
converted into cDNA by reverse transcription. cDNA were amplified by PCR by 
using suitable arbitrary oligonucleotide primers that have a statistical chance of 
annealing to a corresponding sequence in an mRNA population. The amplified cDNA 
fragments were separated in a high-resolution polyacrylamide gel under denaturing 
condition. Once a differentially expressed mRNA is identified, differential expressed 
bands were identified and excised from the differential display gel. cDNA were then 
eluted from the gel band and then reamplified to produce an amount of cDNA 
sufficient for subsequent subcloning and analysis of expression. Effective differential 
gene expressions were confirmed by preliminary screening with reverse dot blot 
analysis and further confirmed by Northern blot analysis, before determining the 
sequences of the cloned gene. 
4.2 Materials and Methods 
4.2.1 Materials 
4.2.1.1 Chemicals 
TRIZOL® reagent was purchased from Invitrogen Corporation. Isopropanol was 
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purchased from BDH. Ethanol was perchased from Riedel-de Haen. Chloroform was 
purchased from Merck. Nuclease-free water was purchased from Promega. 
Formamide was purchased from Boehringer Mannheim. Phenol: chloroform: isoamyl 
alcohol (25:24:1, pH 4.7) was purchased from Invitrogen Corporation. DIG Easy Hyb, 
blocking reagent, anti-Digoxigenin-AP, and RNA molecular weight marker I 
(digoxigenin-labeled, 0.39-6.9 kb) were purchased from Roche. Ampicillin was 
purchased from Sigma. X-gal，IPTG and Tween 20 were purchased from USB. 
Trypton peptone, yeast extract and bacto agar were purchased from Becton Dickinson. 
Other chemicals were purchased from Sigma. 
4.2.1.2 Enzyme 
RNase-free DNase I (HPLC pure) was purchased from Amersham Biosciences. 
TTA K 
SUPERSCRIPT II RNase H Reverse Transcriptase was purchased from Invitrogen. 
Restriction enzymes and buffers were purchased from New England Biolabs. 
4.2.1.3 Kits 
HIEROGLYPH™ mRNA Profile Kit and fluoroDD Kit were purchased from 
Beckman. T7 Promoter 22-mer (5' GTAATACGACTCACTATAGGGC 3') and M13 
reverse 24-mer (5' AGCGGATAACAATTTCACACAGGA 3') primers were 
purchased from Beckman. AdvanTAge™ PCR Cloning Kit was purchased from 
Clontech. SMART™ PCR cDNA Synthesis Kit was purchased from Clontech. 
QIAGEN^ Spin Miniprep Kit and QIAquick® Gel Extraction Kit were purchased 
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from QIAGEN®. DIG-Chem-Link Labeling and Detection kits set were purchased 
from Roche. 
4.2.1.4 Others 
The non-fluorescent 3' oligo(dT) anchored primers, 5'-arbitrary primers, and 
dNTP mix were synthesized and purchased from Invitrogen. HR-1000™ 5.6% 
Denaturing polyacrylamide gel, TBE buffer, and TMR-labeled molecular weight DNA 
marker were purchased from Beckman. Bio-Dot® microfiltration apparatus was 
purchased from BIO-RAD. Hybond-N+ membranes were purchased from Amersham 
Biosciences. Gel blotting paper was purchased from Schleicher & Schuell. 3 MM 
Whatman filter paper was purchased from Whatman®. 
4.2.2 Methods 
4.2.2.1 Isolation of the total RNA from the mas transfectants by 
TRIZOL ® Reagent 
The transfected DHFR" CHO cells were grown to confluence in the selection medium 
[IMDM medium supplemented with 10% (v/v) dialyzed fetal bovine serum (FBS); 
1% (v/v) penicllin/streptomycin] in 100-mm tissues culture dish. The cells on the 
plate were lysed by adding 3 ml of TRIZOL® Reagent into the dish and the cell lysate 
were passed several times through a 1-ml pipette. The lysate was incubated at room 
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temperature for 5 minutes and transferred into 1.5 ml centrifuge tubes. 
Chloroform (0.2 ml/ml of TRIZOL® Reagent) was added into the lysates. Tubes were 
shaken vigorously by hand for 15 seconds and then incubated at room temperature for 
2 to 3 minutes. The samples were centrifuged at 12,000 g for 15 minutes at 4 The 
upper aqueous phases containing the RNA were transferred to a fresh tube. Isopropyl 
alcohol (0.5 ml/1 ml of TRIZOL® Reagent) was used to precipitate the RNA. Samples 
were incubated at room temperature for 10 minutes and centrifuged at 12,000 g for 10 
minutes at 4 °C. 
The supernatant was discarded. The RNA pellet was washed once with 1 ml of 75% 
ethanol. The RNA was centrifuged at 7,500 g for 5 minutes at 4 °C. Afterward, RNA 
pellet was dried at room temperature for 5-10 minutes. It is important not to let the 
RNA pellet dry completely as this will greatly decrease its solubility. RNA was 
dissolved in RNase-free water. 
4.2.2.2 DNase I treatment 
Total RNA isolated was treated by DNase I in order to remove any possible genomic 
DNA contamination. Otherwise, genomic DNA will also be amplified in RT-PCR and 
leads to false positive results of RT-PCR. 
Total RNA (-50 jig) was treated with DNase I in a 100 |li1 reaction mixture containing 
50 mM Tris-HCl (pH 7.5), 10 mM MgCl2 and 10 U RNase-free DNase I. The mixture 
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was mixed gently by finger tipping and incubated at 37�C for 30 minutes. After 30 
minutes, the mixture was diluted to 500 |li1 with nuclease-free water and then mixed 
with 500 |Lil of phenol: chloroform: isoamyl alcohol by vortexing. After mixing, the 
mixture was centrifUged at 15,000 g at 4 for 30 minutes. Supernatant (400 |li1) were 
transferred to a new 1.5-ml microcentrifuge tube and mixed with 40 |li1 of 3M sodium 
acetate (pH 5.2) and 800 |li1 of 100% ethanol overnight to precipitate the RNA. The 
mixture was centrifUged at 15,000 g at 4 for 30 minutes. Supernatant was 
discarded and RNA pellet was washed with 75% ethanol in DECP-treated water. RNA 
pellet obtained was centrifiiged at 15,000 g at 4 for 1 minute, supernatant was 
discarded carefully and washing steps were repeated two more times. Finally, RNA 
pellet was air-dried and resuspended in 30 |li1 of nuclease-free water and stored at -80 
4.2.2.3 Reverse transcription (RT) and non-fluorescent PCR 
According to fluoroDD manual of Beckman, 240 different combinations of PCR 
primer pairs will be generated by using 12 different 3’ oligo(dT) anchored primers 
(APs) and 20 different 5' arbitrary primers (ARPs). It is a fact that not all the primer 
combinations in the RT-PCR can give notable differential display patterns in different 
samples. Preliminary screenings with non-fluorescent primers were applied to select 
primer pairs that can generate differential mRNA patterns before performing 
fluorescent differential display (fluoroFDD). In preliminary screening, 
non-fluorescent PCR products were separated in agarose gel and visualized in the 
presence of 0.5 |ag/ml of ethidium bromide. 
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Reverse transcription reactions were carried out by mixing 0.2 |ag of freshly diluted 
and DNase I treated total RNA as well as 0.2 [xM AP into a final volume of 4 |li1, the 
mixtures were then denatured at 70 for 5 minutes and quickly chilled in ice. First 
strand buffer (Ix), 25 \xM dNTP mix, 10 mM DTT and 2 U of SUPERSCRIPT™ II 
RNase H Reverse Transcriptase and sterile water were then added to give a final 
reaction volume of 20 |il. For negative control of reverse transcription, 
SUPERSCRIPT™ II RNase H Reverse Transcriptase was excluded from the reaction 
mix. The RT reactions were performed in a thermal cycler with following conditions: 
42 for 5 minutes, 50 for 50 minutes, 70 ^ C for 15 minutes, and then held at 4°C. 
First strand cDNA synthesized was stored at -20 until use. 
Non-fluorescent RT-PCR was carried out by mixing with 4 |LI1 of first-strand cDNA, 
Ix PCR buffer, 50 |AM dNTP mix, 0.35 |liM AP, 0.35 |liM ARP, 0.5 U of Taq 
polymerase and sterile water to give a final volume of 10 |li1. The reaction was 
denatured at 95 for 2 minutes, followed by 4 cycles of denaturation at 92 ""C for 15 
seconds, annealing at 50 for 30 seconds, and elongation at 72 for 2 minutes, and 
followed by 30 cycles of denaturation at 92 for 15 seconds, annealing at 60 for 
30 seconds, elongation at 72 for 2 minutes, and for 7 minutes and stored at 
4°C. The amplified cDNA fragments were separated on a 1.5% agarose minigel with 
0.5 |Lig/ml ethidium bromide. 
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4.2.2.4 Reverse transcription and fluorescent differential 
display-PCR 
The combinations of AP and ARP primers that displayed a differential display pattern 
between the moy-transfected and vector-transfected cells in the preliminary screening 
were chosen for the fluorescent differential display-PCR (fluoroDD-PCR). In the 
fluoroDD, the 12 anchored primers are 5'-end labeled with a fluorescent tag, 
tetramethylrodamine (TMR). The conditions and procedures of the first strand cDNA 
synthesis and fluoroDD were the same as that mentioned in section 4.2.2.3. In 
synthesis of first strand cDNA, the APs and dNTP mix were obtained from 
HIEROGLYPH™ mRNA Profile Kit. In fluoroDD, the TMR-APs, ARPs and dNTP 
mix were obtained from fluoroDD Kit. After fluoroDD-PCR, the TMR-labeled cDNA 
fragments were stored at -20°C until use. 
4.2.2.5 High resolution fluorescent differential display (Fluoro DD) 
gel 
Following fluoroDD-PCR, the TMR-labeled cDNA fragments were 
electrophoretically separated on a high-resolution polyacrylamide gel under 
denaturing conditions. 
The inner side of the unnotched glass plate was treated with 4 N NaOH to provide a 
hydrophilic surface for the gel to contact, while the inner side of the notch plate was 
treated with Glass Shield (Beckman). The notch and unnotched plates were assembled 
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with a pair of 250 microns spacers. Then a high resolution polyacrylamide gel was set 
by mixing 70 ml of 5.6% denaturing HR-1000 gel with 320 i^l of freshly prepared 
10% ammonium persulfate and 32 i^l of N, N ,N，，N'-tetramethylethylene diamine 
(TEMED). The gel was allowed to polymerize overnight. Before running the 
fluoroDD gel, prior to loading samples, a flat field background was recorded by 
scanning the gel in the GenomyxSC fluorescent imaging scanner (Genomyx, USA). 
This allows the computer to subtract the background and improved the signal-to-noise 
ratio. 
Samples (4 |il) and TMR-labeled molecular weight DNA marker (1.2 |LI1) were mixed 
with 2 |Lil and 1.5 |LI1 of fluoroDD loading dye respectively. Samples and DNA marker 
were denatured and concentrated in a thermal cycler at 95°C for 4 minutes. The 48 or 
64-well, 250 microns thickness sharkstooth comb was used in the fluoroDD gel. The 
DNA samples and markers were loaded entirely to the well. FluoroDD gel 
electrophoresis was carried out in the GenomyxLR DNA electrophoresis system 
(Genomyx, USA). Upper buffer chamber and lower chamber were filled with 125 ml 
of 0.5x and 250 ml of Ix TBE respectively. The fluoroDD gel was run at 3000V， 
lOOW, 55 for 3 to 5 hours. After gel electrophoresis, the gel was dried in the 
GenomyxLR DNA electrophoresis system at 50�C for 25 minutes and washed with 4 
liters of distilled water. Drying and washing steps were repeated. Finally, the gel was 
dried again and scanned in the GenomyxSC fluorescent imaging scanner. 
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4.2.2.6 Gel band excision of differentially expressed cDNA fragments 
After the gel was scanned in GenomyxSC fluorescent imaging scanner, differentially 
displayed cDNA fragments were identified by comparing the patterns showing 
between pFRSV/mos-and pFRSV-transfected CHO cells. The candidate bands were 
excised from the gels. For locating the position of cDNA fragments in the fluoro DD 
gel, a virtual grid image was overlaid onto the fluoro DD gel image. 
By referring to the gel image with the Virtual Grid overlay, the exact locations of 
bands that appeared to be differentially expressed were identified and the 
corresponding location in a physical grid that matched the virtual grid overlay was 
marked with a fine marker. To excise the gel fragments, the marked physical grid was 
then placed on the platform of an Excision Workstation. The unnotched glass plate, 
with dried gel side up, was placed on the top of the physical grid and tape was used to 
fix the glass plate and the physical grid together in exact alignment. Sterile scalpel 
blades were used to excise the target gel bands. To ensure accurate excision of cDNA 
fragments, the gel was re-scanned after gel excision. The cDNA fragments were 
eluted by incubating the gel slide in 25 |LI1 of TE buffer (10 mM Tris-Cl，0.1 mM 
EDTA, pH 7.5) at 37°C for 1 hr and stored at -20°C. 
4.2.2.7 Gel band reamplification 
The DNA eluted from the gels was used as template for reamplification to obtain 
enough amount of cDNA fragment for subcloning. 
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Differentially expressed cDNA fragments were reamplified by mixing 4 ul of DNA 
gel elute with Ix PCR buffer, 1.5 mM MgCk, 20 |LIM dNTP mix, 0.2 |LIM ML3 reverse 
24-mer primer (5'-AGCGGATAAC AATTTC AC AC AGGA-3 % 0.2 ^M T7 Promoter 
22-mer primer (5'-GTAArACGACTCACTATAGGGC-3'), and 0.5 U of Taq 
polymerase in a final volume of 20 |LI1. The reamplifiaction condition was set as 
follows: 95 X for 2 minutes, followed by 4 cycles of 92°C for 30 seconds, 50 for 
30 seconds, 72 for 2 minutes, and then followed by 25 cycles of 92 for 30 
seconds, 60 for 30 seconds, 72 ""C for 2 minutes, and 72�C for 7 minutes and stored 
at 4°C. The reamplified cDNAwas separated in a 2% agarose gel. 
4.2.2.8 Subcloning of reamplified cDNA fragments 
Reamplified cDNA fragments were subcloned into a cloning vector for reverse dot 
blot analysis, DNA sequencing, and Northern blot analysis 
Subcloning was performed by using AdvanTAge^^ PCR Cloning Kit. Ligation 
mixture contained 1 |il of reamplified PCR products, Ix ligation buffer, 5 ng of 
pT-Adv vector and 4 U of T4 DNA ligase as well as sterile water in a final volume of 
20 |Lil. The mixture was incubated at 14�C overnight. Ligation mixture (2 jiil) was 
mixed with TOP 10F' E.coli competent cells and chilled on ice for 30 minutes. The 
mixture was then kept in a water bath for 90 seconds and immediately chilled on 
ice for 2 minutes. LB medium (800 |LI1) was added to the mixture and incubated at 
37°C for 1 hour. After incubation, cells were centrifUged at 1000 g at 4°C for 8 
minutes. Supernatant was discarded and cells were resuspended in 300 |LI1 of LB 
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medium. Cells were spread on LB agar plates containing 100 |Lig/ml ampicillin, 
covered with 40 \x\ of 40 mg/ml X-Gal and 40 |LI1 of 100 mM IPTQ and kept at 31"C 
incubator for 16 hr. 
Individual white colonies was inoculated into 3 ml of LB medium containing 100 
|Lig/ml ampicillin and incubated at 37°C shaker for 16 hours at 250 rpm. The bacterial 
culture (1 ml) was centrifuged at 20,000 g for 1 minute. Supernatant was discarded 
and cell pellet was resuspended in 17 |LI1 of autoclaved distilled water. The mixtures 
were then boiled for 1 minute and centrifuged at 20,000 g for 1 minute. Supernatant 
(17 |Lil) was digested with 1 |al of 20 U/|il EcoRI and 2 i^l of lOx EcoRI buffer at 37^C 
for 2 hr and separated on a 2% agarose gel. The clones that released inserts were 
screened and grown in LB containing 100 |Lig/ml ampicillin for DNA purification. 
4.2.2.9 Purification of plasmid DNA from recombinant clones for 
reverse dot blot analysis 
Overnight cultures (2 ml) were centrifuged at 4000 g for 8 minutes. Cell pellet was 
resuspended in 100 \i\ of Solution I [50 mM glucose, 25 mM Tris-HCl (pH 8.0) and 
10 mM EDTA (pH 8.0)], containing 4 mg/ml of lysozyme and mixed by vortexing. 
Solution II (200 III) (0.2 N NaOH and 1% SDS) were added and mixed gently by 
inverting for several times. The mixture was allowed to stand at room temperature for 
5 minutes. Solution III (150 |j1) (3 M potassium acetate and 5 M glacial acetic acid) 
were added and mixed immediately by inverting for several times. The mixture was 
kept at room temperature for 5 minutes. The mixture was centrifuged at 20,000 g for 5 
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minutes at 4°C. Supernatant was transferred to new tubes and mixed with equal 
volume of phenol: chloroform: isoamyl alcohol (25: 24; 1) by vortexing. The tubes 
were centrifuged at 20,000 g for 8 minutes. The supernatants were transferred into 
new tubes and mixed with 0.1 volume of 3 M sodium acetate (pH 5.2) and 2 - 2.5 
volume of absolute ethanol for precipitation of DNA. After ethanol precipitation, the 
DNA pellets were washed with 75% ethanol and the DNA pellets were resuspended in 
sterile distilled water. 
4.2.2.10 Reverse dot blot analysis 
Within a gel band, there may consist of several cDNA fragments that are similar in 
fragment length but different in base sequences. In order to identify the true 
differential expressed cDNA and eliminate the false-positive clones, reverse dot blot 
analysis was used to screen out any false-positive clones before they were subjected 
to DNA sequencing. 
4.2.2.10.1 Preparation of cDNAdot blot 
Positively charged nylon membranes and 3 MM Whatman paper were pre-wet in 
distilled water. The wet membrane and 3 MM Whatman paper were fixed into a 
Microfiltration Apparatus (Bio-Rad) as described by manufacture. Prior to addition of 
DNA sample, 400 |il of distilled water was added into each well to rehydrate the 
membrane. DNA samples (10 |Lig) in 150 |li1 distilled water were then applied to 
membranes by vacuum suction. After drainage of samples, 0.4 N NaOH (400 |li1) was 
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added to wash the membranes for twice by vacuum suction. After the NaOH was 
completely removed by suction pump, the membrane was disassembled from the 
apparatus. The membrane was then placed on the top of 3 MM filter paper pre-soaked 
in denaturation solution (0.5 M NaOH, 1.5 M NaCl) for 5 minutes. Then, membrane 
was transferred onto the a 3 MM Whatman paper with neutralization solution (IM 
Tris-Cl, 1.5 M NaCl) blotting for 15 minutes and then onto 2x SSC for 10 minutes. 
The membrane was air-dried at room temperature. The dry membrane was irradiated 
at 254 nm to cross-link the DNA to the membrane by exposing the dry membrane to a 
total energy of 0.12 J/cm . The membranes were stored in sealed bags at room 
temperature. 
4.2.2.10.2 Preparation of DIG-labeled cDNA library probes 
Total RNA from 80 [iM MTX treated pFRSV/mos- or pFRSV-transfected CHO cells 
were reverse transcribed and reamplified according to SMART™ PCR cDNA 
Synthesis Kit. Total RNA (1 (ig) was reverse transcribed in a mixture containing of Ix 
First Strand Buffer, 2 mM DTT, 1 mM dNTP mix, 1 pM 3，SMART CDS Primer II A, 
1 i^M SMART II Oligonucleotide, and 10 U PowerScript™ Reverse Transcriptase in a 
final volume of 10 |j1 The RT reaction was carried out in a thermal cycler and 
incubated at 42°C for 60 minutes, ll^C for 7 minutes, and stored at 4°C. First strand 
cDNA was diluted to 50 \x\ with 40 |LI1 of TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 
7.5) and stored at -20°C until use. 
For probe synthesis, optimal numbers of PCR cycles have to be determined 
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experimentally. Firstly, four PCR tubes with exactly the same content were set for 
each RT product. For each tube, diluted first strand cDNA (5 |LI1) was mixed in a 
mixture containing Ix Advantage 2 PCR Buffer, 0.2 mM dNTP mix, 0.2 |LIM 5' PCR 
Primer II A and 0.4 U Advantage 2 Polymerase in a final volume of 100 i^l. PCR was 
carried out in a thermal cycler (GeneAmp® PCR system 2400) with denaturation at 
95�C for 1 minute, followed by 24 cycles of denaturation at 95°C for 15 seconds, 
annealing at 65°C for 30 seconds, extension at 68°C for 6 min, and held at 4'^ C. After 
15 cycles, one tube of each quadruplicated sample was removed from the thermal 
cycler and kept on ice while others was allowed to continue the rest of PCR cycles. 
Aliquots were removed at 15 cycles, 18 cycles, 21 cycles and 24 cycles and 5 |LI1 of 
each aliquot was separated on a 1.2% agarose gel. After determining optimal number 
of cycles, additional cycles were performed for the tube stopped at 15 cycles as 
follows: 95°C for 1 minute, followed by additional cycles of 95°C for 15 seconds, 
65°C for 30 seconds, 68°C for 6 minutes, and stored at 4°C. After addition of cycles, 
PCR products (5 |il) were resolved on a 1.2% agarose gel. PCR products (19 |li1) were 
diluted to 200 |LI1 with nuclease-free water, mixed with 200 |LI1 of phenol: chloroform: 
isoamyl alcohol (25:24:1) and mixed thoroughly by vortexing. The mixture was 
centrifuged at 20,000 g for 15 minutes. Supernatant (180 |Ltl) were transferred to new 
tubes and precipitated by mixing with 0.1 volume of 3 M sodium acetate (pH 5.2) and 
2.5 volume of absolute ethanol at -80 °C overnight. After precipitation, the tubes were 
centrifuged at 20,000 g for 30 minutes, and supernatant was discarded. DNA pellet 
obtained was washed by 1 ml of 70% ethanol, centrifuged at 20,000 g for 10 minutes, 
and supernatant was discarded carefully. The DNA pellet was washed twice with 70% 
ethanol. Finally, DNA pellet was air-dried and resuspended in 36 |Lil of nuclease-free 
water. Purified cDNA library was stored at —20 °C until use. 
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To use as probe for reverse dot blot, cDNA was labeled with Digoxigenin. Purified 
cDNA (18 |Lil) were mixed with 2 \x\ of DIG-Chem-Link reagent and incubated at 85 
for 30 minutes. After 30 minutes, the labeling reaction was stopped by adding 5 |il 
of stop solution. The labeled cDNA library probes were then stored at 4°C. 
4.2.2.10.3 Hybridization 
The dried blot membranes were put into a hybridization tube and rinsed with 2X SSC 
gently. The membrane then hybridized with 25 ml of Dig Easy Hybridization buffer in 
a hybridization oven at 42 for 4 hours. Labeled cDNA library probes (25 fal) were 
boiled for 10 minutes and quick chilled on ice. The entire boiled probes were added to 
25 ml of fresh Dig Easy Hybridization buffer. Following hybridization, the blots were 
then hybridized with the probe solution and incubated at 42 overnight. The 
hybridized blots were washed twice with 2X SSC/0.1% SDS at 42 for 10 minutes 
and then washed twice with 0.5X SSC/0.1% SDS at 60�C for 15 minutes with gentle 
shaking. The hybridized blots were washed with washing buffer (0.1 M maleic acid, 
0.15 M NaCl; pH 7.5, 0.3 % tween 20) for 5 minutes and then incubated in IX 
Blocking solution [IX Blocking solution in maleic acid buffer (pH 7.5)] for 45 
minutes with gently shaking. Afterwards, an anti-digoxigenin-AP (Fab fragments) was 
added to the Blocking solution in dilution of 1:5000. It was incubated at room 
temperature with shaking for 1 hour. The Blocking solution was discarded and the 
membranes were washed with 100 ml of washing buffer (0.1 M maleic acid, 0.15 M 
NaCl; pH 7.5, 0.3 % tween 20) for 15 minutes at room temperature with gentle 
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shaking twice. The membrane was equilibrated with detection buffer (0.1 M NaCl, 0.1 
M Tris/HCl pH 9.5) for 5 minutes at room temperature. The membranes were then 
transferred into clean baked glass trays that were wrapped with tin foil. NET buffer 
(0.1 M NaCl, 0.1 M Tris/HCl pH 9.5, 0.05 M MgCls, 0.5 mg/ml NET, 0.19 mg/ml 
BCIP) was added slowly onto the membrane and the glass trays were covered with tin 
foil until the color was fully developed. 
4.2.2.11 Northern blot analysis 
After reverse dot blot analysis, clones that were confirmed showing differential 
expressed between the 80 |uM MTX-treated pFRSV/zTia^ and pFRSV transfected CHO 
cells were re-confirmed with Northern blot analysis. 
The DIG-labeled probes were prepared by using the PCR reaction. To prepare 
DIG-labeled cDNA probe. Firstly, the clone that needed to be further confirmed by 
Northern blot analysis was digested with EcoR I in a reaction mixture containing 10 
|ig DNA plasmid, IX EcoR I NEBuffer (50 mM NaCl, 100 mM Tris-HCl, 10 mM 
MgCb, 0.025% Triton X-100, pH 7.5), and 20 U of EcoR I (20 U/|il) in a final 
volume of 100 jil. The mixture was incubated at 37 °C overnight. The digested DNA 
fragments were separated in a 1% agarose gel and the target DNA fragments were 
purified by using the QIAquick® gel extraction kit. Then, the purified DNA 
fragments were DIG-labeled by PCR method. The PCR mixture contained IX PCR 
buffer; 2 mM MgCb; 0.2 mM dNTP (Digoxigenin-ll-dUTP to dTTP in a ratio of 1:4); 
0.45 |iM AP9 primer (5' ACG ACT CAC TAT AGO OCT TTT TTT TTT TTA C 3，） 
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and ARP 3 primer (5' AC A ATT TCA CAC AGG AGA CCA TTG CA 3'); 20 ng of 
the purified DNA template, and 5 U of Taq DNA Polymerase in a final volume of 20 
The reaction mixture was denaturated at 94 °C for 2 minutes and 1 of Taq DNA 
Polymerase (5 U) was added. The PCR reaction was carried out at a denaturation 
temperature of 94 °C for 30 seconds, an annealing temperature at 58 for 30 
seconds, and extension temperature of 72 °C for 45 seconds for 30 cycles. After an 
extended incubation at 7 2 � C for 7 minutes, the PCR was analyzed in a 1% agarose 
gel in the presence of 0.5 |xg/ml of ethidium bromide. The DIG-labeled DNA probe 
was stored at -20 until use. RNA electrophoresis, RNA blots preparation, 
pre-hybridization, hybridization, and detection were same as described in Chapter 2, 
section 2.2.2.11.1 to 2.2.2.11.7. 
4.3 Results 
4.3.1 Fluorescent differential display (FluoroDD) 
There are 240 different combinations of FluoroDD-PCR primers by using 12 different 
3，oligo (dT) anchored primers (APs) and 20 different 5' arbitrary primers (ARPs) 
(Appendix II). Since there is no way to predict which combination of primers give a 
significant differential gene expression profile, the AP primers were chosen randomly 
to perform the first strand cDNA synthesis reaction. In the present studies, two 
anchored primers (AP) were chosen to perform the reverse transcription reaction, the 
primers were AP 5 (5' ACG ACT CAC TAT AGG GCT TTT TTT TTT TTC A3') and 
AP9 (5' ACG ACT CAC TAT AGG GCT TTT TTT TTT TTA C 3'). Following first 
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strand synthesis, non-fluorescent RT-PCR was then performed with non-TMR-labeled 
ARP 3 (5’ AC A ATT TCA CAC AGG AGA CCA TTG CA 3，）and ARP 1 (5，AC A 
ATT TCA CAC AGG ACG ACT CCA AG 3). 
As shown in Figure 4.1, the comparison of gene expression pattern between the 
mas-stably transfected CHO cells and the control (pFRSV-stably transfected CHO 
cells) showed differential display pattern in the PCR reaction using with primers AP9 
and ARP 3 (lane 1-6 of Figure 4.1). It was found that one obviously and at least four 
slightly differential expressed genes were noted in the mas-stably transfected CHO 
cells. In contrast, PCR reaction with primer AP 5 and ARP 1 between the control and 
mas over-expressing CHO cells showed a very similar expression pattern in the mini 
agarose gel (lane 9-14 of Figure 4.1). 
Following preliminary examination of the gene expression profile with 
non-fluroescent primers, the ARP 3 and fluorescent, tetramethylrodamine (TMR) 
labeled AP 9 as well as ARP 1 and fluorescent, tetramethylrodamine (TMR) labeled 
AP 5 were used in the FDD-PCR reaction and TMR-labeled cDNA fragments were 
electrophoretically separated on a high resolution polyacrylamide gel under 
denaturing conditions. As shown in Figure 4.2’ in agreement with minigel study, there 
were 5 cDNA fragments named as SY 1 (1000 bp), SY 2 (980 bp), SY 3 (950 bp), SY 
4 (750 bp), SY 9 (360 bp) found to be up-regulated while other 5 cDNA fragments as 
SY 5 (560 bp), SY 6 (550 bp), SY 7 (380), SY 8 (360), SY 10 (350) found to be 
down-regulated in the mas-stably transfected CHO cells by using the AP 9 and ARP 3 
primers. On the other hand, there were 2 cDNA fragment named as SY 12 (720 bp) 
and SY 13 (450) found to be up-regulated while 2 other cDNA fragment named as SY 
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AP9+ARP3 AP5+ARP1 
pFRSV pFRSV/丽 pFRSV pFRSVW 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Figure 4.1 Non-fluorescent RT-PCR analysis. The total RNA samples from 80 
mM MTX treated pFRSV/mos-transfected CHO (lane 1-3, and lane 9-11), and 
pFRSV-transfected CHO cell (lane 4-6’ and lane 13-14). Total RNA was firstly 
converted into cDNA by AP 9 and AP 5，and then amplified by corresponding 
anchored primers and ARP 3 and ARP 1，respectively. The red arrow showed 
the differential display cDNA fragments between the vector transfectants and 
mas transfectants by using the primers AP 9 and ARP 3 (lane 1-6) as well as 
APS and ARP 1 (lane 9-14). 
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Figure 4.2 Fluorescent differential display gel showing the differential gene 
expression pattern between ma^-stably transfected and pFRSV vector-stably 
transfected CHO cells. TMR-labeled AP 9 (lane 1-6) and TMR-labeled AP 5 (lane 
7-10) in combination of ARP 1 were used in the fluoro DD-PCR. Duplicated PCR 
reaction for each sample was done. Red arrows showed the putative up-regulated 
cDNA fragments which included SY 1, SY 2, SY 3, SY 4, SY 9, SY 12, SY 13 while 
black arrows showed the putative down-regulated cDNA fragments which included 
SY 5, SY 6, SY 1, SY 8, SY 10, SY 11, SY 14. 
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Figure 4.3 Rescanning of gel-bands excised fluoro DD gel. Arrows indicated the gel 
bands that were excised and elute for subcloning. 
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11 (800 bp), SY 14 (400 bp) found to be down-regulated in the mas-sXMy transfected 
CHO cells by using the AP 5 and ARP 1 primers. Among of these differential 
expressed genes being identified, SY 1 and SY 2 which were about 1 kb molecular 
weight showed obviously up-regulated pattern in the /woy-stably transfected CHO cell 
(Figure 4.2). After the differential display cDNA fragments were identified in the 
fluoroDD gel, the cDNA gel bands were excised. The fluoroDD gel was scanned 
again to confirm whether the desired gel bands were excised accurately (Figure 4.3). 
4.3.2 Reverse dot blot analysis 
As for each gel band excised from the fluoroDD gel may contain several cDNA 
fragments that different in base sequence. In order to identify the true differential 
expressed cDNA and eliminate the false-positive clones, reverse dot blot analysis was 
used to screen out any false-positive clones before confirmation with Northern blot 
analysis and DNA sequencing. 
Following reamplification and subcloning into pT-Adv vector, colonies of each gel 
elute were randomly picked to grow and plasmid DNA was prepared. The DNA 
plasmid was subjected to EcoR I digestion in order to release the cloned cDNA 
fragments. As illustrated in Figure 4.4, the cDNA fragments released from clones SY 
1#4, SY 1#6, SY 1#8 displayed an appearance molecular weight about 1000 bp which 
was agreed with the molecular size of cDNA fragment SY 1 in the fluoroDD gel. 
However, the released cDNA fragment size of SY 1#6 is noticeable larger than that of 
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Figure 4.4 EcoR I digestion analysis of the clones derived from the excised gel bands 
in FluoroDD gel. DNA that shown differential expressed pattern were excised and 
eluted from the FluoroDD gel bands, and then reamplified and subcloned into pT-Adv 
vector. After subcloning, colonies were randomly picked. DNA was purified and 
analyzed by EcoR I digestion to release the cloned DNA fragments. (A) EcoR I 
digested clones that were derived from the FluoroDD gel band SY 1 to SY 4. 
Different clones that derived from the same FluoroDD gel bands were numbered after 
the name of the gel band. For instance, clone 4, 6, and 8 of SY 1 were SY 1#4, SY 
l#4 and SY 1#8, respectively. (B) EcoR I-digested clones that were derived from the 
FluoroDD gel band SY 4 to SY 6. (C) EcoR I-digested clones that were derived from 
the FluoroDD gel band SY 7 to SY 10. (D) EcoR I-digested clones that were derived 
from the FDD gel band SY 11 to SY 14. The EcoR I released DNA from SY 1 was 
about 1000 bp, SY 2 was about 1000 bp, SY 3 was about 970 bp, SY 4 was about 800 



























































































































































SY m and SY 1#8 (Figure 4.4 A). Similarly, the cDNA fragment released from clone 
SY 3#4 was slightly lower than that of SY 3#7 and SY 3#8 (Figure 4.4 A)，even 
though all of them were derived from cDNA fragment SY 3 of fluoroDD gel. Also, 
the cDNA fragments released from clones SY 6#4 and SY 6#13 show apparently 
higher molecular size than that of SY 6#3, SY 6#8,and 6#12 (Figure 4.4 B). It was 
interested to note that the cDNA fragments released from clones SY 7#4, SY 7#5 and 
SY 7#9 were all different in molecular size (Figure 4.4 C), although they were all 
dervied from the cDNA fragments SY 7 in fluoroDD gel. This situation was same in 
the clone SY 13, it was found that the cDNA fragments released from clones SY 
13#10, SY 13#14, and SY 13#15 were slightly different in molecular size (Figure 4.4 
D). 
After the sizes of the clones were confirmed by the restriction digestion, they were 
screened by reverse dot blot in order to check which clones displayed the same 
differential displayed pattern corresponding to the fluoroDD gel. Colour image of dot 
blot (Figure 4.5) were scanned with a flatbed scanner (Epson GT-9500) and analyzed 
by the software UN-SCAN-ITTM (Table 4.1). After screening of the reverse dot blot, 
there were 15 clones including SY 1#8, SY 3#8, SY 5#5, SY 5#12, SY 5#14, SY 6#3, 
SY em, SY 7#4, SY 7#5, SY 8#3, SY 9#5, SY 10#9, SY 11#14, SY 13#10, SY 14#9 
that were found to agree with the pattern shown in the fluoroDD gel. In agreement 
with the Southern blot of transfectants (Figure 2.9), the hybridization signal of pure 
plasmid DNA (pFRSV/mas) was higher in pFRSV-transfected CHO cells than that of 
pFRSV/zwoy-transfected CHO cells in the results of reverse dot blot. The 
housekeeping gene GAPDH was almost the same in the pFRSV/Twa^-transfected and 
pFRSV-transfected CHO cells. 
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Figure 4.5 Reverse dot blots analysis. cDNA derived from the total RNA 
pFRSV-transfected CHO cells (A), and pFRSV/wos-transfected CHO cells (B) 
were labeled with digoxigenin and used as probes. DNA (10 (ig) isolated from 
the clones that derived from the fluoroDD gel bands were immobilized on a 
nylon membrane. The blots were then hybridized with the DIG-labeled cDNA 
dervied from pFRSV-transfected CHO cells (A) and pFRSV/woy-transfected 
CHO cells (B). Red arrows showed the up-regulated genes in mas transfectants 
while white arrows showed the down-regulated genes in mas transfectants. 
Position 2F and 3F were the GAPDH cDNA which was used to standardize the 
two blots. 
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Table 4.1 Reverse dot blot analysis  
M Position iFDDgeldiferentialpatteml | pFRSV/ms |Eyession  
m Mas transfectant pattern 
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SY 13#14 2E up-regulated 0.233 0.365 
SY 13#15 3E 一 0.352 ~ 0.303 “ 
彬 — 5E ^ 
pFRSV/mas ^ 0.9% 0.896 
pFRSV/mas 一 7E 1.057 0.868 ‘ 
Mmst Maj^r Uimaiy yp 0J6-5 0,B47 t 
GAPDH 2F — ~ 0.976 ~ 0.975 
GAPDH 3F 1 1.024 1.025 
The result of the reverse dot blot in Figure 4.5 was scanned (Epson GT-9500) and digitized by uisng the 
software UN-SCAN-ITj^. The number showed the raw pixel intensity between the pFRSV and pFRSV/mas 
transfectants. The relative intensity of the clones denied from the fluoroDD could be compared between the 
pFRSV and pFRSV/mas transfectants. 
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Following the first-round reverse dot blot analysis, it was found that the clones that 
derived from the highly differential displayed cDNA fragment bands SY 1 and SY 2 
were not significantly different between control and woy-transfected CHO cells in the 
reverse dot blot. Therefore, cDNA that eluted from SY 1 and SY 2 were then 
reamplified and subcloned again. The newly obtained clones in combination with the 
clones SY 1#8, SY 3#8, SY 5#5, SY 5#12, SY 5#14, SY 6#3, SY 6#13, SY 7#4, SY 
7#5, SY m , SY 9#5, SY 10#9, SY 11#14, SY 13#10, SY 14#9 were then subjected 
to a second round of reverse dot blot analysis. 
Among the newly reamplified and subcloned SYl and SY 2 clones, there were 4 
clones named SY 1#11, SY 1#13, SY 1#15, SY 1#16, which agreed with the 
up-regulated differential display pattern in the fluoroDD gel (Figure 4.6 & Table 4.2). 
However, no clones of SY 2 displayed a pattern in the reverse dot blot that agreed 
with the differential display pattern in the fluoroDD gel. Among the clones that 
subjected to as second round of reverse dot blot analysis, it was found that clones SY 
3#8, SY 4#6, SY 5#12, SY 5#14, SY 8#13, SY 11#14, SY 13#10 gave a similar result 
as the first round dot blot analysis. In line with the first round of dot blot analysis, the 
housekeeping gene GAPDH level was unchanged in the mas- and vector-transfected 
CHO cells in the second round of reverse dot blot analysis. By contrast, positive 
control pOPRSVI//way gave a higher hybridization signal in the mas transfectants than 
that of vector control. 
4.3.3 DNA sequencing analysis of the clones 
According to the results obtained from the fluoroDD gel and reverse dot blot analysis, 
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Figure 4.6 Reverse dot blots analysis. cDNA derived from total RNA of 
pFRSV-transfected CHO cells (A), and pFRSV/mos-transfected CHO cells (B) 
were labeled with digoxigenin and used as probes. DNA (10 jig) isolated from the 
clones derived from the fluoroDD gel bands, were immobilized on a nylon 
membrane. The blots were then hybridized with the DIG-labeled cDNA derived 
from total RNA of pFRSV-transfected CHO cells (A) and pFRSV/wos-transfected 
CHO cells (B). Red arrows were showing the up-regulated genes in mas 
transfectants while white arrows were showing the down-regulated genes in mas 
transfectants. Position 3G and 4G were the GAPDH cDNA which was used to 
standardize the two blots. 
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Table 4.2 Results of reverse dot blot analysis  
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Identity Position display pattern for pattern for mas pFRSV pFRSV/jm? pattern 
mas transfectants transfetcants 
2A : i 镇 ： 幽 9 _ _ _ 
•位 3A i „ • „ : — m ’ � — 
： 4A —纖…..MSI...... 
船 ! ^ 驱-哪 feted ML —.�"I 爱尝一—�悬Hf卞 
c ^ �… - 7A 驅 7 0,933 /f 
: _ . ， _ ， ， . . _ . ： .gA : ： —. J 服._..’ .._„_.幽____ 二二 / ” 9A ‘ — ^ ‘ 0"S77 ~ 
^^ 勵 m ； : _ _ 7 
IB 0.522 0.508 ... 
M • 2B • .. 0^ 22 0,457….… 
""voiiio 3B 0.85 Ol842 、丫 丨z 4B 0.972 0.89 
5B - 0.905 '6.83 
6B 链:::IImKZ 
cv�#i/i 7B , , , .JJJ Q.m 6.439 SY 2#14 8B 叩-聰 ulated NIL — 
作测 9B 0.956 6.'845 
IQB ……..OM 0i53...••..• 
IC “ ••••'•'6"938 0.93 
2C 0.926 0.93 
3C 0.399 0.371 
4C •………�… 涵. • 
SYm I ~ g 阶 蹄 》 � 祐d 即识 _ _ 丨：一 i n — — I I I 
evo^ Q 7C — ^ r ~ 0.019 0?^ t SY 3#8 — up-regulated up-regulated •八 K'nTc ‘ 
oL. y U. / Z j 
3 7 3 .....— ~ ~ : 1 . 0 , 3 0 8 ~ ^ “ 0 . 5 Q 8 个 
•SY4#6 up--regaiated —q"355—:—— 
ID — 0.376~ 0.462 
• 2D ~ ...1.0352 ：蔬L.:  3D 一 , , , … 0.339 0.'329 i 
SY 5#12 — down-regulated down-regulated -；；-。-；； ^ 
4JJ U.JoZ U.J4O  
5D 一 ………0.346 0.'271……. 7 
SY侧4 ……… 0：279.…… ^ 
界饼3 _ 7D ‘ “ 0,3 0.39— 
—“ 艱 dowQ-xeguIsied do 純 rcegolated，一孕蔡，，.「，.参樊 
c^ x/ ,jiT：” yD ti-ioi t>�46fr : • 纖 0.419 
SY 7#4 IE 0.388 0.401 
2E , … , , , . '6.464 0.463 
— down-regulated down-regulated -；；"^•；;  
..y ]奶 3E 0.325 0.37 
4E ~ "6.373 0.379 
•SY ： ^ <30WR-regulatecJ —"i^ ir； ‘ 
w ： <iJ.j4 . . . . �nuc 7E , ^  , 1 , , 0.41 0.402 
一 up-regulated up-regulated •..石：涵g 0：461……… 
： 9E “ ‘ ‘ 0 3 9 4 0 ： ^ ““‘‘ 
5Y J0#9 <3o-wn-Tegufated down-regiiated -•�…—“•�…�义、.�"•�" 
SY11#14 ^ down-regulated down-regulated ‘？二^.?-， •^•；^™ 丄 
2F 0.415 0.409 
•SY 'i3#iO ： tip-regutsled 即-regwtaled —奢證― 器證.�— 卞 
SY -14#9 ^ down-regulated down-regulated -……•^•^；；王/- 
6F 0.34 0.342 ：… - SF … “ ‘ 7 7 7 " 0.613 0.454 T 
pjrKo-V/jnis ：^ i^L down-jegwiatea “•�‘一rTAV：—：“•�…"T"；："：; ^ 
yr U.O-j^v / 00 
pOpRSWmas ~ ~ ~ | ~ 亂 NIL — - ^ … - ^ - … … t 
: Q.9S6 G.948 嫌渊 40 涯 j—谨…T…7:逊…1 
The result of the reverse dot blot in Figure 4.6 was scanned (Epson GT-9500) and digitized by uisng the software UN-
SCAN-ITTM. The number showed the raw pixel intensity between the pFRSV and pFRSV/mas transfectants. The 
relative intensity of the clones denied from the fluoroDD could be compared between the pFRSV and pFRSV mas 
transfectants. 
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clones SY l#U, SY 1#13, SY 1#15，SY 1#16, SY3#8, SY4#6, SY 13#10 were found 
to be up-regulated in thQ mas transfectants, while clones SY 5#12, SY 5#14, SY 8#13, 
SY 11#14 were found to be down-regulated in the mas transfectants (Table 4.2). 
For further analysis, clones were subjected to DNA sequencing (Figure 4.7). After the 
sequencing results were obtained, it was found that all sub-clones of SY 1 and SY 3 
encoded the same fragment (Figure 4.8). Intriguingly, clone SY 1#15 and SY 3#8 
shared extended nucleotide homology with each other except missing a stretch of 71 
bp in the latter (Figure 4.9). It suggested that cDNA of SY 1#15 and SY 3#8 may 
come from single gene but underwent a different post-transcriptional splicing process. 
Furthermore, based on sequence of subclones, the complete cDNA sequences of 
fragment SY 1 and SY 5 were reassembled as shown in Figure 4.10. 
In order to investigate whether the clones were related to any known genes in the 
Genbank database, the sequences were submitted to the NCBI blast search 
(http://www.ncbi.nlm.nih.gov/BLAST/). Among the sequences subjected to the blast 
search, clones SY 4#6 and SY 11#14 were found to be aligned with known genes in 
the GenBank databases. The clone SY 4#6 was found to share with the Chinese 
hamster growth-regulated (Gro) gene (GenBank accession no. 103560) with 97% 
nucleotide homology within the coding sequence (Figure 4.11). The clone SY 11#14 
was found to share with the suppressor of K+ transport defect (Skd3) gene (GenBank 
accession no. NM一022947) with 93% nucleotide homology within the coding 
sequence (Figure 4.12). Other clones were not found to align with any known 
sequence in the nr and EST database of NCBI. 
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Figure 4.7 DNA sequence of clones derived from FluoroDD gel. Plasmid DNA was 
purified by QIAGEN® Spin Miniprep KIT and submitted to dye terminator cycle 
sequencing (DTCS) reactions. DNA sequences of clone SY 1#11 (686 bp) (A), SY 
1#13 (604 bp) (B), SY 1#15 (719 bp) (C)，SY 1#16 (604 bp) (D), SY 3#8 (709 bp) (E), 
SY 4#6 (639 bp) (F), SY 5#12 (399 bp) (G), SY 5#14 (725 bp) (H), SY 8#13 (562 bp) 
(I), SY 11#14 (334 bp) (J), SY 13#10 (689 bp) (K). The N characters in the sequences 
indicated the unreadable nucleotides. Sequences of AP and ARP were highlighted 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































***** **** * * * * ** * * * * * * * * ** ********** 
1 15 16 30 31 45 46 60 61 75 76 90 
1 SY1#15 TTGCCAAGCTATITA GGTGACACTATAGAA TACTCAAGCTATGCA TCAAGCTrGGTAC-C GAGCTQGGATCCACT AGTAACGGCCGCCAG 
2 SY3#8 TAC GACrCA--CTATAGG GCGAATTCCGCCCTC TAGAT-GCATGCTOG AG- - -CGGCCDCCAG 
**** ******* *** *************** *************** *************** *************** 
91 105 106 120 121 135 136 150 151 165 166 180 
1 SY1#15 TCTCCTCGA ATTOGCCCTTG TAATACGACTCACTA T A G G G C T m r m T TTTACmTAAATAT mATrTCCAAATTT 
2 SY3#8 TCTCATCGATATUTG CAGAATrCGGC-TTG TAATACGACTCACTA T A G G G C T m r m T nTACmTAAATAT nTATrTCCAAAnT 
�<��)�*;)�*******»�*!)�* *** *** ** *************** *************** *************** *********** 
181 195 196 210 211 225 226 240 241 255 256 270 
1 SY1#15 TTTCTAAAAATACCA ATAAATAGCGGCGTT GGTGGTGCACAOCIT TAATCCCAGCACTCA GGAGGCAGAGGCAGG CTCATCTCrGTCAGT 
2 SY3#8 irrGTAAAAATACCA ATAAATACCGGCGTT GGTGGTGCACACCIT TAATCCCAGCACTCA GGAGGCAGAGGCAGG CTGATCrCTGT----
******* *************** 
271 285 286 300 301 315 316 330 331 345 346 360 
1 SY1#15 TTGAGGCCAGCCTGG TCTCCAGAGGGAGTG OCAGGATAGGCTCTA AAGCTACACAGAGAA ACIUTCTCTCAAAAA AACAAAAAAAGAAAA 
2 SY3#8 CTCAAAAA AACAAAAAAAGAAAA 
**：•：************ *************** *************** *************** *************** *************** 
361 375 376 390 391 405 406 420 421 435 436 450 
1 SY1#15 AAATAOCAATAAATA TITAAACITCrCAGT TCTAAGACATAGATG CATTAAAAAGGCATT GTCTCITACAGAAAT CACTTAAAATCTCTA 
2 SY3#8 AAATAOCAATAAATA nTAAACTTCrCAGT TCTAAGACATAGATG CATTAAAAAGGCATT GTCTCITACAGAAAT CACTTAAAATGrCTA 
*************** * *******»：***** *************** *************** *************** *************** 
451 465 466 480 481 495 496 510 511 525 526 540 
1 SY1#15 AGGCATATACAGAAA TTACAGTrCTCAAAG CTTCAACACAAATTG ATCACCCACTCTAAT GCTGTAAAACACTTC AATAAATAACAACTG 
2 SY3#8 AGGCATATACAGAAA mCAGTTCTCAAAG CTTCAACACAAATTG ATCACTaCTCTAAT GCTGTAAAACACITC AATAAATAACAACTG 
************!)：** *************** ************ ** *************** *** * ** ****** ************** 
541 555 556 570 571 585 586 600 601 615 616 630 
1 SY1#15 ATAGTCrrTCACOGG TACAAAGTAGATGTG CACATATATTCGNCC TACATTAAAATGACC TCCNTNGCCCATTCA CTACCCCAGCTACCC 
2 SY3#8 ATAGTOTTCACOGG TACAAAGTAGATGTG CACATATATTCGCOC TACATTAAAATGACC TCCnTGCNCATTCA CTACCCCAGCTACCA 
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********* ***** *** ** ****** ** * ***** *** **** *** * *** *** *** * * * 
631 645 646 660 661 675 676 690 691 705 706 720 
1 SY1#15 ACACCATGGGTCAGC ATGAAATGGCTGCCT CANANNTA1TANTAT ANTONCNTGGGGAAN AAGGGANNOCTAAAC CCTNCAN-TNANGAA 
2 SY3#8 ACACCATGG-TGAGC ATGNANTGNCTGCCT CANAANTATTAATAT NANNTNCTGOGAGAA NAOGNAAAOCTTAAC CCTCCNAATAANGAN 
*** *** * 
721 735 736 750 751 765 766 780 781 795 796 810 
1 SY1#15 TGAGGATmr -
2 SY3#8 TGANGATNNATNCAT CTNCNATINNATnT AAATAAACAGTAANT TCANTGGCATNNGNC AGCNGNTCNANCNAT COCTAGTTATINACr 
811 825 826 840 841 855 856 870 871 885 886 900 
1 SY1#15 719 
2 SY3#8 ATTIN 709 
Figure 4.9 The sequencing alignment between clone SY 1#15 and SY The asterisks 
above indicated the matched nucleotides between these two clones. The solid red bar 
indicated the additional 71 bp stretch of SY 1#11. There was about 80% of the 
nucleotide sequences matched between these two clones. The sequence of the AP9 were 
highlighted with red color. 
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Figure 4.10 Assembled sequence of clone SY 1 and SY 5. Sequence of clone SY 
1#15-AP9 and SY 5#14-AP9 were converted into reverse complement (green color) 
and arranged with the sequence of clone SY 1#11-ARP 3 and SY 5#12-ARP 3 (black 
color) respectively, to assemble the cDNA fragment of the clone SY 1 and SY 5. The 
sequence of ARP 3 was highlighted with red color while the reverse complementary 
sequence of AP9 was highlighted with blue color. 
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SY4#6: 28 tgcacccaaaccgaagtcatagccactctcaagaatggtcaggaagcttgccttaaccct 87 
111111111111 "111111111111111111111111111111111111111111111111 
Sbjct: 238 tgcacccaaaccgaagtcatagccactctcaagaatggtcaggaagcttgccttaaccct 297 
SY4#6: 88 gaagcccccatggttcagaagattgtccaaaagatgctaaagagcggaatccgtaagtaa 147 
111111111111111111111111111111111111111111111111111111111111 
Sbjct: 298 gaagcccccatggttcagaagattgtccaaaagatgctaaagagcggaatccgtaagtaa 357 
SY4#6: 148 cagagaaagaagtaagattgctttggtggcgcatctgtgatcgctgacttctgacaacac 207 
111111111111111111111111111111111111111111111111111111111111 
Sbjct: 358 cagagaaagaagtaagattgctttggtggcgcatctgtgatcgctgacttctgacaacac 417 
SY4#6: 208 tggcttaacacattttacagtttcttacaagaaccctatttatttatgtatttatttatt 267 
11 I11 11 I11 11 I11 11111 I11 11 I11 11 11111 I11 I11 11 I11 11 11111 I11 I11 I 
Sbjct: 418 tggcttaacacattttacagtttcttacaagaaccctatttatttatgtatttatttatt 477 
* ** 
SY4#6: 268 tcacaaagcttgtgtattttatttttacatnaatatnnaacattgtggatgtgttttatc 327 
1111111111111111111111111111 11 11111 11111 11111 I11 111111111 
Sbjct: 478 tcacaaagcttgtgtattttatttttacattaatatttaacattgtggatgtgttttatc 537 
* 
SY4#6: 328 aatggtagttcagttctgattgttcagtttgaagatggtaggcttaaaatatctcagtan 387 
I1111111111111111111111111111111111111111111111111111111111 
Sbjct: 538 aatggtagttcagttctgattgttcagtttgaagatggtaggcttaaaatatctcagtaa 597 
* * * * * 
SY4#6: 388 actaatatttatggggagancatnaagtgtc-accactgtaagagaagcatgtggngttn 446 
11I111111111 111111 I11 1111111 11111111111111111111111 II1 
Sbjct: 598 actaatatttattgggagaccattaagtgtcaaccactgtaagagaagcatgtggggttg 657 
* * * 
SY4#6: 447 ggnaaaaagcagagagatgagagcatatgatcatgtntgtatnagggtgaggga 500 
11 111111111111111111111111111111111 11111 11111111111 
Sbjct: 658 ggaaaaaagcagagagatgagagcatatgatcatgtttgtattagggtgaggga 711 
Figure 4.11 Alignment of the sequence of clone SY 4#6 with the sequence of the Chinese 
hamster growth regulated gene (Sbjct) in GenBank (accession no. J03560). The sequenced 
SY 4#6 contained 602 bp while the mRNA of the Chinese hamster growth gene contained 
950 bp. There were about 97% of the sequences matched between SY 4#6 and the Chinese 
hamster growth regulated gene within the coding sequence (52 to 357). The asterisks 
above showed the unmatched nucleotides. 
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* * * 
Query: 1 ggatgccatcttcatcatgacttccaatgtagccagcgatgagattgcccagcatgcact 60 
11111111111111111111111111111111111111111111111111111111 I 
Sbjct: 1416 ggatgccatcttcatcatgacttccaatgtagccagtgatgagatcgcccagcatgcatt 1475 
* * * 
Query: 61 gcagctgaggcaggaagctttggagatgagccgaaatcgaattgctgaaaaccttgggga 120 
I11 11111 11111111111111111111111111111111 11111111111111111 
Sbjct: 1476 gcaactgagacaggaagctttggagatgagccgaaatcgaatagctgaaaaccttgggga 1535 
* * * * 
Query: 121 cgtccagattagtgacaagatcaccatctcaaagaactttaaggagaatgtgatccgccc 180 
11111111111111111111111111111111111111 11 111111 1111111 11 
Sbjct: 1536 tgtccagattagtgacaagatcaccatctcaaagaacttcaaagagaatatgatccgacc 1595 
* **** * 
Query: 181 catcctgaaagctcacttccggagagatgagtttctgggattttttaatgagatcgtcta 240 
111111111111111111111111111 111111111111 I 11111111111111 
Sbjct: 1596 catcctgaaagctcacttccggagagacgagtttctgggaaggatcaatgagatcgtcta 1655 
* * 
Query: 241 cttcctccctttttgccactcagagctcatccagctggtcaacaaggaactgaacttctg 300 
111111111111 11111111 11111111111111111111111111111111111111 
Sbjct: 1656 cttcctccctttctgccactcggagctcatccagctggtcaacaaggaactgaacttctg 1715 
Query: 301 ggccaagaga 310 
111111I111 
Sbjct: 1716 ggccaagaga 1725 
Figure 4.12 Alignment of sequence of clone SY 11#14 with the sequence of Rattus 
norvegicus suppressor of K + transport defect 3 (Skd3) gene (Sbjct) in Genbank 
(accession no. NM_022947). The sequenced SY 11#14 contained 334 bp with the 
mRNA of the Rattus norvegicus suppressor of K + transport defect 3 (Skd3) gene 
contained 2138 bp. There were about 93% of the sequences matched between SY 
11 # 14 and the Rattus norvegicus suppressor of K + transport defect 3 (Skd3) gene 
within the coding region (46-2079). The asterisks above showed the unmatched 
nucleotides. 
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4.3.4 Confirmation of differential display pattern of the subclones by 
Northern blot analysis 
Northern blot analysis was used to confirm the differential expressed genes that found 
in the fluoroDD and reverse dot blot analysis. Among the clones confirmed with the 
reverse dot blot, one obvious up-regulated novel clone SY 3#8 (Figure 4.6 & Table 
4.2), was subjected for further analysis by preparing DIG-labeled probes, hybridizing 
with the total RNA isolated from mas tranfected CHO cells (Figure 4.13) and nude 
mice tumor tissue injected with mas transfectants (Figure 4.14). 
As illustrated in Figure 4.13, the blot was hybridized DIG-labeled probe prepared 
from clone SY 3#8. It was found that total RNA sample collected from parental 
DHFR deficient CHO cells (lane 1, 2)，pFRSV-transfected CHO cells treated with 80 
HM MTX (lane 3, 4), pFRSV/ma^-transfected CHO cells without MTX treatment 
(lane 5, 6), and pFRSV/ma^-transfected CHO cells treated with 80 pM MTX (lane 7, 
8), there were two signal bands 3500 bp (band A), 1821 bp (band B) that were 
detected in all samples (lane 1-8). In contrast, there was one additional signal band 
that was detected at molecular size about 1750 bp (band C) that appeared only in 
RNA sample of mas transfectants (lane 5-8). The signal band A (3500 bp) gave 
weaker intensity in pFRSV/ma^-transfected cells (lane 5-8) than that of parental and 
pFRSV-tranfected CHO cells (lane 1-4). However, the signal band B (1821 bp) gave 
similar intensity in all RNA samples of mas transfectants and control (lane 1-8). 
Moreover, the signal band C (1750 bp) gave a strong intensity in 
pFRSV/Twa^-transfectants (lane 5-8) but no detectable signal in control (lane 1-4). 
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Figure 4.13 Northern blot analysis of mas-stably transfectants with 
DIG-labeled clone SY 3#8. Total RNA isolated from parental DHFR 
deficient CHO cells (lane 1, 2), pFRSV-transfected CHO cells treated with 
80 \jM MTX (lane 3，4), pFRSV/mas-transfected CHO cells without MTX 
treatment (lane 5, 6), pFRSV/wos-transfected CHO cells treated with 80 
^ MTX (lane 7, 8). The blot was hybridized with the DIG-labeled cDNA 
of clone SY 3#8 prepared by PCR as described in section 4.2.2.11. 
DIG-labeled DNA marker was shown in lane M. 
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Following confirmation of the up-regulation of clone SY 3#8 in stable mas 
transfectants by Northern blot analysis, total RNA from the nude mice tumor tissue 
was also evaluated. As illustrated in Figure 4.14, the detection signal pattern was 
similar to that found on the Northern blot with total RNA from ma^-transfected CHO 
cells. There were two signal bands 3500 bp (band A), 1821 bp (band B) found in all 
samples (lane 1-8) but one additional signal band at molecular size about 1750 (band 
C) that appeared in RNA sample of mas transfectants (lane 5-8). The signal band A 
(3500 bp) gave weaker intensity in pFRSV/ma^-transfected cells (lane 5-8) than that 
of parental and pFRSV-tranfected CHO cells (lane 1-4). However，the signal band B 
(1821 bp) gave similar intensity in all RNA samples of mas transfectants and control 
(lane 1-8). Moreover, the signal band C (1750 bp) gave a strong intensity in 
pFRSV/wa^-transfectants (lane 5-8) but no detectable signal in control (lane 1-4). 
There was a very strong signal band (band D; 400 bp) found in the total RNA of mas 
transfectants (lane 5-8), which might be due to the degradation of RNA in the nude 
mice tumor tissues. In order to normalize the total RNA sample on the northern blot, 
the blot was stripped and rehybridized with DIG-labeled GAPDH cDNA probe 
(Figure 4.15). Except for the GAPDH transcripts identified on the blot, there were two 
extra bands at molecular size about 3500 bp (band A) and 1821 bp (band B) that were 
found on the blot, which might be due to incomplete stripping of the DIG-labeled SY 
3#8 probe as illustrated by the intense 400 bp signal (band D). 
Another clone that showed up-regulation in the Twa^-transfected CHO cells is the 
Chinese hamster growth-related gene. The cDNA of Chinese hamster growth-related 
gene was used to prepare the DIG-labeled cDNA probes and hybridized to the 
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Figure 4.14 Northern blot analysis of mas-stably transfectants-induced 
tumor tissue with DIG-labeled clone SY 3#8. Total RNA isolated from 
nude mice tissue injected with parental DHFR deficient CHO cells (lane 1, 
2), nude mice tissue injected with pFRSV-transfected CHO cells treated 
with 80 jiM MTX (lane 3, 4)，nude mice tumor tissue injected pFRSV/wos-transfected CHO cells without MTX treatment (lane 5, 6), nude mice tumor tissue injected pFRSV/wos-transfect d CHO cells treatedwith 80 i^M MTX (lan  7, 8). The blot was hybridized wi h heDIG-labeled cDNA of clone SY 3#S prepared by PCR as described in section 4.2.2.11. DIG-label d DNA marker w s shown in lane M. 
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Figure 4.15 Normalization of Northern blot of mas transfectants-induced tumor 
with DIG-labeled GADPH cDNA. Total RNA isolated from nude mice tissue 
injected with parental DHFR deficient CHO cells (lane 1，2)，nude mice tissue 
injected with pFRSV-transfected CHO cells treated with 80 [M MTX (lane 3, 
4), nude mice tumor tissue injected with pFRSV/mas-transfected CHO cells 
without MTX treatment (lane 5, 6), nude mice tumor tissue injected 
pFRSV/薩-transfected CHO cells treated with 80 [M MTX (lane 7, 8). The 
blot was previous hybridized with the DIG-labeled DNA of clone SY 3#8 as 
showed in Figure 4.15, and then it was stripped and rehybridized with 
DIG-labeled GAPDH cDNA. DIG-labeled DNA marker was shown in lane M. 
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Figure 4.16 Northern blot analysis of mas-stably transfectants with 
DIG-labeled clone SY 4#6 (Chinese hamster growth-related gene). Total 
RNA isolated from parental DHFR deficient CHO cells (lane 1，2), 
pFRSV-transfected CHO cells treated with 80 ^M MTX (lane 3, 4)， 
pFRSV/mos-transfected CHO cells without MTX treatment (lane 5, 6)， 
pFRSV/znos-transfected CHO cells treated with 80 i^M MTX (lane 7, 8). 
The blot was hybridized with the DIG-labeled cDNA of clone SY 4#6 
prepared by PCR as described in section 4.2.2.11. DIG-labeled DNA 
morlr^^r wroc cV*r\�im ir» lono 
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Northern blot shown in Figure 4.16. As illustrated in Figure 4.16，there was no signal 
dtetected in the total RNA sample of wild-type DHFR" CHO cells. One weak signal at 
position A (1600bp) was detected in the total RNA sample of vector-transfected CHO 
cells. On the hand, in the total RNA sample of mos-transfected CHO cells without 
MIX treatment as well as with 80 |LIM MTX treatment, one obvious signal was 
detected at position A (1600 bp). This signal (1600bp) was showing stronger signal 
intensity in /wa5-transfected CHO cells than that in vector-transfected CHO cells. 
4.4 Discussion 
It had been reported that mas caused tumor formation in nude mice after the 
transformed NIH 3T3 cells were injected into nude mice (Young et al., 1986). In our 
study, we showed that mos-transfected CHO cells caused tumor formation in nude 
mice. Furthermore, we have extended the finding that over-expression of the mas 
gene itself was sufficient to induce tumor formation by amplifying mas transgene 
copy number in transfected cells. Recently, Xu and co-workers (2000) found that 
transgenic mice with over-expressing mas in the cone photoreceptor cells caused cone 
cell degeneration without tumor formation (Xu et al., 2000). The discrepancy in these 
results may be explained by the expression level of mas, as discussed in section 3.4. 
The fluoroDD analysis has demonstrated that over-expression of mas up-regulated as 
well as down-regulated different genes in /was'-transfected CHO cells. The fluoroDD 
analysis agreed with the results of differential display pattern that was found in the 
mini agarose gel in the preliminary screening. cDNA fragments that showed 
differential expression in the mini agarose gel, also gave same differential expression 
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in the fluoroDD gel and reverse dot blot. Since there are 240 different combinations 
of primer pairs in the fluoroDD PCR reaction, not all the combinations of the primer 
pairs can give notable differential display patterns. Hence, it is worth to use the 
non-fluorsecent RT-PCR to screen the primer pairs in mini agarose gel. 
Sequencing alignment analysis suggested that two clones, SY 1#15 and SY 3#8, share 
extended nucleotide homology to each other, except there is an additional 71 bp 
stretch in SY 1#15. These two clones came from different cDNA fragment bands in 
the fluoroDD gel, with molecular size at about 1000 bp and 950 bp respectively. Both 
of them were showing up-regulated expression pattern in the mas over-expressing 
cells. It was suggested that these two cDNA fragments might come from a single gene 
family but underwent different post-transcriptional splicing process. 
Sequencing of the clones suggested that most of them were novel genes except for the 
SY 4#6 and SY 11#14, which showed alignment to the Chinese hamster growth 
regulated gene (GenBank accession no. JOS560) and suppressor of K+ transport defect 
(Skd3) gene (GenBank accession no. NM—022947), respectively. Since clone SY 4#6 
genes shared about 97% nucleotide homology to Chinese hamster growth regulated 
gene within the coding region, we suggested that SY 4#6 may be the Chinese hamster 
growth-regulated gene or other gene that related to the growth regulation in Chinese 
hamster. According to the fluoroDD and reverse dot blot analysis, it was found that 
SY 4#6 was up-regulated in the mas over-expressing CHO cells. Hence, the 
mas-induced tumor formation may be partly due to the uncontrolled regulation of the 
growth-regulated gene after mas gene transformation (Anisowicz et al., 1987). For 
clone SY 11#14 shared about 93% nucleotide homology to suppressor of K+ transport 
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defect (Skd3) gene within the coding region, we suggested that SY 11#14 may be the 
suppressor of K+ transport defect (Skd3) gene. According to the fluoroDD and reverse 
dot blot analysis, it was found that SY 11#14 was down-regulated in the mas 
over-expressing CHO cells. 
FluoroDD has been proved to be highly effective in identifying sequences that are 
differentially expressed in various cell types, and also in detecting genes that are 
underrepresented in an mRNA population, such as those putatively coding for 
regulatory proteins (Liang et al., 1992; Liang et al., 1994). One of the remarkable 
advantages of this method is its sensitivity. In contrast to the relatively large amount 
(milligrams) of RNA is required for subtractive and differential hybridization 
techniques, fluoroDD can efficiently identify specific mRNA using micro- or even 
nanograms of total RNA (Colonna-Romano et al., 1995). Another essential feature of 
fluoroDD is that, compared to conventional cloning techniques, it identifies large 
numbers of differentially expressed mRNA, which can be subsequently cloned (Bauer 
et al., 1993). 
FluoroDD was found to be effective in identifying differential expressed genes, but it 
still has its liminations. Negative signal on the Northern blot (i.e. the same or no 
signal detected) are common (Liang et al., 1995). False positive can be minimized 
when preparation of RNA from cells or tissues by removing trace amount of 
chromosomal contamination. It is because even trace amount of chromosomal DNA 
that can be recognized by the anchored and arbitrary primers in the RT-PCR, therefore 




5.1 General model for mas-induced tumor formation 
Tumors result from subversion of processes that control normal growth, location, and 
mortality of cells. Generally, the loss of normal control mechanisms arises from 
acquisition of mutations in three broad categories of genes (Hesketh 1995): 
1. Proto-oncogenes, the normal products of which are components of signaling 
pathways that regulate proliferation and other cellular activity. However, it 
become a dominant oncogene and thus produces tumorigenicity after mutation. 
For example, ETS and RAS. 
2. Tumor suppressor genes that generally exhibit recessive behavior. However, the 
loss of function of tumor suppressor genes in cancers leads to deregulated control 
of cell cycle progression, and cellular adhesion. For example, RBI and P53. 
3. DNA repair enzymes, mutations in which promote genetic instability. For 
example, MSH2 mdMSH3. 
Among the three categories of gene mutation resulting in tumor formation, we are 
focusing on the activation of mas proto-oncogene in causing tumor formation. In 
normal cells, proto-oncogene activation may occur by mutation, DNA rearrangement, 
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or gene amplification (Hesketh 1995). In this report, we have addressed the question 
of how mas oncogene was activated and transformed normal cells to tumors. Previous 
studies suggested that mas oncogene induced tumor formation after /woy-transfected 
NIH 3T3 cells were injected into nude mice. Mutations in the coding region were not 
detected, but the 5' non-coding region of mas gene was rearranged. It was proposed 
that the activation of the mas oncogene was due to the rearrangement of the 5' 
non-coding region of mas gene (Young et al., 1986; Janssen et al., 1988). To further 
extend the studies, we found that over-expression of mas oncogene itself was 
sufficient to cause tumor formation in nude mice as inoculation of Twa^-transfected 
CHO cells with over-expression of mas induced tumor formation. It was not 
necessary for the rearrangement of 5' non-coding region of mas in inducing tumor 
formation. Our finding agrees with the study of Van't Veer and co-workers (1988), in 
which they have reported that the amplification of mas by the alphoid repeat may 
contribute to the tumorgenicity in nude mice (Van't Veer et al., 1988). According to 
these findings, we suggested that the mas-induced tumor formation was due to 
over-expression of mas gene in cells. 
Since mas was found to be a seven putative transmembrane domain protein that 
shares structural similarity to other G-protein coupled receptor (Young et al., 1988), 
mas may play a role in the signaling pathways that activate a cascade of 
second-messagers in regulating cell proliferation. It is known that tumor formation 
results from uncontrolled cell proliferation and/or apoptosis, which can be due to the 
aberrant functions of one or more components in the signaling pathways. It is 
intriguing that many proteins that are involved in the signal transduction pathway of 
growth factor receptors can transform cells. For instance, over expression or mutant 
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forms of epidermal growth factor (EGF) receptor, GRB-2, SOS, RAS, RAF are 
reported to cause oncogenic transformation. In case of cellular transformation with 
over-expression of signaling molecules, sustained signaling may result in malignant 
transformation (Sharif et al., 1994). Indeed, using fibroblast cells and in vitro 
transfection assay, 5HTic and muscarinic acetylcholine receptors (Gutkind et al., 1991) 
were shown to have transforming activity when activated by their agonists. Such 
ligand-dependent transformation raised the interesting issue of whether such receptors 
could also be constitutively activated by mutation. It was subsequently shown by 
Allen and co-workers in 1991, specific point mutation in the C-terminal 
juxtamembrane region of the predicted third intracellular loop of the aiB-adrenoceptor 
gave a transforming receptor which did not require ligand activation for its activity. 
These receptors all share phospholipase C as their presumptive signal transduction 
pathway, strengthening the correlation between the PLC pathway and malignant 
transformation (Allen et al., 1991; Kjelsberg et al., 1992). Hence, over-expression of 
mas may over-activate its down-stream signaling events. However, it is still under 
investigation whether there are endogenous mas ligands to activate the over-expressed 
mas in the signaling pathways, or over-expression can transfer mas to become a 
ligand-independent receptor, which in turn leads to uncontrolled cell proliferation in 
the transformed cells. 
It is of interest to note that the tumor's growth in the nude mice after inoculation of 
the transformed CHO cells regressed spontaneously after a period of time (-three 
weeks). This phenomenon was not described by Young and his co-worker (1986); as 
well as Johannes and his co-worker (1988) in their nude mice tumorigenicity assays 
(Young et al., 1986; Janssen et al., 1988). It was recognized that modulation of the 
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normal processes that lead to cell loss or apoptosis is also sufficient for tumor 
development. Mathematical modeling of cellular behavior predicted that tumors might 
indeed arise when exponential cell growth occurred, usually when stem cells fail to 
die or differentiate (Hesketh 1995). On the other hand, tumor formation may also 
arise when a new, higher equilibrium was reached in which an abnormally high 
number of cells were present within a population as a result of fully differentiated 
cells failing to undergo apoptosis (Tomlinson et al., 1995). Mas was found to induce 
degeneration of cone photoreceptor cells when it was targeted over-expressing in the 
photorecetor cells (Xu et al., 2000). However, mas was found to induce tumor 
formation and the subsequent tumor regression in our nude mice tumorgenicity assay, 
a possibility arises that mas seems to modulate the equilibrium between the cell 
proliferation and apoptosis. In our study, it was suggested that at the early phase 
mas-induced cell proliferation was dominant to that of apoptosis. However, the 
dominant effect of cell proliferation became faded out after a certain period of time. 
The transformed CHO cells with higher mas expression seemed to retain this 
dominant proliferative effect for a longer time. We suggested that higher expression of 
mas may shift the equilibrium favoring cell growth rather than apoptosis. 
The epidemiology of cancer strongly suggests that to drive a cell through various 
stages preceding tumor formation in vivo requires accumulation of several genetic 
lesions. In experimental animals, chemical induction of tumors generally requires the 
sequential application of two types of agents, an "initiator" and "promoter". The 
initiator is usually a mutagen that has irreversible effects and must be administered 
before the promoter (Hesketh 1995). These model systems indicate that the initiating 
event in tumorigenesis is mutation and that subsequent tumor progression may be 
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mediated by either genetic or epigenetic mechanism. In vitro cellular studies generally 
support the notion that transformation is at least a two-stage process, one oncogene 
being needed for immortalization and another for transformation. In our fluoroDD 
results, we were able to identify the alternation of gene expression in the 
wos-transfected CHO cells. We proposed that mas induced tumor formation by 
up-regulating and/or down-regulating other gene expression. In our study, one gene 
that was up-regulated in mas over-expressing cells was identified as Chinese hamster 
growth-regulated gene (Genebank accession no. J03560). It was reported that 
uncontrolled expression of growth regulation genes might contribute, to tumor 
formation (Anisowicz et al.，1987). In conclusion, we suggested that the possible 
molecular mechanisms of mas-induced tumors may attribute to two steps. Firstly, as 
mas was predicted as a G protein-coupled receptor, over-expression of mas may result 
in uncontrolled activation of the signaling leading to uncontrolled cell proliferation 
and/or alternation of normal process of apoptosis (Sharif et al., 1994). Secondary, 
over-expression of mas was found to alter gene expression, which may modulate the 
signaling pathway directly or indirectly, resulting in alternation of the equilibrium 
between cell growth and apoptosis. We suggested that over-expression of mas may 
trigger uncontrolled cell growth by shifting the equilibrium favoring to cell growth at 
the beginning. However, a new equilibrium will be established after a period of time 
in which the effect of apoptosis might become dominant, depending on the level of 
mas expression. 
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5.2 Future aspect 
Mas was found to alter the gene expression in the mos-transfected CHO cells. In the 
present study, we were able to identify four novel genes and two known genes of 
which expression were modulated in the ma^-transfected CHO cells. In order to find 
out more candidate genes that were being altered by over-expression of mas, other 
combinations of the anchored primers and arbitrary primers should be used in the 
fluoroDD. Since there was no evidence supported that mas alter gene expression 
pattern is same both in vitro and in vivo, it is of interest to investigate the in vivo gene 
expression pattern in mas-induced tumor tissues from the nude mice. 
Alternatively, subtractive hybridization can be used to identify genes that are 
expressed only in the mas over-expressing cell line and also the nude mice tumor 
tissues. Subtractive hybridization is a powerful technique that enables us to compare 
the expression pattern between the mas over-expressing cell lines and control in order 
to find out any candidate genes that are only expressed in one population but not in 
the other. 
Mas was predicted to be a G-protein coupled membrane receptor, its possible ligands 
were still under investigated. Evidence indicates that mas causes tumor formation, 
exploration of the functional ligands of mas becomes of clinical significance. 
Although it was suggested that angiotensin II might be a possible ligand of mas 
(Jackson et al., 1988), others lines of evidence reported that angiotensin Il-induced 
activity in /wos-transfectants was not inhibited by the angiotensin antagonists [Sar\ 
Val5, Ala^]-ANG H and [Sar\ Val^]-ANG H (Metzger et al., 1994). Hence, it is still an 
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open question what is the functional ligand of mas. After knowing the functional 
ligand of mas, the investigation of its signaling mechanism and the development of 
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1. Solution I 
50 mM sucrose 
25 mM Tris-HCl, pH 8.0 
10inMEDTA,pH8.0 
lyzozyme (4 mg/ml solution I) 
2. Solution n 
0.2 N NaOH 
0.1% SDS 
3. Solution m 
3 M potassium acetate 
11.5 % (v/v) acetic acid 
4. Luria-Bertani (LB) medium 
lOg/LTrytone 




5. LB agar 
lOg/L Trytone 




6. Dialysis buffer 
10 mM Tris-HCl, pH 7.4 
150 mM NaCl 
10mMEDTA,pH8.0 
7. IX Cytomix buffer 
120mMKCl 
O.lSmMCaCk 
10 m M K2HPO4/KH2PO4, p H 7.6 
25mMHEPES, pH 7.6 
2mMEGTA,pH7.6 
5 mM MgCb 
8. Denaturation solution 
0.5 M NaOH 
1.5 M NaCl 
9. Neutralization solution 
0.5 M Tris/HCl pH7.5 




0.3 M sodium citrate, pH 7 
11. 0.5X TBE buffer 
45 mM Tris-borate 
1 mMEDTA 
12. 6X Gel-loading buffers 
0.25% bromophenol blue 
0.25% xylene cyanol FF 
30% glycerol in H2O 
13. Maleic acid buffer 
0.1 M maleic acid 
0.15 M NaCl; pH7.5 
14. Washing buffer 
0.1 M maleic acid 
0.15 M NaCl; pH7.5 
0.3 0/0 tween 20 
15. Detection buffer 
0.1 M NaCl 
0.1 MTris/HCl; pH9.5 
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16. NET solution 
0.1 MNaCl 
0.1 MTris/HCl, pH9.5 
O.OSMMgCb 
0.5 mg/ml NBT 
0.19 mg/ml BCIP 
17. lOX MOPS electrophoresis buffer 
200 mM 4-morpholinopropane-sulfonic acid 
50 mM sodium acetate, 10 mM EDTA，pH 7 
18. Alkaline transfer buffer 
3M NaCI 
O.OlMNaOH 
19. TE buffer 
10 mM Tris-Cl pH7.4 
1 mM EDTA 
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Appendix II 
Sequences of fluoroDD 
TMR-Anchored primers and 
arbitrary primers 
A. TMR-Anchored primers 
1. TMR-T7(dTi2)AP 1 (5//M) 
*-5 'ACGACTCACTATAGGGCTTTTTTTTTTTTGA 3 ’ 
2. TMR-T7(dTi2)AP2 (5 /zM) 
*-5^ACGACTCACTATAGGG€TTTTTTTTTTTTGC 3, 
3. TMR-T7(dTi2)AP3 (5 fi M) 
*-5'ACGACTCACTArAGGGCTTTTTTTTTTTTGG 3, 
4. TMR-T7(dTi2)AP4 (5 ji M) 
*-5^ACGACTCACTATAGGGCTTTTTTTTTTTTGT 3， 
5. TMR-T7(dTi2)AP5 (5 /z M) 
*-5, ACGACTCACTATAGGGCTTTTTTTTTTTTCA 3 ’ 
6. TMR-T7(dTi2)AP6 (5 ji M) 
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*-5’ACGACTCACTATAGGGCTTTTTTTTTTTTCC 3’ 
7. TMR-T7(dTi2)AP7 (5 // M ) 
*-5，ACGACTCACTArAGGGCTTTTTTTTTTTTCG 3' 
8. TMR-T7(dTi2)AP8 (5 (i M ) 
*-5' ACGACTC ACTATAGGGCTTTTTTTTTTTTAA 3， 
9. TMR-T7(dTi2)AP9 (5 j i M ) 
*-5'ACGACTCACTATAGGGCTTTTTTTTTTTTAC 3， 
10. TMR-T7(dTi2)AP10 (5 / z M ) 
*-5, ACGACTCACTATAGGGCTTTTTTTTTTTTAG 3 ’ 
11. TMR-T7(dTi2)AP 11 (5//M) 
*-5 'ACGACTCACTATAGGGCTTTTTTTTTTTTAT 3, 
12. TMR-T7(dTi2)AP12 (5/zM) 
*-5,ACGACTCACTATAGGGCTTTTTTTTTTTTCT 3， 
NOTE: The 17 nucleotides of the T7 promoter sequence are underlined. 
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B. Arbitrary primers (different set of four in each of the five HIEROGLYPH 
kits) 
HIEROGLYPH mRNA Profile Kit 1 (Cat. # 146081) 
13. M13r-ARP1(2//M) -5'ACAATTTCACACAGGACGACTCCAAG 3, 
14. M13r-ARP2(2/zM) -S^ACAATTTCACACAGGAGCTAGCATGG 3' 
15. M13r-ARP3(2"M) -5，ACAATTTCACACAGGAGACCATTGCA3, 
16. M13r-ARP4(2 //M) -5,ACAATTTCACACAGGAGCTAGCAGAC 3， 
HIEROGLYPH mRNA Profile Kit 2 (Cat. # 146082) 
13.M13r-ARP5(2//M) -5'ACAATTTCACACAGGAATGGTAGTCT 3, 
14. M13r-ARP6(2//M) -5'ACAATTTCACACAGGATACAACGAGG 3， 
15. M13r-ARP7(2//M) -S^ACAATTTCACACAGGATGGATTGGTC 3, 
16. M13r-ARP8(2//M) -5 ^  ACAATTTCACACAGGATGGTAAAGGG 3, 
HIEROGLYPH mRNA Profile Kit 3 (Cat. # 146083) 
13. M13r-ARP9(2 ji M) -5, AC AATTTC AC AC AGGATAAGACTAGC 3, 
14. M13r-ARP10(2/zM) -5 ’ AC AATTTC AC AC AGGAGATCTC AGAC 3 
15. M13r-ARP 11(2//M) -S'ACAATTTCACACAGGAACGCTAGTGT 3， 
16. M13r-ARP12(2//M) -5'ACAATTTCACACAGGAGGTACTAAGG 3， 
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HIEROGLYPH mRNA Profile Kit 4 (Cat. # 146084) 
13.M13r-ARP13(2/zM) -5'ACAATTTCACACAGGAGTTGCACCAr 3, 
14. M13r-ARP14(2"M) -5'ACAATTTCACACAGGATCCATGACTC 3, 
15. M13r-ARP15(2/iM) -5,ACAATTTCACACAGGACTTTCTACCC 3， 
16. M13r-ARP16(2/zM) -S'ACAATTTCACACAGGATCGGTCATAG 3' 
HIEROGLYPH mRNA Profile Kit 5 (Cat. # 146085) 
13. M13r-ARP17(2//M) -5,ACAATTTCACACAGGACTGCTAGGTA3, 
14. M13r-ARP18(2//M) -5'ACAATTTCACACAGGATGATGCTACC 3， 
15. M13r-ARP19(2/zM) -5'ACAATTTCACACAGGATTTTGGCTCC 3, 
16. M13r-ARP20(2//M) -S^ACAATTTCACACAGGATCGATACAGG 3' 
Note: The 16 nucleotides of the Ml 3 reverse (-48) sequence are underlined. 
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